"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_BURLOGAROFOLO",2000,70,7.42857142857143,2.95714285714286,0.542857142857143,0.385714285714286,0.542857142857143,1.58015267175573,1.15151515151515,1.28571428571429,1.11764705882353,0.228571428571429,3,32,3,3,30,0.46,0.04,0.04,0.43,53.21,1.17390553893438,NA,0.257142857142857,0.685714285714286,0.399,0.346,0.361,0.369,"TARCISIO NOT;SECONDO GUASCHINO;ALESSANDRO VENTURA;IRENE BERTI;ANTONIO AMOROSO;SÉRGIO CROVELLA;GIUSEPPE RICCI;GIUSEPPE TONINI;ANDREA SARTORE;ALESSIO FASANO;DANIELE SBLATTERO;DOROTI PIRULLI;MARINA CUTTINI;MARISA REBAGLIATO;GIANPAOLO MASO;R. NATALE;EVA GRIMALDI;ROBERTO MARZARI;ANDREW BRADBURY;LOREDANA LEPORE","7;7;6;5;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3","MARIE‐JOSÈPHE SAUREL‐CUBIZOLLES;SECONDO GUASCHINO;VALENTINA BALDAS;LUIGI PADUANO;LOREDANA LEPORE;TARCISIO NOT;ALESSANDRO VENTURA;GIUSEPPE TONINI;VALENTINA KIREN;GIUSEPPE RICCI;ANDREA SARTORE;SÉRGIO CROVELLA;GIANPAOLO MASO;R. NATALE;IRENE BERTI;PAOLO PERISSUTTI;STEFANO DA POZZO;ANTONIO AMOROSO;DANIELE SBLATTERO;M ANDOLINA","1.25;1.04;1;1;0.95;0.92;0.87;0.85;0.7;0.67;0.67;0.65;0.61;0.61;0.58;0.58;0.58;0.56;0.51;0.51","TARCISIO NOT;ALESSANDRO VENTURA;IRENE BERTI;ANTONIO AMOROSO;SÉRGIO CROVELLA;GIUSEPPE RICCI;GIUSEPPE TONINI;ANDREA SARTORE;ALESSIO FASANO;DANIELE SBLATTERO;DOROTI PIRULLI;MARINA CUTTINI;MARISA REBAGLIATO;GIANPAOLO MASO;R. NATALE;LOREDANA LEPORE;E. PRESANI;MICHELE BONIOTTO;MARCO RABUSIN;JAN PERSSON","7;6;5;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3","MARIE‐JOSÈPHE SAUREL‐CUBIZOLLES;VALENTINA BALDAS;LUIGI PADUANO;LOREDANA LEPORE;TARCISIO NOT;ALESSANDRO VENTURA;GIUSEPPE TONINI;VALENTINA KIREN;GIUSEPPE RICCI;ANDREA SARTORE;SÉRGIO CROVELLA;GIANPAOLO MASO;R. NATALE;IRENE BERTI;PAOLO PERISSUTTI;STEFANO DA POZZO;ANTONIO AMOROSO;DANIELE SBLATTERO;M ANDOLINA;DOROTI PIRULLI","1.25;1;1;0.95;0.92;0.87;0.85;0.7;0.67;0.67;0.65;0.61;0.61;0.58;0.58;0.58;0.56;0.51;0.51;0.51","GESINE HANSEN;JAN PERSSON;MARINA CUTTINI;MARISA REBAGLIATO;U. DE VONDERWEID;ALESSANDRO VENTURA;TARCISIO NOT;MICHELA NADAI;RICHARD DE LEEUW;MONIQUE KAMINSKI;RODOLFO SARACCI;ADIK LEVIN;AUDRŨNAS KUCINSKAS;ISTVÁN BERBIK;MARGARET REID;SYLVIE LENOIR;IRENE BERTI;CHIARA TREVISIOL;ANTONIO AMOROSO;ANDREW BRADBURY","861;861;861;861;861;727;726;619;619;616;616;487;487;487;487;487;478;477;438;406","U. DE VONDERWEID;ALESSANDRO VENTURA;TARCISIO NOT;MARINA CUTTINI;MICHELA NADAI;CHIARA TREVISIOL;ANTONIO AMOROSO;DANIELE SBLATTERO;ELENA NERI;STEFANO NERI;IRENE BERTI;ALBERTO TOMMASINI;ADIK LEVIN;AUDRŨNAS KUCINSKAS;GESINE HANSEN;ISTVÁN BERBIK;JAN PERSSON;MARCO SCHROELL;MARGARET REID;MARISA REBAGLIATO","861;727;726;619;619;477;438;406;319;273;263;262;245;245;245;245;245;245;245;245","TARCISIO NOT;ALESSANDRO VENTURA;ANTONIO AMOROSO;GIUSEPPE TONINI;SÉRGIO CROVELLA;ANDREA SARTORE;DANIELE SBLATTERO;DOROTI PIRULLI;GIUSEPPE RICCI;IRENE BERTI;LOREDANA LEPORE;CHIARA TREVISIOL;E. PRESANI;M ANDOLINA;MARCO RABUSIN;MICHELE BONIOTTO;U. DE VONDERWEID;ALBERTO TOMMASINI;ALESSIO FASANO;ANDREA SPANÒ","7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;SOCIOLOGY;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;ENGINEERING;ART;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY","60;36;7;6;5;4;3;3;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;SURGERY;BIOCHEMISTRY;OBSTETRICS;INTENSIVE CARE MEDICINE;PATHOLOGY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;ENVIRONMENTAL HEALTH;DEMOGRAPHY;ENDOCRINOLOGY;GYNECOLOGY;CELL BIOLOGY;DERMATOLOGY;OPTICS;CLINICAL PSYCHOLOGY;FAMILY MEDICINE;PSYCHIATRY","40;27;27;18;12;11;10;9;9;8;8;6;5;5;5;4;4;4;3;3;3","GENE;DISEASE;PREGNANCY;ANTIBODY;TRANSPLANTATION;BONE MARROW;POPULATION;CHEMOTHERAPY;ENZYME;IMMUNOPATHOLOGY;IN VITRO;INCIDENCE (GEOMETRY);BLOOD PRESSURE;CELL CULTURE;CHLAMYDIA;DIABETES MELLITUS;EPIDEMIOLOGY;HUMAN IMMUNODEFICIENCY VIRUS (HIV);KIDNEY;LEUKEMIA","17;12;9;8;8;7;6;5;4;4;4;4;3;3;3;3;3;3;3;3","COELIAC DISEASE;BONE MARROW TRANSPLANTATION;FETUS;MUTATION;TISSUE TRANSGLUTAMINASE;APLASTIC ANEMIA;AUTOIMMUNE DISEASE;GENE EXPRESSION;GESTATIONAL AGE;PHENOTYPE;BASAL (MEDICINE);CHILDBIRTH;CHROMOSOME;CYCLOPHOSPHAMIDE;EXON;GENOTYPE;INFERTILITY;INTRON;MYELODYSPLASTIC SYNDROMES;NEPHROPATHY;RECOMBINANT DNA;RNA;SEXUAL INTERCOURSE;THYROIDITIS","6;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ALTERNATIVE SPLICING;AUTOIMMUNE THYROIDITIS;BONE MARROW TRANSPLANT;COMPLEMENTATION;ENDOMYSIUM;HAPLOTYPE;RNA SPLICING;ACUTE LYMPHOCYTIC LEUKEMIA;ANTI-THYROID AUTOANTIBODIES;ASCUS (BRYOZOA);ATP-BINDING CASSETTE TRANSPORTER;CENTRAL PRECOCIOUS PUBERTY;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHROMATID;COLPOSCOPY;COMPLEMENT FACTOR B;CONDOM;CONNECTIVE TISSUE DISEASE;CYTOMEGALOVIRUS INFECTION;DONOR LYMPHOCYTE INFUSION;ENHANCER;FANCONI ANEMIA;FEMALE INFERTILITY;GROWTH HORMONE–RELEASING HORMONE;HERPESVIRIDAE;HUMAN UMBILICAL VEIN ENDOTHELIAL CELL;HYPOTHALAMIC HAMARTOMA;IN SITU HYBRIDIZATION;INTRAUTERINE GROWTH RESTRICTION;LIQUID-BASED CYTOLOGY;MIXED LYMPHOCYTE REACTION;OVARIAN CARCINOMA;P-GLYCOPROTEIN;PEDIATRIC TRAUMA;PENETRANCE;PLACENTA;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;PROBAND;PROMOTER;PROPIDIUM IODIDE;READING RATE;RHODAMINE 123;RIBONUCLEOPROTEIN;SEMEN ANALYSIS;SEROPREVALENCE;SISTER CHROMATIDS;SMALL FOR GESTATIONAL AGE;SOMATOTROPIC CELL;UMBILICAL ARTERY;UNEXPLAINED INFERTILITY;VENTRICULOMEGALY;VESICOURETERAL REFLUX;VILLOUS ATROPHY;VINCRISTINE","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ITALY;CELIAC DISEASE;BONE MARROW TRANSPLANTATION;;MIDDLE AGED;THYROIDITIS, AUTOIMMUNE;ANIMALS;ANTIBODIES;INFANT, NEWBORN;TRANSGLUTAMINASES;AGE FACTORS;ENZYME-LINKED IMMUNOSORBENT ASSAY;INFANT","59;34;24;23;22;17;16;14;13;12;11;10;8;7;7;7;7;6;6;6","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;HEMATOPOIETIC STEM CELL BIOLOGY;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;IMPACT OF MATERNAL MENTAL HEALTH ON OFFSPRING;MECHANISMS OF MULTIDRUG RESISTANCE IN CANCER;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;ADOLESCENT SEXUAL HEALTH AND BEHAVIOR PATTERNS;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;BLOOD-BRAIN BARRIER AND NEUROVASCULAR INTERACTIONS;CHRONIC KIDNEY DISEASE AND ITS IMPLICATIONS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DEVELOPMENT OF READING SKILLS AND DYSLEXIA;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIVERSITY AND FUNCTION OF GUT MICROBIOME;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES","9;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CELIAC DISEASE;TISSUE TRANSGLUTAMINASE;ADOLESCENT HEALTH;APLASTIC ANEMIA;GLUTEN SENSITIVITY;HEMATOPOIETIC CELL TRANSPLANTATION;TREATMENT OUTCOMES;AUTOIMMUNE THYROIDITIS;BASAL (MEDICINE);BONE MARROW TRANSPLANT;ENDOMYSIUM;EXON SKIPPING;FETAL GROWTH RESTRICTION;GOLD STANDARD (TEST);HEMATOPOIETIC STEM CELLS;INFANT MORTALITY;MINIGENE;MULTIDRUG RESISTANCE;OUTPATIENT CLINIC;PENETRANCE","5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","BONE MARROW;CELIAC DISEASE;MARROW TRANSPLANTATION;AUTOIMMUNE THYROIDITIS;CLINICAL OUTCOME;DIAGNOSTIC ASSAY;HUMAN RECOMBINANT;INNOVATIVE DIAGNOSTIC;MARROW TRANSPLANT;PRETERM INFANTS;RAPID DETECTION;RECOMBINANT TISSUE;TISSUE TRANSGLUTAMINASE;TRANSGLUTAMINASE ELISA;ABERRATIONS SISTER;ACUTE LYMPHOBLASTIC;ADULT POPULATION;ADULTS RELATIVES;ADVANCED EPITHELIAL;AGXT GENE;AIDS PROGRESSION;ALLOGENEIC BONE;ALTERNATIVE DRUGS;ANGIOTENSIN CONVERTING;ANTERIOR UVEITIS;ANTIBODY LIBRARIES;ANTIBODY REPERTOIRE;ARTIFICIAL NUTRITION;ASSOCIAZIONE ITALIANA;AUTOIMMUNE THROMBOCYTOPENIA","8;8;5;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TRIESTE ITALYSEARCH;BURLO GAROFOLO;IRCCS BURLO;GAROFOLO CHAIR;GENETIC SERVICE;GENETICS UNIVERSITY;MEDICAL GENETIC;PEDIATRIC CLINIC;SERVICE IRCCS;CLINIC UNIVERSITY;COELIAC DISEASE;DOT BLOT;GLYCOPROTEIN SYNDROME;ROME ITALYSEARCH;BLOT ASSAY;DI ROCCO;FLOW CYTOMETRY;SERENA VATTA;CATANIA ITALYSEARCH;FULL-TEXT VERSION;GASLINI INSTITUTE;GENOA ITALYSEARCH;GIANNINA GASLINI;IMMUNOSORBENT ASSAY;INSTITUTE GENOA;INSTITUTE UNIVERSITY;LA SAPIENZA;MILAN ITALYSEARCH;MONOCLONAL ANTIBODIES;NEUROLOGY PEDIATRIC","16;15;15;14;14;14;14;14;14;10;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4",8,0.11,8.71,7,4,1,0,1,4.75,0,1.5,7,0,0,5.5,0,5.25,0,1,4.75,0,0,0,103.75,103.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,19.5,151,1.65,0,0,1.5,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY","2;2;1","CANCER;CLINICAL RESEARCH;HEMATOLOGY;RARE DISEASES;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;TRANSPLANTATION;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;PEDIATRIC CANCER;PREVENTION","2;2;2;2;2;2;2;2;2;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM","2","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;MYELOMA;NOT SITE-SPECIFIC CANCER","2;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1",2,681226,54430.51,5,38,7.5,1,7,25890.3378378378,2.70371133966809,"IRCCS MATERNO INFANTILE BURLO GAROFOLO;ANDALUSIAN HEALTH SERVICE;ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;AZIENDA OSPEDALIERA DI PADOVA;BAMBINO GESÙ CHILDREN'S HOSPITAL;CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY;CATHOLIC UNIVERSITY OF THE SACRED HEART;CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT-PIERRE;CHILDREN'S HEALTH IRELAND AT CRUMLIN;DÉLÉGATION PARIS 11;EALING HOSPITAL NHS TRUST;ERASMUS MC;GUY'S AND ST THOMAS' NHS FOUNDATION TRUST;HEINRICH HEINE UNIVERSITY DÜSSELDORF;HOSPICES CIVILS DE LYON;HOSPITAL DE BASURTO;HOSPITAL DE DONA ESTEFÂNIA;HOSPITAL DEL MAR;HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN;HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","1;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CON - COORDINATION OF RESEARCH ACTIONS (FUNDING SCHEME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);TELETHON GRANT PROJECTS - 2000 (PROGRAM)","1;1;1","30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;50 PHILOSOPHY AND RELIGIOUS STUDIES;5001 APPLIED ETHICS","1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HIV/AIDS;INFECTIOUS DISEASES;PEDIATRIC","1;1;1;1;1","INFECTION","1","5.1 PHARMACEUTICALS;5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT);6.1 PHARMACEUTICALS;6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)","1;1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2001,49,5.91836734693878,2.57142857142857,0.551020408163265,0.428571428571429,0.551020408163265,1.55555555555556,1.35,1.61538461538462,1.42105263157895,0.183673469387755,4,16,17,3,11,0.33,0.35,0.06,0.22,23.16,0.506938803689517,NA,0.163265306122449,0.714285714285714,0.417,0.346,0.422,0.355,"ALESSANDRO VENTURA;CLARA RIZZARDI;M. MELATO;SECONDO GUASCHINO;ANTONIO MESSINEO;SERGIO FACCHINI;ANTONIO AMOROSO;FRANCESCO DE SETA;MARIA ANGELA RUSTICO;FULVIO PARENTIN;MICHELE BONIOTTO;SÉRGIO CROVELLA;GIUSEPPE RICCI;M. CANDUSSO;JOSEPH F. FITZGERALD;MARIO LIUBICH;MARINA CUTTINI;GIANPAOLO MASO;G. P. MANDRUZZATO;MARCELLO MORGUTTI","8;6;6;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2","CLARA RIZZARDI;FULVIO PARENTIN;M. MELATO;MARINA CUTTINI;ALESSANDRO VENTURA;BRUNO BEMBI;TORE NILSTUN;ANTONIO MESSINEO;SECONDO GUASCHINO;MARIA ANGELA RUSTICO;FRANCESCO DE SETA;M. CANDUSSO;SERGIO FACCHINI;THE EURONIC STUDY GROUP;JOSEPH F. FITZGERALD;ANTONIO AMOROSO;GIUSEPPE RICCI;GIORGIO TAMBURLINI;GIANPAOLO MASO;G. P. MANDRUZZATO","1.67;1.58;1.58;1.5;1.17;1;1;0.87;0.76;0.65;0.62;0.53;0.51;0.5;0.48;0.45;0.45;0.44;0.4;0.4","ALESSANDRO VENTURA;M. MELATO;SECONDO GUASCHINO;ANTONIO MESSINEO;SERGIO FACCHINI;ANTONIO AMOROSO;FRANCESCO DE SETA;MARIA ANGELA RUSTICO;FULVIO PARENTIN;MICHELE BONIOTTO;SÉRGIO CROVELLA;GIUSEPPE RICCI;M. CANDUSSO;JOSEPH F. FITZGERALD;MARIO LIUBICH;MARINA CUTTINI;GIANPAOLO MASO;G. P. MANDRUZZATO;MARCELLO MORGUTTI;SILVIA ZEZLINA","8;6;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2","FULVIO PARENTIN;M. MELATO;MARINA CUTTINI;ALESSANDRO VENTURA;BRUNO BEMBI;TORE NILSTUN;ANTONIO MESSINEO;SECONDO GUASCHINO;MARIA ANGELA RUSTICO;FRANCESCO DE SETA;M. CANDUSSO;SERGIO FACCHINI;JOSEPH F. FITZGERALD;ANTONIO AMOROSO;GIUSEPPE RICCI;GIORGIO TAMBURLINI;GIANPAOLO MASO;G. P. MANDRUZZATO;LEO FISCHER-TAMARO;Y. J. MEIR","1.58;1.58;1.5;1.17;1;1;0.87;0.76;0.65;0.62;0.53;0.51;0.48;0.45;0.45;0.44;0.4;0.4;0.4;0.4","GIORGIO TAMBURLINI;ANTÔNIO JLA CUNHA;ERIC A. F. SIMÕES;LULU MUHE;MARTIN WEBER;NATHANIEL F. PIERCE;PATRIA ANGOS;SHAMIM QAZI;TERRY NOLAN;ALESSANDRO VENTURA;ALBERTO TOMMASINI;ANDREW BRADBURY;DANIELE SBLATTERO;ENRICO TONGIORGI;FIORELLA FLORIAN;ROBERTO MARZARI;TARCISIO NOT;ANTONIO AMOROSO;FRANCESCO DE SETA;SECONDO GUASCHINO","397;387;387;387;387;387;387;387;387;292;186;186;186;186;186;186;186;81;79;79","GIORGIO TAMBURLINI;ALESSANDRO VENTURA;ALBERTO TOMMASINI;DANIELE SBLATTERO;TARCISIO NOT;FRANCESCO DE SETA;BRUNO BEMBI;A. BENETTONI;ANTONIO AMOROSO;SERGIO FACCHINI;GIUSEPPE RICCI;DAVIDE DE SANTO;SECONDO GUASCHINO;C. MARTINI;FOUROGH KATOUZIAN;GIOVANNI CIANA;GIOVANNI MARIA SEVERINI;ROSSANA BUSSANI;E. PANFILI;M. CANDUSSO","397;292;186;186;186;79;78;67;67;67;66;61;61;57;57;57;57;57;56;56","ALESSANDRO VENTURA;M. MELATO;ANTONIO MESSINEO;FRANCESCO DE SETA;ANTONIO AMOROSO;GIUSEPPE RICCI;SERGIO FACCHINI;A. BENETTONI;BRUNO BEMBI;DAVIDE DE SANTO;DOROTI PIRULLI;E. PANFILI;ELENA GIOLO;FULVIO PARENTIN;GIORGIO TAMBURLINI;M. CANDUSSO;MARCELLO MORGUTTI;MARINA CUTTINI;MARIO LIUBICH;MICHELE BONIOTTO","6;6;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;ENGINEERING;POLITICAL SCIENCE;COMPUTER SCIENCE;PHILOSOPHY;PHYSICS;SOCIOLOGY;BUSINESS;CHEMISTRY;ECONOMICS;GEOGRAPHY;PSYCHOLOGY","42;21;6;6;4;4;4;4;2;2;2;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;SURGERY;RADIOLOGY;IMMUNOLOGY;LAW;BIOCHEMISTRY;DERMATOLOGY;OBSTETRICS;PEDIATRICS;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;CARDIOLOGY;ENGINEERING ETHICS;GYNECOLOGY;LIBRARY SCIENCE;MECHANICAL ENGINEERING;SOCIAL SCIENCE;ASTROBIOLOGY;CELL BIOLOGY;ECONOMIC GROWTH;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;GASTROENTEROLOGY;HUMANITIES;MEDICAL EDUCATION;MEDICAL PHYSICS;MOLECULAR BIOLOGY;NURSING;OPERATING SYSTEM;PSYCHIATRY","19;14;12;11;9;6;6;5;5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","DISEASE;GENE;PREGNANCY;CANCER;ANTIBODY;ENZYME;HEALTH CARE;INFLAMMATION;ETHICAL ISSUES;HORMONE;HYPOXEMIA;INTENSIVE CARE;LESION;LUNG;LYMPHOMA;MAGNETIC RESONANCE IMAGING;MEDICAL ETHICS;MEDLINE;MULTIPLE MYELOMA;OXIDATIVE STRESS;PULMONARY FUNCTION TESTING;RADIOGRAPHY;REFRACTORY (PLANETARY SCIENCE);RELEVANCE (LAW);RESPIRATORY DISTRESS;THORACOTOMY;ULTRASONOGRAPHY;VENTILATION (ARCHITECTURE)","8;7;7;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FETUS;PHENOTYPE;AMYOTROPHIC LATERAL SCLEROSIS;BIRTH WEIGHT;CHEST RADIOGRAPH;COLORECTAL CANCER;CONGENITAL LOBAR EMPHYSEMA;CROHN'S DISEASE;GENE EXPRESSION;GENOTYPE;INFLAMMATORY BOWEL DISEASE;LUNG VOLUMES;LYMPHOPROLIFERATIVE DISORDERS;MANNAN-BINDING LECTIN;MEDIASTINAL SHIFT;MYCOSIS FUNGOIDES;PNEUMONECTOMY;PROINFLAMMATORY CYTOKINE;PSEUDOLYMPHOMA;THALIDOMIDE","4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLONOSCOPY;CUTANEOUS LYMPHOMA;FETAL GROWTH;GROWTH RESTRICTION;IN UTERO;INTRAUTERINE GROWTH RESTRICTION;ACID SPHINGOMYELINASE;AMNIOTIC FLUID;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;BORRELIA;BROMOCRIPTINE;COMPLEMENT FACTOR B;COMPLEMENT FACTOR I;COMPLEMENT MEMBRANE ATTACK COMPLEX;COMPLEMENTATION;DECAY-ACCELERATING FACTOR;DISMUTASE;ESOPHAGEAL SPHINCTER;FACTOR H;FOLLICLE-STIMULATING HORMONE;GENE MAPPING;GENETIC HETEROGENEITY;GENOMIC ORGANIZATION;GLYCOGEN DEBRANCHING ENZYME;GLYCOGEN STORAGE DISEASE TYPE I;GLYCOGEN STORAGE DISEASE TYPE II;HOMEOBOX;HRHIS;INTERNAL ANAL SPHINCTER;LUNG VOLUME REDUCTION SURGERY;MANNOSE RECEPTOR;OVARIAN PREGNANCY;OVULATION INDUCTION;PENICILLIN AMIDASE;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;PROMOTER;SOD1","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;MALE;;AMYOTROPHIC LATERAL SCLEROSIS;INFANT, NEWBORN;ITALY;INFERTILITY, FEMALE;PREGNANCY;CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL;LUNG;OVARY;PULMONARY EMPHYSEMA;ADOLESCENT;ALLERGENS;CELIAC DISEASE;CHILD;CHILD, PRESCHOOL;INTENSIVE CARE UNITS, NEONATAL","34;22;15;14;13;8;8;8;7;7;6;6;6;6;5;5;5;5;5;5","PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;CLASSIFICATION AND TREATMENT OF CUTANEOUS LYMPHOMAS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;ETHICAL CONSIDERATIONS IN PEDIATRIC MEDICAL DECISION-MAKING;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;CHOLESTEROL-LOWERING TREATMENT;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;COPPER AND ZINC IN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF ECTOPIC PREGNANCY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EMERGENCY DEPARTMENT CROWDING;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES","3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","AGGRESSIVE FIBROMATOSIS;CD30+ LYMPHOPROLIFERATIVE DISORDERS;CELIAC DISEASE;CHEST RADIOGRAPH;CONGENITAL LOBAR EMPHYSEMA;CROHN'S DISEASE;CUTANEOUS LYMPHOMA;CUTANEOUS LYMPHOMAS;DIAGNOSIS;DOPPLER ULTRASOUND;ETHICAL CONSIDERATIONS;FETAL GROWTH;FETAL GROWTH RESTRICTION;FETAL LUNG DEVELOPMENT;GROWTH RESTRICTION;INTRAUTERINE GROWTH RESTRICTION;LUNG VOLUME;LYMPHOPROLIFERATIVE DISORDERS;MEDIASTINAL SHIFT;MEDICAL ETHICS","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CLINICAL QUIZ;CELIAC DISEASE;CROHN DISEASE;DISEASE PRELIMINARY;GROWTH RESTRICTION;INTENSIVE CARE;INTERSTITIAL EMPHYSEMA;INTRAUTERINE GROWTH;LUNG VOLUME;NEONATAL INTENSIVE;PRELIMINARY RESULTS;PULMONARY INTERSTITIAL;REDUCTION SURGERY;SEVERE UNILATERAL;STICKLER SYNDROME;UNILATERAL PULMONARY;VITREOUS PHENOTYPE;VOLUME REDUCTION;ADHESION OFIBORRELIA;AL VITREOUS;ALUMINUM HYDROXIDE-ADSORBED;AMINO COMPOUNDS;AMNIOTIC FLUID;AMYOTROPHIC LATERAL;ANAL SPHINCTER;ATYPICAL FIBROXANTHOMA;AUTOANTIBODY RESPONSE;BIOLOGICAL FACTORS;BONE VELOCITY;BORIC ACID","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","LPA CONCENTRATIONS;CROHN DISEASE;CUTANEOUS PURPURA;OVARIAN PREGNANCY;REFRACTORY CROHN;SERUM LPA;ABDOMINAL PAIN;ABDOMINAL ULTRASOUND;ACTIVITY INDEX;AUTHORITY LEVELS;BASELINE LPA;CAPTION AVAILABLEFIG;CHILD HEALTH;COLICKY ABDOMINAL;CYCLE DAY;DISEASE ACTIVITY;ECTOPIC PREGNANCY;FACTOR ALPHA;GESTATIONAL SAC;HEALTH AUTHORITY;HEALTH INDICATOR;HEALTH INDICATORS;ILEOCECAL VALVE;INDICATOR SYSTEM;INDICATORS PROPOSED;INFERTILE WOMEN;INFLAMMATORY BOWEL;INITIAL PRESENTATION;INTESTINAL LYMPHOCYTES;INTRAPERITONEAL BLEEDING","8;6;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",7,0.14,3,2.5,0,0,0,0,5,0,3.25,3,0,0,1,0,1,0,0,1,0,0.5,0,59.5,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,6,95,1.25,0,0,27,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES","1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2002,67,7.47761194029851,2.73134328358209,0.388059701492537,0.462686567164179,0.417910447761194,1.63392857142857,1.18181818181818,1.40909090909091,1.16666666666667,0.26865671641791,1,23,13,5,22,0.34,0.19,0.07,0.33,39.6,0.717744071859429,NA,0.17910447761194,0.791044776119403,0.431,0.349,0.415,0.387,"ALESSANDRO VENTURA;SECONDO GUASCHINO;EVA GRIMALDI;R PREGAZZI;ANDREA SARTORE;GIUSEPPE RICCI;TARCISIO NOT;ALBERTO TOMMASINI;STEFANO MARTELOSSI;IRENE BERTI;SANDRA PERTICARARI;E. PRESANI;PAOLO BORTOLI;MANOLA COMAR;ROBERTO MARZARI;ANTONIO AMOROSO;FILIPPO ANSALDI;LOREDANA LEPORE;FRANCESCO DE SETA;IRENE BRUNO","11;10;7;7;7;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3","ALESSANDRO VENTURA;SECONDO GUASCHINO;GIUSEPPE TONINI;R PREGAZZI;ANDREA SARTORE;EVA GRIMALDI;GIUSEPPE RICCI;DANIELA CODRICH;ANTONIO MESSINEO;IRENE BERTI;STEFANO MARTELOSSI;SANDRA PERTICARARI;E. PRESANI;PAOLO BORTOLI;IRENE BRUNO;MARIA ANGELA RUSTICO;ALBERTO TOMMASINI;PAOLO TAMARO;C. CAMPELLO;AGOSTINO ACCARDO","1.76;1.57;1.2;1.14;1.14;1.09;0.96;0.83;0.83;0.72;0.69;0.65;0.65;0.64;0.62;0.59;0.57;0.56;0.54;0.53","ALESSANDRO VENTURA;SECONDO GUASCHINO;EVA GRIMALDI;R PREGAZZI;ANDREA SARTORE;GIUSEPPE RICCI;TARCISIO NOT;ALBERTO TOMMASINI;STEFANO MARTELOSSI;IRENE BERTI;SANDRA PERTICARARI;E. PRESANI;PAOLO BORTOLI;MANOLA COMAR;ANTONIO AMOROSO;FILIPPO ANSALDI;LOREDANA LEPORE;FRANCESCO DE SETA;IRENE BRUNO;ARMANDO SARTI","11;10;7;7;7;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3","ALESSANDRO VENTURA;SECONDO GUASCHINO;GIUSEPPE TONINI;R PREGAZZI;ANDREA SARTORE;EVA GRIMALDI;GIUSEPPE RICCI;DANIELA CODRICH;ANTONIO MESSINEO;IRENE BERTI;STEFANO MARTELOSSI;SANDRA PERTICARARI;E. PRESANI;PAOLO BORTOLI;IRENE BRUNO;MARIA ANGELA RUSTICO;ALBERTO TOMMASINI;PAOLO TAMARO;PAULA SAUD DE BORTOLI;A. BENETTONI","1.76;1.57;1.2;1.14;1.14;1.09;0.96;0.83;0.83;0.72;0.69;0.65;0.65;0.64;0.62;0.59;0.57;0.56;0.5;0.5","SECONDO GUASCHINO;TARCISIO NOT;IRENE BERTI;ALESSIO FASANO;CARLO CATASSI;GIOVANNI V. COPPA;PENELOPE BAMFORD;PINAKI PANIGRAHI;RAHZI EL ASMAR;CARLO PATRONO;BIANCA ROCCA;E. MELLONI;FRANCO O. RANELLETTI;GIORGIO ZAULI;GIOVANNI CIABATTONI;LIA GUIDOTTI;LUCIA CATANI;NICOLA MAGGIANO;PAOLA SECCHIERO;CESARE CAMPELLO","596;595;381;337;337;337;337;337;337;334;318;318;318;318;318;318;318;318;318;281","TARCISIO NOT;IRENE BERTI;SECONDO GUASCHINO;GIORGIO ZAULI;CESARE CAMPELLO;E. PRESANI;SANDRA PERTICARARI;ALBERTO TOMMASINI;ALESSANDRO VENTURA;FRANCESCO DE SETA;DAVIDE DE SANTO;PAOLO BORTOLI;GIOVANNI CIANA;M ANDOLINA;E. FRAGONAS;ELENA GIOLO;GIUSEPPE RICCI;S. CANOVA;BRUNO BEMBI;PIERLANFRANCO D’AGARO","572;381;372;318;281;223;223;222;206;197;193;179;139;127;117;117;117;117;115;115","ALESSANDRO VENTURA;ALBERTO TOMMASINI;STEFANO MARTELOSSI;ANDREA SARTORE;E. PRESANI;IRENE BERTI;SANDRA PERTICARARI;TARCISIO NOT;ARMANDO SARTI;CESARE CAMPELLO;FRANCESCO DE SETA;GIUSEPPE RICCI;IRENE BRUNO;PAOLO TAMARO;SECONDO GUASCHINO;BRUNO BEMBI;EGIDIO BARBI;ALDO SCABAR;C. MARTINI;CRISTIANA MALORGIO","9;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;SOCIOLOGY;MATHEMATICS;ENGINEERING;POLITICAL SCIENCE","56;36;7;5;5;4;4;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PATHOLOGY;SURGERY;BIOCHEMISTRY;GYNECOLOGY;ENDOCRINOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;MOLECULAR BIOLOGY;MICROBIOLOGY;OBSTETRICS;CELL BIOLOGY;VIROLOGY;NEUROSCIENCE;OPTICS;UROLOGY;ANESTHESIA;ARTIFICIAL INTELLIGENCE;AUDIOLOGY;CANCER RESEARCH;COGNITIVE PSYCHOLOGY;QUANTUM MECHANICS;SOCIAL SCIENCE","32;25;20;15;14;13;11;9;9;8;8;8;7;7;6;6;4;4;4;3;3;3;3;3;3;3","GENE;PREGNANCY;DISEASE;ANTIBODY;ENZYME;POPULATION;URINARY INCONTINENCE;CANCER;PELVIC FLOOR;FLOW CYTOMETRY;INCIDENCE (GEOMETRY);BACTERIA;CELL;IMMUNE SYSTEM;IN VITRO;STEM CELL;STROMAL CELL;VAGINA;VIRUS;ANTIBIOTICS;BACTERIAL VAGINOSIS;BIOPSY;BLOOD PRESSURE;BONE MARROW;ENDOTHELIUM;EPIDEMIOLOGY;GANGLIOSIDE;GESTURE;IMITATION;LOGISTIC REGRESSION;MODALITIES;MODALITY (HUMAN–COMPUTER INTERACTION);MOTOR SKILL;NONVERBAL COMMUNICATION;PATHOPHYSIOLOGY;PERINEUM;PLATELET;PUBLIC HEALTH;RECEPTOR;SECRETION;SENSORY SYSTEM;TUBERCULOSIS;URINARY SYSTEM;VACCINATION;VAGINITIS","13;11;9;8;8;7;6;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;ALLELE;FETUS;GENOTYPE;MONOCLONAL ANTIBODY;VAGINAL DELIVERY;INFLAMMATORY BOWEL DISEASE;PHENOTYPE;STRESS INCONTINENCE;TISSUE TRANSGLUTAMINASE;CD34;COELIAC DISEASE;COLORECTAL CANCER;EXON;HEPATITIS C VIRUS;HEXOSAMINIDASE;INNATE IMMUNE SYSTEM;PELVIC FLOOR DYSFUNCTION;PELVIC FLOOR MUSCLE;PROGENITOR CELL;RECOMBINANT DNA;STIMULUS MODALITY;TRANSFECTION;ULCERATIVE COLITIS;VAGINAL FLORA;VIRAL DISEASE","5;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLONOSCOPY;COMPOUND HETEROZYGOSITY;ENDOMYSIUM;POINT MUTATION;PRENATAL DIAGNOSIS;RADIOIMMUNOTHERAPY;7-DEHYDROCHOLESTEROL REDUCTASE;ACUTE LYMPHOCYTIC LEUKEMIA;ALLELE FREQUENCY;ALTERNATIVE SPLICING;AMNIOTIC FLUID;BURKHOLDERIA CEPACIA COMPLEX;COMPLEMENT MEMBRANE ATTACK COMPLEX;FLAVIVIRIDAE;FRACTAL ANALYSIS;FRAMESHIFT MUTATION;HAPLOTYPE;HBSAG;HEPACIVIRUS;INTERLEUKIN 21;LEPTOSPIRA INTERROGANS;MEGAKARYOCYTE;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MISSENSE MUTATION;MOLECULAR EPIDEMIOLOGY;MOLECULAR MEDICINE;NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;ONCOGENE;PARACELLULAR TRANSPORT;PLACENTA;PROPIDIUM IODIDE;RHODAMINE 123;RIBOTYPING;SACCADIC SUPPRESSION OF IMAGE DISPLACEMENT;SECOND TRIMESTER;SEMEN ANALYSIS;SYNOVIAL FLUID;THROMBOPOIETIN;TRANSVERSION;UMBILICAL ARTERY;VASCULOGENESIS;VIRAL VECTOR;X-INACTIVATION","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;;CHILD;ADOLESCENT;CELIAC DISEASE;TRANSGLUTAMINASES;URINARY INCONTINENCE, STRESS;CHILD, PRESCHOOL;INFANT;HEPATITIS C;ITALY;VAGINOSIS, BACTERIAL;AGED;GTP-BINDING PROTEINS;LEUKOCYTES;MIDDLE AGED;PREGNANCY","50;37;24;19;16;15;12;12;12;11;10;9;8;8;8;7;7;7;7;7","PELVIC FLOOR DISORDERS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DEVELOPMENTAL PERSPECTIVE ON MOTOR SKILL COMPETENCE;HEPATITIS C INFECTION AND TREATMENT;MENSTRUAL HEALTH AND DISORDERS;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ANESTHESIA AND SEDATION MANAGEMENT;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;BIOLOGICAL BASIS AND CLINICAL MANAGEMENT OF SYPHILIS;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;CHALLENGES AND INNOVATIONS IN BIOINFORMATICS EDUCATION;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;DIAGNOSIS AND MANAGEMENT OF ABDOMINAL TUBERCULOSIS;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC ESOPHAGITIS;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;EMERGENCY DEPARTMENT CROWDING","6;5;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","GLUTEN SENSITIVITY;PELVIC FLOOR DYSFUNCTION;STRESS INCONTINENCE;TISSUE TRANSGLUTAMINASE;ADOLESCENT AND YOUNG ADULT ONCOLOGY;BACTERIAL VAGINOSIS;CELIAC DISEASE;CHILDHOOD MOTOR SKILLS;COGNITIVE DEVELOPMENT;COMPOUND HETEROZYGOSITY;DEVELOPMENTAL COORDINATION DISORDER;DEVELOPMENTAL SURVEILLANCE;ENDOMYSIUM;FETAL DNA ANALYSIS;GANGLIOSIDE;HEXOSAMINIDASE;IMMUNOSCINTIGRAPHY;MODALITIES;MODALITY (HUMAN–COMPUTER INTERACTION);PANCOLITIS","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BOWEL DISEASE;CELIAC DISEASE;INFLAMMATORY BOWEL;ACUTE ABDOMEN;ANTIBODY IMMUNOSCINTIGRAPHY;ANTIGRANULOCYTE MONOCLONAL;BACTERIAL VAGINOSIS;DCD EFFECTS;FLOW CYTOMETRY;INPUT MODALITIES;LUPUS ERYTHEMATOSUS;MONOCLONAL ANTIBODY;POSTPARTUM PERINEAL;RISK FACTORS;SENSORY INPUT;SYSTEMIC LUPUS;ABNORMAL UMBILICAL;ACUTE LEUKEMIA;ADVANCED MOLECULAR;AIEOP PROSPECTIVE;AMNIOTIC FLUID;ANIMAL MODEL;ANTI-TISSUE TRANSGLUTAMINASE;ARTERY FLOW;AUTOIMMUNE DISORDERS;BACTERIAL EXPOSURE;BARRIER FUNCTION;BLADDER NECK;BONE DISEASE;BONE MARROW-DERIVED","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENOMIC DNA;VANIER MT;NIEMANN-PICK TYPE;LYMPH NODES;PENTCHEV PG;GENET -GOOGLE;NPC GENE;HEPATIC HILUM;PORTAL VEIN;BLANCHETTE-MACKIE EJ;MORRIS JA;NIEMANN-PICK DISEASE;PLANETARY HEALTH;POSTMENOPAUSAL WOMEN;ACUTE ABDOMEN;EXTRAPULMONARY TUBERCULOSIS;FORWARD PRIMER;HUM GENET;NPC PATIENTS;PORTAL HYPERTENSION;REVERSE PRIMER;TUBERCULOUS LYMPHADENITIS;VEIN THROMBOSIS;ABDOMINAL TUBERCULOSIS;ACTA -GOOGLE;BIOPHYS ACTA;CHOLESTEROL TRAFFICKING;MC VANIER;NEUFELD EB;PATTERSON MC","19;18;15;12;12;10;10;9;9;8;8;8;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6",10,0.15,6,4.75,1,2,0,0,7,0,1,4.75,0,0,3.25,1,1.5,0,1,3,1,0,0,52.25,52.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,24,3300,0.93,1,1,126,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROBLASTOMA;NEUROSCIENCES;PEDIATRIC;PREVENTION;RARE DISEASES","1;1;1;1;1;1;1;1","CANCER","1","6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","1;1;1","NEUROBLASTOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2003,56,7.51785714285714,2.51785714285714,0.428571428571429,0.464285714285714,0.428571428571429,1.38613861386139,1.09090909090909,1.44444444444444,1.09090909090909,0.178571428571429,3,25,10,5,12,0.45,0.18,0.09,0.21,82.23,1.55366338348712,NA,0.267857142857143,0.839285714285714,0.425,0.252,0.317,0.252,"SECONDO GUASCHINO;ALESSANDRO VENTURA;FEDERICO MARCHETTI;EVA GRIMALDI;SANDRA PERTICARARI;T. GERARDUZZI;EGIDIO BARBI;ANDREA SARTORE;ANTONIO AMOROSO;E. PRESANI;ANNA SAVOIA;PAOLO BORTOLI;ANDREA TINELLI;PAOLO GRESELE;MANOLA COMAR;IRENE BERTI;PAOLO GASPARINI;SABINA CAUCI;TARCISIO NOT;ACHILLE IOLASCON","8;5;4;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2","SECONDO GUASCHINO;FULVIO PARENTIN;MARZIA LAZZERINI;D DESANTO;PAOLO GASPARINI;EVA GRIMALDI;ANDREA SARTORE;SANDRA PERTICARARI;FEDERICO MARCHETTI;ANTONIO AMOROSO;CLARA RIZZARDI;EGIDIO BARBI;ALESSANDRO VENTURA;CLAUDIO TIRIBELLI;PAOLO PAOLUCCI;MAURO MELATO;M. MELATO;DOROTI PIRULLI;T. GERARDUZZI;PAOLO PERISSUTTI","1.38;1.33;1;1;0.83;0.78;0.78;0.67;0.64;0.64;0.58;0.57;0.56;0.5;0.5;0.5;0.5;0.5;0.5;0.44","SECONDO GUASCHINO;ALESSANDRO VENTURA;EVA GRIMALDI;SANDRA PERTICARARI;T. GERARDUZZI;EGIDIO BARBI;ANDREA SARTORE;ANTONIO AMOROSO;E. PRESANI;ANNA SAVOIA;PAOLO BORTOLI;MANOLA COMAR;IRENE BERTI;PAOLO GASPARINI;TARCISIO NOT;FULVIO PARENTIN;FILIPPO ANSALDI;LOREDANA LEPORE;DANIELA DE FLORENTIIS;GIOVANNI CIANA","8;5;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2","SECONDO GUASCHINO;FULVIO PARENTIN;MARZIA LAZZERINI;D DESANTO;PAOLO GASPARINI;EVA GRIMALDI;ANDREA SARTORE;SANDRA PERTICARARI;ANTONIO AMOROSO;EGIDIO BARBI;ALESSANDRO VENTURA;MAURO MELATO;M. MELATO;DOROTI PIRULLI;T. GERARDUZZI;PAOLO PERISSUTTI;G. DAL MOLIN;C. CAMPELLO;PAOLO BORTOLI;E. PRESANI","1.38;1.33;1;1;0.83;0.78;0.78;0.67;0.64;0.57;0.56;0.5;0.5;0.5;0.5;0.44;0.44;0.44;0.44;0.42","ALESSANDRO VENTURA;T. GERARDUZZI;TARCISIO NOT;ALESSIO FASANO;D. KRYSZAK;FABIOLA FORNAROLI;IRENE BERTI;IVOR D. HILL;JOSEPH A. MURRAY;KÁROLY HORVÁTH;MARY THORPE;MICHELLE PIETZAK;PETER H.R. GREEN;RICHARD B. COLLETTI;SANDRO DRAGO;STEFANO GUANDALINI;STEVEN S. WASSERMAN;YORAM ELITSUR;ANNA SAVOIA;CARLO L. BALDUINI","1985;1873;1721;1670;1670;1670;1670;1670;1670;1670;1670;1670;1670;1670;1670;1670;1670;1670;509;509","ALESSANDRO VENTURA;TARCISIO NOT;IRENE BERTI;T. GERARDUZZI;ANNA SAVOIA;GIORGIO ZAULI;ARIANNA GONELLI;ASSUNTA PANDOLFI;DANIELA MILANI;DAVIDE ZELLA;EDVIGE CARNEVALE;PAOLA SECCHIERO;STEFANO MARTELOSSI;SECONDO GUASCHINO;MARINA CUTTINI;PAOLO TAMARO;ELENA NERI;GIULIO ANDREA ZANAZZO;IRENE BRUNO;SANDRA PERTICARARI","1917;1721;1670;1670;509;407;291;291;291;291;291;291;284;240;145;144;135;135;135;132","SECONDO GUASCHINO;ALESSANDRO VENTURA;SANDRA PERTICARARI;ANNA SAVOIA;E. PRESANI;ALBERTO TOMMASINI;ANTONIO AMOROSO;BRUNO BEMBI;CESARE CAMPELLO;DANIELA DE FLORENTIIS;DAVIDE DE SANTO;DOROTI PIRULLI;EGIDIO BARBI;FILIPPO ANSALDI;FULVIO PARENTIN;G. CONOSCENTI;G. DAL MOLIN;GIORGIO ZAULI;GIOVANNI CIANA;IRENE BERTI","5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;SOCIOLOGY;BUSINESS;PSYCHOLOGY","51;33;10;4;2;2;1;1","GENETICS;INTERNAL MEDICINE;IMMUNOLOGY;BIOCHEMISTRY;GYNECOLOGY;SURGERY;MOLECULAR BIOLOGY;PATHOLOGY;DERMATOLOGY;OPTICS;OBSTETRICS;PEDIATRICS;MICROBIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;OPHTHALMOLOGY;VIROLOGY;CELL BIOLOGY;ENDOCRINOLOGY;FAMILY MEDICINE","25;24;13;10;10;10;8;8;7;7;6;6;5;4;4;4;4;3;3;3","GENE;PREGNANCY;DISEASE;ANTIBODY;ENZYME;EPIDEMIOLOGY;POPULATION;VIRUS;INCIDENCE (GEOMETRY);VAGINA;ANEMIA;ANTIGEN;APOPTOSIS;ARTHRITIS;BACTERIAL VAGINOSIS;BIOPSY;CANCER;DNA;EXACT TEST;FLOW CYTOMETRY;FOCUS (OPTICS);IN VITRO;INFLAMMATION;INTRACARDIAC INJECTION;PELVIC FLOOR;PROPOFOL;PROSPECTIVE COHORT STUDY;SIGNAL TRANSDUCTION;STEM CELL;URINARY INCONTINENCE","14;11;9;8;5;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;FETUS;GENOTYPE;ALLELE;GENE EXPRESSION;PHENOTYPE;TISSUE TRANSGLUTAMINASE;BORRELIA BURGDORFERI;CHROMOSOME;ERYTHROPOIESIS;EXON;GESTATIONAL AGE;MAPK/ERK PATHWAY;PELVIC FLOOR MUSCLE;STRESS INCONTINENCE;VAGINAL DELIVERY;WESTERN BLOT;ALKALINE PHOSPHATASE;AMPICILLIN;ANNEXIN;ANTIBIOTIC RESISTANCE;AUTOSOMAL RECESSIVE TRAIT;BIRTH WEIGHT;BONE DISEASE;BONE MINERAL;CARDIOMYOPATHY;CD19;CD34;CD8;CHEMOKINE;CHRONIC LIVER DISEASE;COELIAC DISEASE;CORPUS ALBICANS;CROHN'S DISEASE;CUMULATIVE INCIDENCE;DELAYED PUBERTY;DILATED CARDIOMYOPATHY;DNA DAMAGE;DYDROGESTERONE;ENDOTHELIAL STEM CELL;ENZYME REPLACEMENT THERAPY;ERYTHROMYCIN;ESCHERICHIA COLI;ETANERCEPT;FIRST-DEGREE RELATIVES;GARDNERELLA VAGINALIS;GENOMIC DNA;GESTATION;GLYCOGEN STORAGE DISEASE;HAEMATOPOIESIS;HAEMOPHILUS INFLUENZAE;HAZARD RATIO;HEALTH INDICATOR;HEPATITIS C VIRUS;HORMONE REPLACEMENT THERAPY (FEMALE-TO-MALE);HYPERURICEMIA;IMMUNOFLUORESCENCE;IMMUNOGLOBULIN G;INFANT MORTALITY;INFLAMMATORY BOWEL DISEASE;INFLIXIMAB;JUVENILE RHEUMATOID ARTHRITIS;LABIA MINORA;LARYNGOSPASM;LASER TREATMENT;LATANOPROST;LINEAGE (GENETIC);LIVER TRANSPLANTATION;LUNG DISEASE;LUPUS ERYTHEMATOSUS;LYMPHOBLASTIC LEUKEMIA;MESSENGER RNA;METASTASIS;MIDAZOLAM;NECK OF URINARY BLADDER;NEGATIVE STAIN;NEURAMINIDASE;OBSTETRICS AND GYNAECOLOGY;ODONTOGENIC MYXOMA;OLIGONUCLEOTIDE;PELVIC FLOOR DYSFUNCTION;PENICILLIN;PERIPHERAL BLOOD MONONUCLEAR CELL;PI3K/AKT/MTOR PATHWAY;PLASMAPHERESIS;POLYCLONAL ANTIBODIES;POLYMERASE CHAIN REACTION;PRIMARY HYPEROXALURIA;PROGRAMMED CELL DEATH;PROLIFERATING CELL NUCLEAR ANTIGEN;PROTEIN KINASE A;PROTEIN KINASE B;PROTOCOL (SCIENCE);REAL-TIME POLYMERASE CHAIN REACTION;RECOMBINANT DNA;RNA;SELECTIVE IGA DEFICIENCY;SENSORINEURAL HEARING LOSS;SEROLOGY;STAPHYLOCOCCUS AUREUS;STOP CODON;STREPTOCOCCUS PNEUMONIAE;SYSTEMIC DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS;TIBOLONE;TRANSPORTER;VAGINAL FLORA;VASCULAR ENDOTHELIAL GROWTH FACTOR;VULVOVAGINAL CANDIDIASIS","5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;BORRELIA;COMPOUND HETEROZYGOSITY;GENOTYPING;KARYOTYPE;ACUTE LYMPHOCYTIC LEUKEMIA;ALLELIC HETEROGENEITY;AMP RESISTANCE;ATAXIA-TELANGIECTASIA;ATP-BINDING CASSETTE TRANSPORTER;BACTERIAL OUTER MEMBRANE;BIMATOPROST;CANDIDA KRUSEI;CD3;CHEMOKINE RECEPTOR;CHROMATID;CHROMOSOME INSTABILITY;DNA METHYLATION;DNA MICROARRAY;ENDOMYSIUM;FAS RECEPTOR;GENE EXPRESSION PROFILING;GENE MUTATION;GENETIC HETEROGENEITY;GERMLINE MUTATION;GLYCOGEN STORAGE DISEASE TYPE II;HETEROZYGOTE ADVANTAGE;IMMUNOGLOBULIN A;INEFFECTIVE ERYTHROPOIESIS;LOSS OF HETEROZYGOSITY;MEGAKARYOCYTE;MOLECULAR EPIDEMIOLOGY;NEPHRONOPHTHISIS;OMPHALOCELE;OSTEOCALCIN;OSTEOPENIA;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PLACENTA;POINT MUTATION;PRIMARY TUMOR;PROPIDIUM IODIDE;SIALIDASE;SINGLE-STRAND CONFORMATION POLYMORPHISM;SJÖGREN SYNDROME;STREPTOCOCCUS PYOGENES;VASCULAR ENDOTHELIAL GROWTH FACTOR A","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;ADOLESCENT;CHILD;ITALY;MIDDLE AGED;CHILD, PRESCHOOL;URINARY INCONTINENCE, STRESS;AGED;CELIAC DISEASE;;BORRELIA BURGDORFERI;LYMPHOCYTES;ENDOTHELIUM, VASCULAR;INFANT;INFANT, NEWBORN;PREGNANCY;DNA MUTATIONAL ANALYSIS","47;32;19;17;16;16;14;14;13;11;10;10;9;8;8;7;7;7;7;6","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;PELVIC FLOOR DISORDERS;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;ANESTHESIA AND SEDATION MANAGEMENT;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;INFLUENZA VIRUS RESEARCH AND EPIDEMIOLOGY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF APOPTOSIS AND CELL DEATH;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;TICK-BORNE DISEASES AND PATHOGENS TRANSMISSION;;ATOPIC DERMATITIS AND SKIN MICROBIOME;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;CLASSIFICATION AND MANAGEMENT OF ODONTOGENIC TUMORS;CUTANEOUS ADNEXAL NEOPLASMS AND RELATED SYNDROMES;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;DIAGNOSIS AND TREATMENT OF RETINOPATHY OF PREMATURITY;EPIDEMIOLOGY AND CAUSES OF PRETERM BIRTH;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE","3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;TISSUE TRANSGLUTAMINASE;TREATMENT;AMNIOCENTESIS;CELIAC DISEASE;COMPOUND HETEROZYGOSITY;ECHOCARDIOGRAM GUIDELINES;ENDOSCOPIC SEDATION;ERYTHROPOIESIS;FETAL CARDIAC DISEASE;GLUTEN SENSITIVITY;LYME DISEASE;PAIN MANAGEMENT;PELVIC FLOOR DYSFUNCTION;PELVIC FLOOR MUSCLE;SEDATION;STRESS INCONTINENCE;;ABNORMALITY;ACUTE LYMPHOCYTIC LEUKEMIA","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","ASIAN PREGNANT;CELIAC DISEASE;ECHOGENIC FOCUS;IGARDNERELLA VAGINALISI;INTRACARDIAC ECHOGENIC;PELVIC FLOOR;PREGNANT WOMEN;PRIMARY HUMAN;VAGINAL DELIVERY;ACTUAL SURGICAL;ACUTE LYMPHOBLASTIC;ADVERSE PREGNANCY;ALPHA GLUCOSIDASE;ANALYSIS SYSTEM;ANTENATAL MANIFESTATION;ANTERIOR UVEITIS;ANTIBODIES EVALUATION;ANTIMICROBIAL RESISTANCE;APOPTOSIS CO-CULTURED;ARTICULAR SYNDROME;ATOPIC DERMATITIS;AUTOSOMAL DOMINANT;BACTERIAL VAGINOSIS;BECKWITHWIEDEMANN SYNDROME;BEWO CELLS;BONA FIDE;BONE MARKER;BORRELIA BURGDORFERI;BROMIDE LASER;BURGDORFERII EVADE","2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CERVICAL LENGTH;WEEKS GESTATION;ENDOTHELIAL CELLS;MAY-HEGGLIN ANOMALY;SEBASTIAN SYNDROME;EPSTEIN SYNDROME;FECHTNER SYNDROME;HCV INFECTION;PROBANDS AGED;WESTERN BLOT;ADHESION MOLECULE-;ANOMALY SEBASTIAN;ANTI-GVH IGA;BACTERIAL VAGINOSIS;BIRTH WEIGHT;BLOT ANALYSIS;C-MEDIATED KILLING;C-RESISTANT STRAINS;CANCER PATIENTS;DCM PATIENTS;DIGITAL TEST;DÖHLE-LIKE BODIES;ECHOCARDIOGRAPHIC ABNORMALITIES;ENDOTHELIAL CELL;EPIDURAL ANALGESIA;FIRSTDEGREE RELATIVES;FLOOR MUSCLE;FLOW CYTOMETRY;FOLLOWUP PERIOD;GESTATIONAL AGE","6;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",4,0.07,96.81,33.75,4,8,0,8.5,5,0,4,36,0,0,60,0,8,2,9,48,1,0.5,0,225.25,225.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2004,82,8.26829268292683,3.5,0.573170731707317,0.463414634146341,0.585365853658537,2.58558558558559,1.38235294117647,2.23529411764706,1.33333333333333,0.317073170731707,3,30,38,2,7,0.37,0.46,0.02,0.09,30.93,0.657267896368649,NA,0.280487804878049,0.74390243902439,0.471,0.453,0.508,0.529,"ALESSANDRO VENTURA;TARCISIO NOT;T. GERARDUZZI;STEFANO MARTELOSSI;ALBERTO TOMMASINI;I. GIUSEPPIN;FEDERICO MARCHETTI;FILIPPO ANSALDI;MARZIA LAZZERINI;EGIDIO BARBI;A. LENHARDT;ROBERTO MARZARI;ANTONIO AMOROSO;SÉRGIO CROVELLA;DANIELE SBLATTERO;VALENTINA BALDAS;GRAZIA DI LEO;BRUNO BEMBI;PIERLANFRANCO D’AGARO;PIETRO CROVARI","28;14;12;12;10;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5","ALESSANDRO VENTURA;T. GERARDUZZI;STEFANO MARTELOSSI;TARCISIO NOT;EGIDIO BARBI;MARINA CUTTINI;G DILEO;PRISCO MIRANDOLA;I. GIUSEPPIN;ALBERTO TOMMASINI;MARZIA LAZZERINI;SÉRGIO CROVELLA;FEDERICO MARCHETTI;MARCO PENNESI;LAURA TRAVAN;PAOLO GASPARINI;ANTONIO AMOROSO;BRUNO BEMBI;FILIPPO ANSALDI;E. E. N. NERI","3.57;1.59;1.5;1.44;1.34;1.09;1;1;0.99;0.9;0.88;0.85;0.82;0.79;0.79;0.76;0.76;0.73;0.67;0.67","ALESSANDRO VENTURA;TARCISIO NOT;T. GERARDUZZI;STEFANO MARTELOSSI;ALBERTO TOMMASINI;I. GIUSEPPIN;FEDERICO MARCHETTI;FILIPPO ANSALDI;MARZIA LAZZERINI;EGIDIO BARBI;A. LENHARDT;ANTONIO AMOROSO;SÉRGIO CROVELLA;VALENTINA BALDAS;GRAZIA DI LEO;BRUNO BEMBI;PIERLANFRANCO D’AGARO;CESARE CAMPELLO;FRANCESCO DE SETA;E. ZAMUNER","28;14;12;12;10;8;7;7;7;7;6;6;6;6;5;5;5;5;4;4","ALESSANDRO VENTURA;T. GERARDUZZI;STEFANO MARTELOSSI;TARCISIO NOT;EGIDIO BARBI;MARINA CUTTINI;G DILEO;PRISCO MIRANDOLA;I. GIUSEPPIN;ALBERTO TOMMASINI;MARZIA LAZZERINI;SÉRGIO CROVELLA;FEDERICO MARCHETTI;MARCO PENNESI;LAURA TRAVAN;PAOLO GASPARINI;ANTONIO AMOROSO;BRUNO BEMBI;FILIPPO ANSALDI;E. E. N. NERI","3.57;1.59;1.5;1.44;1.34;1.09;1;1;0.99;0.9;0.88;0.85;0.82;0.79;0.79;0.76;0.76;0.73;0.67;0.67","ALESSANDRO VENTURA;SÉRGIO CROVELLA;T. GERARDUZZI;TARCISIO NOT;GIORGIO TAMBURLINI;ALBERTO TOMMASINI;A. LENHARDT;DANIELE SBLATTERO;ROBERTO MARZARI;A MARMONT;ALAN TYNDALL;F ZINTL;IGOR LISUKOV;JAKOB PASSWEG;MAURIZIO MUSSO;VALENTINA BALDAS;DANIELA SANTON;STEFANO MARTELLOSSI;ANDREA SPANÒ;ANDREW BRADBURY","517;461;422;395;370;354;307;265;265;261;261;261;261;261;261;246;232;232;213;213","ALESSANDRO VENTURA;TARCISIO NOT;SÉRGIO CROVELLA;GIORGIO TAMBURLINI;EMANUELE NERI;IRENE BERTI;IRENE BRUNO;T. GERARDUZZI;PRISCO MIRANDOLA;M. RABUSIN;GIUSEPPE TONINI;GIOVANNI CIANA;ANTONIO AMOROSO;ALESSANDRA PONTILLO;ALBERTO TOMMASINI;PAOLO GASPARINI;FRANCESCO DE SETA;FEDERICO MARCHETTI;LOREDANA LEPORE;STEFANO MARTELOSSI","503;381;374;370;213;213;213;209;183;177;155;153;152;134;127;124;122;113;109;103","ALESSANDRO VENTURA;TARCISIO NOT;STEFANO MARTELOSSI;T. GERARDUZZI;ALBERTO TOMMASINI;I. GIUSEPPIN;EGIDIO BARBI;MARZIA LAZZERINI;FEDERICO MARCHETTI;FILIPPO ANSALDI;ANTONIO AMOROSO;A. LENHARDT;GRAZIA DI LEO;PIERLANFRANCO D’AGARO;BRUNO BEMBI;CESARE CAMPELLO;EMANUELE NERI;GIOVANNI CIANA;SECONDO GUASCHINO;VALENTINA BALDAS","26;13;12;11;9;8;7;7;7;6;6;5;5;5;4;4;4;4;4;4","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;ENGINEERING;PHILOSOPHY;SOCIOLOGY;ART;MATHEMATICS;ECONOMICS;GEOGRAPHY;HISTORY;MATERIALS SCIENCE;POLITICAL SCIENCE","71;32;12;8;6;4;3;3;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;IMMUNOLOGY;PATHOLOGY;SURGERY;VIROLOGY;ENDOCRINOLOGY;OPTICS;MOLECULAR BIOLOGY;PSYCHIATRY;FAMILY MEDICINE;HUMANITIES;OBSTETRICS;ASTROBIOLOGY;BIOINFORMATICS;DEMOGRAPHY;GYNECOLOGY;LIBRARY SCIENCE;NURSING","46;22;21;18;17;17;15;15;14;12;8;8;6;5;4;4;4;3;3;3;3;3;3","DISEASE;POPULATION;GENE;ENZYME;ANTIBODY;VIRUS;INCIDENCE (GEOMETRY);DIABETES MELLITUS;TRANSPLANTATION;BIOPSY;EMERGENCY DEPARTMENT;ERYTHROCYTE SEDIMENTATION RATE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);PREGNANCY;ANEMIA;ANTIGEN;EPIDEMIOLOGY;GLUTEN;IMMUNE SYSTEM;IN VITRO;MULTIPLE MYELOMA;PHYSICAL EXAMINATION;REFRACTORY (PLANETARY SCIENCE);UNIVERSITY HOSPITAL","29;19;17;12;9;9;8;6;6;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","TISSUE TRANSGLUTAMINASE;COELIAC DISEASE;MUTATION;PEDIATRIC GASTROENTEROLOGY;INFLAMMATORY BOWEL DISEASE;AUTOANTIBODY;GENOTYPE;PHENOTYPE;ULCERATIVE COLITIS;AZATHIOPRINE;EXON;GLUTEN FREE;HEMAGGLUTININ (INFLUENZA);HEMATOPOIETIC STEM CELL TRANSPLANTATION;LINEAGE (GENETIC);PHYLOGENETIC TREE;THALIDOMIDE;VIRAL DISEASE;ALLELE;AUTOLOGOUS STEM-CELL TRANSPLANTATION;COMPLEMENT SYSTEM;DEFENSIN;GESTATION;GLIADIN;IMMUNOGLOBULIN G;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLIXIMAB;INFLUENZA A VIRUS;LIVER TRANSPLANTATION;MANNAN-BINDING LECTIN;MUTANT;NEURAMINIDASE;POLYMERASE CHAIN REACTION","8;7;7;7;6;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ENDOMYSIUM;HERPESVIRIDAE;BETA DEFENSIN;CORONAVIRUS DISEASE 2019 (COVID-19);FICOLIN;GESTATIONAL DIABETES;IMMUNOGLOBULIN A;MISSENSE MUTATION;POINT MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;ACCIDENTAL POISONING;ACID SPHINGOMYELINASE;ALPHA-GALACTOSIDASE;ALTERNATIVE COMPLEMENT PATHWAY;AMPLICON;ANENCEPHALY;ANTI-THYROID AUTOANTIBODIES;ANTIBODY OPSONIZATION;ANTIGENIC DRIFT;AUTOIMMUNE THYROIDITIS;BILIARY ATRESIA;BK VIRUS;CLADE;CLASSICAL COMPLEMENT PATHWAY;CLINICAL PHENOTYPE;COLLECTIN;COMPOUND HETEROZYGOSITY;CORRELATION DIMENSION;CROHN DISEASE;CYSTINE;DISABILITY-ADJUSTED LIFE YEAR;DNA MICROARRAY;EVANS SYNDROME;FAMILY PLANNING;FLUDARABINE;FLUORESCENCE IN SITU HYBRIDIZATION;FRACTAL ANALYSIS;FRAMESHIFT MUTATION;GENE EXPRESSION PROFILING;GENE MUTATION;GENE ONTOLOGY;GENOTYPING;GITELMAN SYNDROME;HEMORRHAGIC CYSTITIS;INFLAMMATORY BOWEL DISEASES;INTERLEUKIN 21;JC VIRUS;MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS;MICROARRAY ANALYSIS TECHNIQUES;MICROHEMATURIA;MICROSCOPIC HEMATURIA;MOLECULAR EPIDEMIOLOGY;MUTANT PROTEIN;ORTHOMYXOVIRIDAE;OSTEOCALCIN;PARACELLULAR TRANSPORT;PHARMACOGENETICS;PROBAND;PYRAZINAMIDE;THIOPURINE METHYLTRANSFERASE;UMBILICAL CORD BLOOD TRANSPLANTATION;WILD TYPE","3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;;MALE;CELIAC DISEASE;CHILD;ITALY;ADULT;CHILD, PRESCHOOL;ADOLESCENT;INFANT;MUTATION;TRANSGLUTAMINASES;LUPUS ERYTHEMATOSUS, SYSTEMIC;ANIMALS;AUTOANTIBODIES;NIEMANN-PICK DISEASES;VAGINA;IMMUNOGLOBULIN A;INFANT, NEWBORN","49;32;31;25;22;18;18;17;16;15;14;11;11;9;7;7;7;7;6;6","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;INFLUENZA VIRUS RESEARCH AND EPIDEMIOLOGY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;ETHICAL CONSIDERATIONS IN PEDIATRIC MEDICAL DECISION-MAKING;IMPACT OF GESTATIONAL DIABETES MELLITUS ON PREGNANCY;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;ANALYSIS OF GENE INTERACTION NETWORKS;ANESTHESIA AND SEDATION MANAGEMENT;AUTOIMMUNE ENCEPHALITIS: CLINICAL CHARACTERISTICS AND MANAGEMENT;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF ABDOMINAL TUBERCULOSIS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS","13;4;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","DIAGNOSIS;TISSUE TRANSGLUTAMINASE;GLUTEN SENSITIVITY;PEDIATRIC GASTROENTEROLOGY;CELIAC DISEASE;ERYTHROCYTE SEDIMENTATION RATE;ENDOMYSIUM;GLUTEN FREE;INFLAMMATION;LINEAGE (GENETIC);REFRACTORY (PLANETARY SCIENCE);AUTOLOGOUS STEM-CELL TRANSPLANTATION;BETA DEFENSIN;CYTOMEGALOVIRUS;DIABETES;ETIOLOGY;FICOLIN;GESTATIONAL DIABETES MELLITUS;GLIADIN;IMMUNOGLOBULIN A","8;8;7;7;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","BOWEL DISEASE;INFLAMMATORY BOWEL;CELIAC DISEASE;COELIAC DISEASE;DISEASE IBD;CLINICAL QUIZ;NORTHERN ITALY;TRANSGLUTAMINASE ANTIBODIES;ADULT CELIAC;ANTI TRANSGLUTAMINASE;ANTIENDOMISIUM ANTIBODIES;CELIAC POPULATION;CELL TRANSPLANTATION;DIABETES UNIVERSAL;DIAGNOSED CELIAC;DISEASE CD;GESTATIONAL DIABETES;HEALTHY STATUS;HLA DQ;IGA NEPHROPATY;ITALIAN PATIENTS;ITALY RESULTS;LATE DIAGNOSED;LUPUS ERYTHEMATOSUS;NATIONAL REGISTRER;PAEDIATRIC INFLAMMATORY;PATIENTS TESTED;PEDIATRIC DEPARTMENT;SELECTIVE SCREENING;SERIES COLLECTED","8;8;6;5;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CELIAC DISEASE;PATIENTS AFFECTED;HEALTHY CONTROLS;CD PATIENTS;COELIAC DISEASE;HIV- INFECTION;ACTIVE EUTHANASIA;CELIAC PATIENTS;GLUTEN-FREE DIET;HLA DQ;ACE INHIBITORS;AUTOLOGOUS ALLOGENEIC;DISEASE CD;DNA SEQUENCES;ENDOMETRIAL THICKNESS;FRACTAL DIMENSION;HIV--POSITIVE CHILDREN;MEDIAN RANGE;PAEDIATRIC POPULATION;PATIENTS TESTED;SEVERE OBSTETRIC;SV DNA;TESTING POSITIVE;ABNORMAL BLEEDING;ALLELE FREQUENCIES;ANTIMICROBIAL PEPTIDES;AUTOSOMAL RECESSIVE;BETA DEFENSIN;BURLO GAROFOLO;COX- POSITIVITY","11;11;8;7;7;7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3",9,0.11,6,4,0,0,0,1,15,1,2,15,0,0,0,0,1,0,0,0,0,0,0,42,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,16394,1.02,0,0,2,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3213 PAEDIATRICS","1;1","HEMATOLOGY;INFECTIOUS DISEASES;PEDIATRIC;PREVENTION;SEPSIS","1;1;1;1;1","INFECTION","1",NA,NA,NA,NA,NA,NA,1,183388,36677.6,3,5,1,1,8,14875.7045045045,5.51234396832564,"ENTE OSPEDALIERO OSPEDALI GALLIERA;IRCCS MATERNO INFANTILE BURLO GAROFOLO;THE SAN RAFFAELE TELETHON INSTITUTE FOR GENE THERAPY;UNIVERSITY OF BRESCIA;UNIVERSITY OF FLORENCE","1;1;1;1;1","TELETHON FOUNDATION","1",NA,NA,"TELETHON GRANT PROJECTS - 2004 (PROGRAM)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY","1;1","AUTOIMMUNE DISEASE;CLINICAL RESEARCH;GENETICS;NEURODEGENERATIVE;PEDIATRIC;TRANSPLANTATION","1;1;1;1;1;1",NA,NA,"2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2005,79,7.91139240506329,2.59493670886076,0.430379746835443,0.455696202531646,0.443037974683544,1.91588785046729,1.13333333333333,2,1.20689655172414,0.354430379746835,5,36,22,7,10,0.46,0.28,0.09,0.13,42.24,0.797837768852566,NA,0.265822784810127,0.784810126582278,0.508,0.345,0.394,0.356,"ALESSANDRO VENTURA;SÉRGIO CROVELLA;TARCISIO NOT;BRUNO BEMBI;SECONDO GUASCHINO;EGIDIO BARBI;ALBERTO TOMMASINI;GIANPAOLO MASO;FEDERICO MARCHETTI;MICHELE BONIOTTO;PAOLO PERISSUTTI;ADRIANO CATTANEO;FRANCESCO DE SETA;ARMANDO SARTI;AGOSTINO ACCARDO;ALESSIO FASANO;FLORIANA ZENNARO;MARÍA GABRIELA PITTIS;FRANCESCA PANERARI;GLÓRIA PELIZZO","11;9;7;7;7;6;6;5;5;5;5;4;4;4;4;4;4;4;3;3","SERGIO DEMARINI;ADRIANO CATTANEO;PAOLO PERISSUTTI;ALESSANDRO VENTURA;SECONDO GUASCHINO;SÉRGIO CROVELLA;STEFANO MARTELLOSSI;MARCO PENNESI;BRUNO BEMBI;VALENTINA BALDAS;AGOSTINO ACCARDO;G. DAL MOLIN;EGIDIO BARBI;STEFANO PENSIERO;FEDERICO MARCHETTI;ARMANDO SARTI;FRANCESCA PANERARI;MICHELE BONIOTTO;ALBERTO TOMMASINI;FULVIO PARENTIN","2;1.69;1.67;1.5;1.45;1.38;1.17;1.11;1.09;1.08;1.08;1;0.99;0.92;0.87;0.84;0.81;0.78;0.76;0.75","ALESSANDRO VENTURA;SÉRGIO CROVELLA;TARCISIO NOT;BRUNO BEMBI;SECONDO GUASCHINO;EGIDIO BARBI;ALBERTO TOMMASINI;GIANPAOLO MASO;FEDERICO MARCHETTI;MICHELE BONIOTTO;PAOLO PERISSUTTI;ADRIANO CATTANEO;FRANCESCO DE SETA;ARMANDO SARTI;ALESSIO FASANO;FLORIANA ZENNARO;MARÍA GABRIELA PITTIS;FRANCESCA PANERARI;GLÓRIA PELIZZO;LUCA RONFANI","11;9;7;7;7;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3","SERGIO DEMARINI;ADRIANO CATTANEO;PAOLO PERISSUTTI;ALESSANDRO VENTURA;SECONDO GUASCHINO;SÉRGIO CROVELLA;STEFANO MARTELLOSSI;MARCO PENNESI;BRUNO BEMBI;VALENTINA BALDAS;G. DAL MOLIN;EGIDIO BARBI;STEFANO PENSIERO;FEDERICO MARCHETTI;ARMANDO SARTI;FRANCESCA PANERARI;MICHELE BONIOTTO;ALBERTO TOMMASINI;FULVIO PARENTIN;GIORGIO TAMBURLINI","2;1.69;1.67;1.5;1.45;1.38;1.17;1.11;1.09;1.08;1;0.99;0.92;0.87;0.84;0.81;0.78;0.76;0.75;0.75","TARCISIO NOT;FRANCESCO ZULIAN;IVAN FOELDVARI;A. FASANO;A. SAPONE;ANTONIO CARROCCIO;CARLO CATASSI;CINZIA D'AGATE;GIUSEPPE IACONO;LUCIA ZAMPINI;MANJUSHA THAKAR;MARIA GRAZIA CLEMENTE;MARIAROSARIA DI PIERRO;RAMZI EL ASMAR;SANDRO DRAGO;LOREDANA LEPORE;A. M. NELSON;ANDREA PESERICO;BALU H. ATHREYA;CARLA DE MORAES MACHADO","834;513;513;459;459;459;459;459;459;459;459;459;459;459;459;442;424;424;424;424","TARCISIO NOT;LOREDANA LEPORE;ALESSIO FASANO;ANNA SAPONE;IRENE BERTI;RONALD H. ZIELKE;T. GERARDUZZI;TAMMARA L. WATTS;M ANDOLINA;SÉRGIO CROVELLA;BRUNO BEMBI;ALESSANDRO VENTURA;ADRIANO CATTANEO;GIANPAOLO MASO;FRANCESCO DE SETA;ANTONIO AMOROSO;EGIDIO BARBI;ORIANO RADILLO;G. D’OTTAVIO;ANDREA SARTORE","834;442;303;303;303;303;303;303;224;209;207;198;197;185;152;123;111;111;110;107","ALESSANDRO VENTURA;SÉRGIO CROVELLA;BRUNO BEMBI;TARCISIO NOT;ALBERTO TOMMASINI;EGIDIO BARBI;GIANPAOLO MASO;PAOLO PERISSUTTI;ADRIANO CATTANEO;FLORIANA ZENNARO;MARÍA GABRIELA PITTIS;MICHELE BONIOTTO;SECONDO GUASCHINO;G. D’OTTAVIO;LOREDANA LEPORE;FRANCESCO DE SETA;STEFANO PENSIERO;FEDERICO MARCHETTI;VALENTINA BALDAS;ANDREA DARDIS","10;9;7;7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;BUSINESS;MATHEMATICS;HISTORY;SOCIOLOGY","67;49;7;4;4;3;3;3;3;2;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;SURGERY;PATHOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;AUDIOLOGY;GASTROENTEROLOGY;CELL BIOLOGY;MICROBIOLOGY;MOLECULAR BIOLOGY;OBSTETRICS;OPTICS;ANESTHESIA;ENVIRONMENTAL HEALTH;GYNECOLOGY;PHYSIOLOGY;ANATOMY;CARDIOLOGY;COMPUTATIONAL BIOLOGY;DERMATOLOGY;ECONOMIC GROWTH;INTENSIVE CARE MEDICINE;NURSING;ONCOLOGY;OPHTHALMOLOGY;PHARMACOLOGY;PSYCHIATRY;RADIOLOGY","42;35;20;18;16;12;11;10;6;6;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","GENE;DISEASE;PREGNANCY;ANTIBODY;CHEMOTHERAPY;ENZYME;INTESTINAL PERMEABILITY;BLOOD PRESSURE;EYE MOVEMENT;HORMONE;POPULATION;TIGHT JUNCTION;ADVERSE EFFECT;BREASTFEEDING;COHORT;EPIDEMIOLOGY;FAMILY HISTORY;GLUTEN;HUMAN IMMUNODEFICIENCY VIRUS (HIV);ANTIBIOTICS;BACTERIAL VAGINOSIS;BIOPSY;CALCIUM;CANCER;CONFIDENCE INTERVAL;DIABETES MELLITUS;ENAMEL PAINT;HEALTH CARE;HEARING LOSS;HYDROCORTISONE;IDENTIFICATION (BIOLOGY);IMMUNE SYSTEM;IN VIVO;INCIDENCE (GEOMETRY);INTESTINAL MUCOSA;KIDNEY;LECTIN;LEUKEMIA;MEMBRANE;NAUSEA;OBSERVATIONAL STUDY;OSTEOPOROSIS;OTITIS;PAST MEDICAL HISTORY;PROSPECTIVE COHORT STUDY;PSYCHOLOGICAL INTERVENTION;REGIMEN;TOXIN;TRANSPLANTATION;ULTRASOUND;URINARY SYSTEM;VIRUS;VITAMIN D AND NEUROLOGY","22;14;14;8;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GENOTYPE;MUTATION;GESTATION;ALLELE;AUTOIMMUNE DISEASE;HEART RATE;LOW BIRTH WEIGHT;OCCLUDIN;SACCADIC MASKING;B CELL;BONE MASS;BONE MINERAL;CHROMOSOME;DEMINERALIZATION;FETUS;FLUDROCORTISONE;GENE EXPRESSION;GESTATIONAL AGE;GLIADIN;GROWTH HORMONE;HYPEREMESIS GRAVIDARUM;MANNAN-BINDING LECTIN;METABOLIC BONE DISEASE;RECOMBINANT DNA;RICKETS;SEROLOGY;TISSUE TRANSGLUTAMINASE","6;6;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GENOTYPING;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;IMMUNOGLOBULIN D;KARYOTYPE;MISSENSE MUTATION;OSTEOPENIA;POLYMORPHISM (COMPUTER SCIENCE);ACCESSORY SPLEEN;ACID SPHINGOMYELINASE;ALPHA (FINANCE);ANTIRETROVIRAL THERAPY;AUTONOMIC NERVOUS SYSTEM;CD3;CHLAMYDOPHILA PNEUMONIAE;CHROMATIN REMODELING;CHROMOSOME 7 (HUMAN);CHROMOSOME INSTABILITY;COMPOUND HETEROZYGOSITY;CONNECTIVE TISSUE DISEASE;CONNEXIN;FETAL HEAD;FETAL MOVEMENT;HEART RATE VARIABILITY;HERPESVIRIDAE;MULTIPLEX POLYMERASE CHAIN REACTION;MUTANT PROTEIN;NOD MICE;OMPHALOCELE;OVARIAN CARCINOMA;PARACELLULAR TRANSPORT;PHARMACOGENETICS;PIN1;PNEUMOCYSTIS PNEUMONIA;PRENATAL DIAGNOSIS;PROMOTER;REGULATORY SEQUENCE;RNA SPLICING;SIALIDASE;SINGLE-NUCLEOTIDE POLYMORPHISM;SOMATOTROPIC CELL;THIOPURINE METHYLTRANSFERASE;TOTAL BODY IRRADIATION;TRANSCRIPTIONAL REGULATION;VARIANTS OF PCR;VO2 MAX;WILD TYPE","4;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;ITALY;ADULT;CHILD, PRESCHOOL;;GAUCHER DISEASE;INFANT;ADOLESCENT;GENETIC PREDISPOSITION TO DISEASE;INFANT, NEWBORN;MANNOSE-BINDING LECTIN;ANIMALS;DNA MUTATIONAL ANALYSIS;IMMUNOSUPPRESSIVE AGENTS;PREGNANCY;HIV INFECTIONS;IMMUNOGLOBULIN G","61;41;34;22;20;19;18;16;14;13;12;11;11;10;9;9;9;9;8;8","LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;BLOOD RHEOLOGY AND COAGULATION MECHANISMS;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF ADRENAL INSUFFICIENCY;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LYMPHOID NEOPLASMS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;ANESTHESIA AND SEDATION MANAGEMENT;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;CALCINEURIN-NFAT SIGNALING IN TRANSCRIPTIONAL REGULATION;CLASSIFICATION AND MANAGEMENT OF ODONTOGENIC TUMORS;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DEUTERIUM INCORPORATION IN PHARMACEUTICAL RESEARCH","8;6;4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","INTESTINAL PERMEABILITY;GAUCHER DISEASE;GLUTEN SENSITIVITY;TREATMENT;CELIAC DISEASE;OCCLUDIN;BACTERIAL VAGINOSIS;FLUDROCORTISONE;GLIADIN;GLUCOCEREBROSIDASE MUTATIONS;HYDROCORTISONE TREATMENT;HYPEREMESIS GRAVIDARUM;IDENTIFICATION (BIOLOGY);IMMUNOGLOBULIN D;INTESTINAL MUCOSA;METABOLIC BONE DISEASE;OSTEOPENIA;OVARIAN CANCER;PAST MEDICAL HISTORY;PRENATAL DIAGNOSIS","5;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CELIAC DISEASE;ITALIAN PATIENTS;ADDISONS DISEASE;ANIMAL MODEL;AUTOIMMUNE DISEASES;CELL LINES;CELL TRANSPLANTATION;DISEASE CHOOSING;ESAPEPTIDE MODIFIES;GAUCHER DISEASE;GAUCHERS DISEASE;HEART RATE;HYPER-IGD SYNDROME;HYPOTHYROIDISM UNTREATED;INTESTINAL CELL;INTESTINAL MUCOSA;INTESTINAL PERMEABILITY;PHOSPHORUS NUTRITION;PRETERM INFANTS;SEROLOGICAL SCREENING;STEM CELL;SYNTHETIC ESAPEPTIDE;TOXIN SYNTHETIC;TWENTY-FOUR WEEKS;ABDOMINAL DEFECT;ABERRANT RNA;ACID -GLUCOSIDASE;ACUTE OTITIS;ADVANCED OVARIAN;ALLELE SPECIFIC","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","ADDISONS DISEASE;BLOOD PRESSURE;CORTISONE ACETATE;PGML RI;HR CI;INTESTINAL PERMEABILITY;MGDL RI;TSH MILLIUNITSML;RENAL GLUCOSURIA;ACETATE MGDAILY;ALDOSTERONE PGML;ELECTROLYTE LEVELS;FETAL THYROID;FLUDROCORTISONE MG;GESTATIONAL AGE;HELICOBACTER PYLORI;SERUM CORTISOL;SODIUM THYROXIN;THYROID HORMONES;USER FEES;NOD MICE;ZONULIN RELEASE;CORTISOL LEVELS;FETAL CORTISOL;FT NG;FT PGML;HAND MOVEMENTS;III QUARTILES;INCREASED INTESTINAL;INCREASING DOSES","14;12;10;10;8;8;8;8;7;6;6;6;6;6;6;6;6;6;6;6;5;5;4;4;4;4;4;4;4;4",16,0.2,6,3.25,40,3,2,3,5,1,2,3.25,0,1,41,7.75,2,0,8,34.5,5,0,0,94.25,86.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,1.01,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES","1;1;1",NA,NA,"ORAL AND GASTROINTESTINAL","1","6.1 PHARMACEUTICALS","1","COLON AND RECTAL CANCER","1","1.1 NORMAL FUNCTIONING","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2006,76,9.13157894736842,3.55263157894737,0.5,0.5,0.5,1.74193548387097,1.1875,1.80952380952381,1.1875,0.184210526315789,2,34,27,5,6,0.45,0.36,0.07,0.08,36.51,0.71484807142428,NA,0.276315789473684,0.763157894736842,0.394,0.287,0.424,0.33,"ALESSANDRO VENTURA;STEFANO MARTELOSSI;TARCISIO NOT;BRUNO BEMBI;VALENTINA BALDAS;LUCA RONFANI;GRAZIA DI LEO;RICCARDO HAUPT;SÉRGIO CROVELLA;GIORGIO TAMBURLINI;EGIDIO BARBI;MARILENA GRANZOTTO;MIRELLA FILOCAMO;GIULIANA DECORTI;MARÍA GABRIELA PITTIS;MARINA CUTTINI;MANOLA COMAR;IRENE BERTI;GABRIELE STOCCO;ANDREA DI CATALDO","16;9;8;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3","ALESSANDRO VENTURA;GIORGIO TAMBURLINI;ARMANDO SARTI;STEFANO MARTELOSSI;TARCISIO NOT;LUCA RONFANI;GRAZIA DI LEO;VALENTINA BALDAS;BRUNO BEMBI;PIERLANFRANCO D’AGARO;PAOLO PERISSUTTI;GIULIANA DECORTI;EGIDIO BARBI;ADRIANO CATTANEO;SÉRGIO CROVELLA;MARILENA GRANZOTTO;F. BALSEMIN;E FILAFERRO;MARINA BUSETTI;CESARE CAMPELLO","2.24;1.35;1.1;1.08;1.03;0.95;0.78;0.71;0.63;0.62;0.58;0.57;0.53;0.53;0.52;0.52;0.5;0.5;0.46;0.46","ALESSANDRO VENTURA;STEFANO MARTELOSSI;TARCISIO NOT;BRUNO BEMBI;VALENTINA BALDAS;LUCA RONFANI;GRAZIA DI LEO;SÉRGIO CROVELLA;GIORGIO TAMBURLINI;EGIDIO BARBI;MARILENA GRANZOTTO;GIULIANA DECORTI;MARÍA GABRIELA PITTIS;MARINA CUTTINI;IRENE BERTI;GABRIELE STOCCO;ADRIANO CATTANEO;MICHELE BONIOTTO;GIULIO ANDREA ZANAZZO;PIERLANFRANCO D’AGARO","16;9;8;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3","ALESSANDRO VENTURA;GIORGIO TAMBURLINI;ARMANDO SARTI;STEFANO MARTELOSSI;TARCISIO NOT;LUCA RONFANI;GRAZIA DI LEO;VALENTINA BALDAS;BRUNO BEMBI;PIERLANFRANCO D’AGARO;PAOLO PERISSUTTI;GIULIANA DECORTI;EGIDIO BARBI;ADRIANO CATTANEO;SÉRGIO CROVELLA;MARILENA GRANZOTTO;F. BALSEMIN;E FILAFERRO;MARINA BUSETTI;CESARE CAMPELLO","2.24;1.35;1.1;1.08;1.03;0.95;0.78;0.71;0.63;0.62;0.58;0.57;0.53;0.53;0.52;0.52;0.5;0.5;0.46;0.46","ALESSANDRO VENTURA;BRUNO BEMBI;STEFANO MARTELOSSI;ALDO SCABAR;EVA PEZZETTA;LAURA BLASON;MARIA BULGHERONI;STEFANIA ZOIA;UMBERTO CASTIELLO;MARINA CUTTINI;G. D’OTTAVIO;RICCARDO HAUPT;ALESSANDRO TOSSI;A BONINI;A. KAZIS;ALAN TYNDALL;ALBERT SAIZ;ALESSANDRA LUGARESI;ALOÏS GRATWOHL;ANDREAS STECK","320;319;277;269;269;269;269;269;269;239;238;236;226;219;219;219;219;219;219;219","BRUNO BEMBI;ALDO SCABAR;EVA PEZZETTA;LAURA BLASON;MARIA BULGHERONI;STEFANIA ZOIA;G. D’OTTAVIO;ALESSANDRO VENTURA;M ANDOLINA;SECONDO GUASCHINO;MARÍA GABRIELA PITTIS;STEFANO MARTELOSSI;VERONICA ILEANA GUERCI;GIULIO ANDREA ZANAZZO;GRAZIA DI LEO;MICHELE BONIOTTO;SÉRGIO CROVELLA;GIOVANNA RUSSO;A.L.E. MONTALVO;GIANCARLO BASAGLIA","319;269;269;269;269;269;238;236;219;202;194;193;192;179;156;151;150;146;139;131","ALESSANDRO VENTURA;STEFANO MARTELOSSI;TARCISIO NOT;VALENTINA BALDAS;BRUNO BEMBI;LUCA RONFANI;GRAZIA DI LEO;GIORGIO TAMBURLINI;MARILENA GRANZOTTO;MARÍA GABRIELA PITTIS;ALBERTO TOMMASINI;EGIDIO BARBI;FORTUNATO FERRARA;IRENE BERTI;GIULIO ANDREA ZANAZZO;GIUSEPPE TONINI;SÉRGIO CROVELLA;VERONICA ILEANA GUERCI;ADRIANO CATTANEO;ALBERTO MARCHI","15;8;8;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;BUSINESS;GEOGRAPHY","68;42;10;5;4;4;4;3;2;2;2;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PATHOLOGY;BIOCHEMISTRY;PEDIATRICS;ENVIRONMENTAL HEALTH;SURGERY;FAMILY MEDICINE;GASTROENTEROLOGY;MOLECULAR BIOLOGY;ENDOCRINOLOGY;MICROBIOLOGY;ONCOLOGY;DEMOGRAPHY;INTENSIVE CARE MEDICINE;LAW;OBSTETRICS;RADIOLOGY;VIROLOGY","40;31;23;18;16;16;9;8;6;6;6;5;5;5;4;4;4;4;4;4","GENE;DISEASE;PREGNANCY;ENZYME;POPULATION;ANTIBODY;HEALTH CARE;IN VITRO;OBSERVATIONAL STUDY;VIRUS;ALTERNATIVE MEDICINE;BREASTFEEDING;CANCER;IMMUNOHISTOCHEMISTRY;ODDS RATIO;TRANSPLANTATION;ACTION (PHYSICS);ADVERSE EFFECT;AMBULATORY;ANTIGEN;ANTIMICROBIAL;BREAST FEEDING;CELL;CELL CULTURE;CHEMOTHERAPY;COHORT;COHORT STUDY;ENDOSCOPY;EPIDEMIOLOGY;GLUCOCORTICOID;GLUTEN;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IMMUNE SYSTEM;KINEMATICS;LUNG;MOVEMENT (MUSIC);MULTIPLE SCLEROSIS;OSTEOPOROSIS;RECEPTOR;RETROSPECTIVE COHORT STUDY;SEDATION;TOXICITY","21;15;11;10;8;7;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ALLELE;GENOTYPE;MUTATION;COELIAC DISEASE;AUTOANTIBODY;TISSUE TRANSGLUTAMINASE;PHENOTYPE;FETUS;GENE EXPRESSION;HEPATITIS B VIRUS;HEPATITIS C VIRUS;INFLAMMATORY BOWEL DISEASE;MUTANT;AMBULATORY CARE;AUTOIMMUNE DISEASE;AZATHIOPRINE;CAESAREAN SECTION;ENOLASE;ENZYME REPLACEMENT THERAPY;GESTATION;GLUCOCORTICOID RECEPTOR;GLUTEN FREE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;INFERTILITY;INTEGRIN;MATERNITY CARE;POLYMERASE CHAIN REACTION;RNA;VIRAL LOAD","7;7;7;6;5;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MISSENSE MUTATION;ALLELE FREQUENCY;POLYMORPHISM (COMPUTER SCIENCE);RNA SPLICING;SINGLE-NUCLEOTIDE POLYMORPHISM;THIOPURINE METHYLTRANSFERASE;ACUTE LYMPHOCYTIC LEUKEMIA;ALPHA (FINANCE);ANGIOID STREAKS;ANTIRETROVIRAL THERAPY;BRONCHOPULMONARY DYSPLASIA;CARMUSTINE;CATHELICIDIN;CHYMOTRYPSIN;COMPOUND HETEROZYGOSITY;CONNECTIVE TISSUE DISEASE;CONNEXIN;DIFFUSING CAPACITY;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;FANCONI ANEMIA;FLUDARABINE;FRAMESHIFT MUTATION;GENOTYPING;GLOBULES OF FAT;GLUTATHIONE S-TRANSFERASE;GLYCOGEN STORAGE DISEASE TYPE II;GPVI;HBSAG;HEMOPEXIN;HEPADNAVIRIDAE;HETEROZYGOTE ADVANTAGE;HPV INFECTION;HYPERTRIGLYCERIDEMIA;IMMUNOGLOBULIN A;INTESTINAL MALABSORPTION;LAMIVUDINE;LOSS FUNCTION;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MILK ALLERGY;MUCOPOLYSACCHARIDOSIS TYPE II;MUTATION TESTING;OPEN READING FRAME;ORGANIC ANION TRANSPORTER 1;PARANEOPLASTIC CEREBELLAR DEGENERATION;PLACENTA;PLATELET GLYCOPROTEIN GPIB-IX COMPLEX;PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;POINT MUTATION;PROMOTER;PROPIDIUM IODIDE;QUANTITATIVE COMPUTED TOMOGRAPHY;RETINOPATHY OF PREMATURITY;REVERSE TRANSCRIPTASE;REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;RIBAVIRIN;SECOND TRIMESTER;SEMEN ANALYSIS;STIFF PERSON SYNDROME;STREPTOCOCCUS AGALACTIAE;THIRD TRIMESTER;VARICOCELE;VIRAL QUASISPECIES;WILD TYPE;ZINC FINGER","7;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;;ADULT;CHILD, PRESCHOOL;ADOLESCENT;ITALY;GENOTYPE;HIV INFECTIONS;INFANT;PREGNANCY COMPLICATIONS, INFECTIOUS;MIDDLE AGED;PREGNANCY;CELIAC DISEASE;ANTIFUNGAL AGENTS;EMERGENCY SERVICE, HOSPITAL;INFANT, NEWBORN;RNA, MESSENGER","53;30;27;23;22;19;17;14;13;10;10;10;10;9;9;8;7;7;7;7","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;HEPATITIS B INFECTION AND TREATMENT;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;ANESTHESIA AND SEDATION MANAGEMENT;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;AUTOIMMUNE ENCEPHALITIS: CLINICAL CHARACTERISTICS AND MANAGEMENT;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;COMPUTATIONAL PRINCIPLES OF MOTOR CONTROL AND LEARNING;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;DIAGNOSIS AND MANAGEMENT OF ADRENAL INSUFFICIENCY;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EFFECTS OF PRENATAL ALCOHOL EXPOSURE ON OFFSPRING;EPIDEMIOLOGY AND MANAGEMENT OF NEONATAL SEPSIS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFECTIONS","7;5;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","TISSUE TRANSGLUTAMINASE;CELIAC DISEASE;BREASTFEEDING;BREASTFEEDING DURATION;BREASTFEEDING SUPPORT;GLUTEN SENSITIVITY;HIV;AUTOANTIBODIES;DIAGNOSIS;ENDOSCOPIC SEDATION;ENOLASE;FOOD ALLERGY;GLUCOCEREBROSIDASE MUTATIONS;GLUTEN FREE;HBV INFECTION;INFANT HEALTH;LYSOSOMAL STORAGE DISORDERS;MATERNITY CARE;NONSENSE-MEDIATED DECAY;PEDIATRIC INTUBATION","5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","COELIAC DISEASE;AUTOIMMUNE DISEASES;BOWEL DISEASE;INFLAMMATORY BOWEL;ADVERSE EFFECTS;CAESAREAN SECTION;CELIAC DISEASE;COHORT STUDY;EUROPEAN COUNTRIES;GASTROINTESTINAL ENDOSCOPY;HEALTH CARE;INFANT FEEDING;KINEMATIC STUDY;MARROW TRANSPLANTATION;MUTATIONS CAUSING;NORTH-EASTERN ITALY;OBSTETRICIANS ATTITUDES;PEDIATRIC POPULATION;PREGNANT WOMEN;SEVERE COWS;ACCIDENTAL ASSOCIATION;ACID-DERIVED DIAGNOSTIC;ACTION PLANNING;ACUTE LYMPHOBLASTIC;ALCOHOL SYNDROME;ALFA-ENOLASE ANTIBODIES;ALFAENOLASE ANTIBODIES;ALLOGENEIC HEMATOPOIETIC;ANDOR HEMOPEXIN;ANEMIA FANCD","5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","ADVERSE EFFECTS;MBL- VARIANTS;ELASTIC FIBERS;VITAMIN K-DEPENDENT;BONE MARROW;CHAIN REACTION;CLASSIC PXE;CUTIS LAXA;HIV TRANSMISSION;POLYMERASE CHAIN;ANGIOID STREAKS;ATP-BINDING CASSETTE;CASSETTE SUBFAMILY;DEVELOPING ADVERSE;EPOXIDE REDUCTASE;FLOW CYTOMETRIC;FLOW CYTOMETRY;GAMMA-GLUTAMYL CARBOXYLASE;LIM BROTH;MULTIPARAMETER FLOW;ODDS RATIO;PEAU DORANGE;PREGNANT WOMEN;PSEUDOXANTHOMA ELASTICUM;SEMEN SAMPLES;SPERM APOPTOSIS;ABCC GENE;ACTIVATED CASPASES;ADVERSE DRUG;AGAR PLATE","6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2",16,0.21,4.42,4,0,1,0,0,4,1,1.5,4.25,0,0,3,0,3.75,1,1,3.25,0,0,0,75,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4,36,0.74,0,0,2,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;INFECTIOUS DISEASES;KIDNEY DISEASE;PEDIATRIC;PREVENTION","1;1;1;1;1;1","INFECTION","1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2007,49,8.57142857142857,2.83673469387755,0.428571428571429,0.448979591836735,0.387755102040816,1.56179775280899,1.05,1.46666666666667,1.05555555555556,0.244897959183673,1,20,17,1,9,0.41,0.35,0.02,0.18,20.76,0.393267879411707,NA,0.387755102040816,0.897959183673469,0.391,0.284,0.343,0.294,"SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALBERTO TOMMASINI;MARILENA GRANZOTTO;STEFANO MARTELOSSI;ORIANO RADILLO;FRANCESCO DE SETA;LUDOVICA SEGAT;CESARE CAMPELLO;DOMENICO LEONARDO GRASSO;GIANPAOLO MASO;CHIARA AGOSTINIS;FLEUR BOSSI;LUCIA RIZZI;PIERLANFRANCO D’AGARO;SECONDO GUASCHINO;MICHELE MILANESE;FRANCESCO TEDESCO;MONICA PICCOLI;ROBERTA BULLA","6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MARILENA GRANZOTTO;STEFANO MARTELOSSI;SÉRGIO CROVELLA;ALBERTO TOMMASINI;ALESSANDRO VENTURA;MARÍA GABRIELA PITTIS;LUDOVICA SEGAT;DOMENICO LEONARDO GRASSO;CESARE CAMPELLO;MIRELLA FILOCAMO;MICHELE MILANESE;PIERLANFRANCO D’AGARO;GLÓRIA PELIZZO;SECONDO GUASCHINO;FRANCESCO DE SETA;ORIANO RADILLO;GIANPAOLO MASO;MONICA PICCOLI;ERICA VALENCIC;G. DAL MOLIN","1.59;0.94;0.88;0.88;0.77;0.68;0.66;0.64;0.63;0.57;0.52;0.51;0.5;0.46;0.45;0.42;0.38;0.38;0.36;0.34","SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALBERTO TOMMASINI;MARILENA GRANZOTTO;STEFANO MARTELOSSI;ORIANO RADILLO;FRANCESCO DE SETA;LUDOVICA SEGAT;CESARE CAMPELLO;DOMENICO LEONARDO GRASSO;GIANPAOLO MASO;PIERLANFRANCO D’AGARO;SECONDO GUASCHINO;MICHELE MILANESE;MONICA PICCOLI;MARÍA GABRIELA PITTIS;MANOLA COMAR;GLÓRIA PELIZZO;ALESSANDRA PONTILLO;TARCISIO NOT","6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2","MARILENA GRANZOTTO;STEFANO MARTELOSSI;SÉRGIO CROVELLA;ALBERTO TOMMASINI;ALESSANDRO VENTURA;MARÍA GABRIELA PITTIS;LUDOVICA SEGAT;DOMENICO LEONARDO GRASSO;CESARE CAMPELLO;MICHELE MILANESE;PIERLANFRANCO D’AGARO;GLÓRIA PELIZZO;SECONDO GUASCHINO;FRANCESCO DE SETA;ORIANO RADILLO;GIANPAOLO MASO;MONICA PICCOLI;G. DAL MOLIN;JENNY BUA;ELISABETTA ZOCCONI","1.59;0.94;0.88;0.88;0.77;0.68;0.66;0.64;0.63;0.52;0.51;0.5;0.46;0.45;0.42;0.38;0.38;0.34;0.33;0.33","CESARE CAMPELLO;MARÍA GABRIELA PITTIS;MASSIMILIANO ROSSI;BRUNO BEMBI;ANTONELLA LISA;G. RAFFA;GIOVANNI RAIMONDO;GIOVANNI SQUADRITO;LUCY COSTANTINO;MASSIMO LEVRERO;TERESA POLLICINO;MIRELLA FILOCAMO;ALESSANDRO VENTURA;SÉRGIO CROVELLA;A ZUPPALDI;ALICE DONATI;ANDREA BALLABIO;BARBARA ROSSI;CATERINA PORTO;FRANCESCA DONAUDY","200;172;163;159;155;155;155;155;155;155;155;123;119;112;110;110;110;110;110;110","CESARE CAMPELLO;MARÍA GABRIELA PITTIS;BRUNO BEMBI;ALESSANDRO VENTURA;SÉRGIO CROVELLA;JENNY BUA;EVA ORZAN;STEFANO MARTELOSSI;EGIDIO BARBI;MARILENA GRANZOTTO;ELISABETTA ZOCCONI;GRAZIANO GASPARINI;ALBERTO TOMMASINI;ALDO SCABAR;FEDERICO MARCHETTI;FULVIO BRADASCHIA;LUCA RONFANI;MARZIA LAZZERINI;MARTA DEGANUTO;SILVIA DOMINISSINI","199;172;159;119;112;81;77;63;62;55;53;53;51;51;51;51;51;51;49;49","ALESSANDRO VENTURA;SÉRGIO CROVELLA;ALBERTO TOMMASINI;STEFANO MARTELOSSI;MARILENA GRANZOTTO;ORIANO RADILLO;CESARE CAMPELLO;DOMENICO LEONARDO GRASSO;MARÍA GABRIELA PITTIS;ALESSANDRA PONTILLO;BRUNO BEMBI;EGIDIO BARBI;ELISABETTA ZOCCONI;EVA ORZAN;FEDERICA PEDERIVA;G. DAL MOLIN;GLÓRIA PELIZZO;LOREDANA LEPORE;LUDOVICA SEGAT;PIERLANFRANCO D’AGARO","6;6;5;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;SOCIOLOGY","44;34;5;5;2;2;2;2;2;1","GENETICS;INTERNAL MEDICINE;IMMUNOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;SURGERY;CELL BIOLOGY;VIROLOGY;AUDIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;OBSTETRICS;DERMATOLOGY;GYNECOLOGY;MOLECULAR BIOLOGY;QUANTUM MECHANICS;ANATOMY;LINGUISTICS;OPTICS;PEDIATRICS;RADIOLOGY","24;24;15;11;8;7;7;5;5;4;4;4;4;3;3;3;3;2;2;2;2;2","GENE;DISEASE;POPULATION;PREGNANCY;VIRUS;ANTIBODY;ENZYME;IMMUNE SYSTEM;PATHOGENESIS;BACTERIAL VAGINOSIS;CANCER;HEARING LOSS;IN VITRO;INFLAMMATION;INTRACELLULAR;LECTIN;MONOCYTE;ACTION (PHYSICS);ADVERSE EFFECT;AFFECT (LINGUISTICS);ALCOHOL;ALTERNATIVE MEDICINE;ANALYTICAL CHEMISTRY (JOURNAL);ASBESTOS;ASSERTIVENESS;ATRESIA;AUTISM;BODY MASS INDEX;CALCIUM;CELL;CELL ADHESION MOLECULE;CEREBROSPINAL FLUID;COCHLEA;COMPONENT (THERMODYNAMICS);CONJUNCTIVA;CONNECTIVE TISSUE;CYTOKINE;CYTOPLASM;DIFFERENTIAL DIAGNOSIS;DYSPLASIA;ENDOSCOPY;EPIDEMIOLOGY;ETIOLOGY;EXTRACELLULAR MATRIX;FOURIER TRANSFORM;FOURIER TRANSFORM INFRARED SPECTROSCOPY;GASTROINTESTINAL TRACT;GLUTEN;GLYCOGEN;GLYCOSYLATION;GOUT;HEART DISEASE;HEPATOCELLULAR CARCINOMA;HERNIA;HISTOLOGY;HORMONE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);INTERVENTION (COUNSELING);LANGUAGE DEVELOPMENT;LESION;LEUKEMIA;LIMITING;LIVER DISEASE;LUMBAR;LUNG;LYMPH NODE;MALAISE;MALIGNANCY;MERCAPTOPURINE;MESOTHELIOMA;MOTILITY;MULTIPLE MYELOMA;MULTIVARIATE ANALYSIS;MUSCLE HYPERTROPHY;MYASTHENIA GRAVIS;OBESITY;OXIDATIVE PHOSPHORYLATION;OXIDATIVE STRESS;PAIN MANAGEMENT;PARAKERATOSIS;PECTUS EXCAVATUM;PERCENTILE;PEUTZ–JEGHERS SYNDROME;RAMAN SPECTROSCOPY;RATING SCALE;REACTIVE OXYGEN SPECIES;RECEPTOR;REFRACTORY (PLANETARY SCIENCE);RETICULAR CONNECTIVE TISSUE;RETICULAR FIBER;SECULAR VARIATION;SHORT STATURE;SOCIAL SKILLS;STEM CELL;STENOSIS;STROMAL CELL;TEACHING METHOD;TERM (TIME);TINNITUS;TRANSFERRIN;TRANSMISSION (TELECOMMUNICATIONS);TRANSPLANTATION;VOCABULARY;XANTHOMA","15;13;8;7;5;4;4;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENOTYPE;ALLELE;FETUS;CROHN'S DISEASE;MUTATION;INNATE IMMUNE SYSTEM;ANAKINRA;AUTOIMMUNE DISEASE;ENZYME REPLACEMENT THERAPY;EXON;GENE EXPRESSION;HEPATITIS B VIRUS;INFLAMMATORY BOWEL DISEASE;MANNAN-BINDING LECTIN;MUTANT;PHENOTYPE;T CELL;ALCOHOL CONSUMPTION;ALZHEIMER'S DISEASE;ANTAGONIST;AUTOIMMUNE HEPATITIS;AUTOIMMUNITY;AZATHIOPRINE;B CELL;BIRTH WEIGHT;CD68;CHRONIC LYMPHOCYTIC LEUKEMIA;COELIAC DISEASE;COGNITIVE IMPAIRMENT;COLORECTAL CANCER;COMPLEMENT SYSTEM;CYTOSOL;DEMENTIA;DIAPHRAGMATIC HERNIA;DOWNREGULATION AND UPREGULATION;FABRY DISEASE;FAMILIAL MEDITERRANEAN FEVER;FIBROBLAST;FOXP3;GAP JUNCTION;GENETIC DISORDER;GESTATION;GESTATIONAL AGE;GLYCOGEN STORAGE DISEASE;GNAS COMPLEX LOCUS;GROWTH HORMONE;HAEMATOPOIESIS;HEK 293 CELLS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATITIS VIRUS;HERPES SIMPLEX VIRUS;IMMUNITY;IMMUNOFLUORESCENCE;IN VITRO FERTILISATION;INFERTILITY;INFLAMMASOME;INFLUENZA A VIRUS;INTERLEUKIN;INTERLEUKIN 2;LAMININ;LINEAGE (GENETIC);LIVE BIRTH;LYSOSOMAL STORAGE DISEASE;MEDIASTINAL SHIFT;NOISE EXPOSURE;NUCLEOTIDE;OCCULT;OVERWEIGHT;PARATHYROID HORMONE;PER CAPITA;PHYLOGENETICS;PHYTOHAEMAGGLUTININ;PREGNANCY RATE;PROINFLAMMATORY CYTOKINE;REDUCTASE;ROTAVIRUS;SEROCONVERSION;THALIDOMIDE;TISSUE TRANSGLUTAMINASE;TRANSFECTION;TYPICALLY DEVELOPING;ULCERATIVE COLITIS;UNIVARIATE ANALYSIS;VIMENTIN;VOCABULARY DEVELOPMENT;WESTERN BLOT","7;6;6;4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLELE FREQUENCY;NOD2;SINGLE-NUCLEOTIDE POLYMORPHISM;COMPOUND HETEROZYGOSITY;GLYCOGEN STORAGE DISEASE TYPE II;PLACENTA;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;7-DEHYDROCHOLESTEROL REDUCTASE;ANTIGENIC DRIFT;ASSISTED REPRODUCTIVE TECHNOLOGY;BRONCHOPULMONARY DYSPLASIA;CARBOHYDRATE DEFICIENT TRANSFERRIN;CD86;CHILDHOOD OBESITY;CLADE;COLONOSCOPY;COMPLEMENT MEMBRANE ATTACK COMPLEX;COMPLEMENTATION;CONGENITAL CYSTIC ADENOMATOID MALFORMATION;CONGENITAL DIAPHRAGMATIC HERNIA;CONNEXIN;CONTROLLED OVARIAN HYPERSTIMULATION;DESMIN;FIRST TRIMESTER;GENE MUTATION;GENE POLYMORPHISM;GENOTYPING;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;HETEROZYGOTE ADVANTAGE;HOX GENE;IL-2 RECEPTOR;INTERLEUKIN 12 RECEPTOR, BETA 1 SUBUNIT;INTERLEUKIN-1 RECEPTOR;INTRACYTOPLASMIC SPERM INJECTION;INTRAVENTRICULAR HEMORRHAGE;LUCIFER YELLOW;MARGINAL ZONE;MISSENSE MUTATION;MOLECULAR EPIDEMIOLOGY;MONOCHORIONIC TWINS;NALP3;NOISE-INDUCED HEARING LOSS;OVARIAN HYPERSTIMULATION SYNDROME;PHARMACOGENETICS;PSEUDOHYPOPARATHYROIDISM;PYRIN DOMAIN;RECEPTOR ANTAGONIST;REOVIRIDAE;RIBAVIRIN;ROTAVIRUS INFECTIONS;T-CELL RECEPTOR;THIOPURINE METHYLTRANSFERASE;TWIN PREGNANCY","4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;MIDDLE AGED;ADOLESCENT;CROHN DISEASE;MANNOSE-BINDING LECTIN;AGED;CHILD;DNA, VIRAL;MUTATION;CHILD, PRESCHOOL;ITALY;POLYMORPHISM, SINGLE NUCLEOTIDE;EUROPE;GENE FREQUENCY;GENOTYPE;VAGINOSIS, BACTERIAL","31;21;18;17;11;11;10;10;9;8;8;8;8;6;6;6;5;5;5;5","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;HEPATITIS B INFECTION AND TREATMENT;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;BARTONELLA INFECTIONS AND ZOONOTIC POTENTIAL;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;CHARGE SYNDROME AND RELATED GENETIC DISORDERS;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;EFFECTS OF NOISE POLLUTION ON HEALTH AND WELL-BEING;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;GENETIC DIVERSITY AND BREEDING OF OKRA;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL","4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","PATHOGENESIS;COMPOUND HETEROZYGOSITY;EPIDEMIOLOGY;GLYCOGEN STORAGE DISEASES;HBV INFECTION;LYSOSOMAL STORAGE DISORDERS;MONOCYTE;PRENATAL DIAGNOSIS;TREATMENT;VAGINAL MICROBIOME;ADULT CONGENITAL HEART DISEASE;AFFECT (LINGUISTICS);AMNIOCENTESIS;ANTIBODIES;ANTIOXIDANT PROPERTIES;ASBESTOS EXPOSURE;ASSERTIVENESS;ASSISTED REPRODUCTIVE TECHNOLOGY;AUTOIMMUNE HEPATITIS;B-CELL RECEPTOR SIGNALING","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CROHNS DISEASE;AFFECT MONOCYTE;BACTERIAL VAGINOSIS;DOMAIN- MUTATIONS;HETEROZYGOUS NUCLEOTIDE-BINDING;HUMAN TROPHOBLAST;LECTIN GENE;MONOCYTE MATURATION;MUTATIONS AFFECT;NUCLEOTIDE-BINDING OLIGOMERIZATION;OLIGOMERIZATION DOMAIN-;TROPHOBLAST INVASION;ACUTE LYMPHOBLASTIC;ADAPTIVE RESPONSE;ADENOMATOID MALFORMATION;ADENOTONSILLAR HYPERTROPHY;AGE-RELATED HEARING;AIDS DEMENTIA;ALTERED INTRACELLULAR;ALZHEIMERS DISEASE;ANTAGONIST POLYMORPHISMS;ANTI-IDIOTYPIC NETWORK;ANTI-INFLAMMATORY ACTION;ASBESTOS EXPOSURE;ASSISTED ENDOSCOPIC;ASSISTED REPRODUCTION;AUTOIMMUNE CHOLANGITIS;AUTOINFLAMMATORY SYNDROMES;BINDING LECTIN;BIOCHEMICAL TOOL","3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CD PATIENTS;CD EXPRESSION;CROHNS DISEASE;NEONATAL OUTCOME;OCCULT HBV;MINOR DEFECTS;NOD GENE;OVARIAN HYPERSTIMULATION;TRANSFERRIN SATURATION;ADVERSE NEONATAL;BOWEL DISEASE;CONTROLLED OVARIAN;DHCR MUTATIONS;FULL-LENGTH HBV;GAA ACTIVITY;HBV STRAINS;INFLAMMATORY BOWEL;INTERLEUKIN IL-;MONOCHORIONIC PLACENTATION;POMPE DISEASE;SERUM FERRITIN;SEVERE MG;ULCERATIVE COLITIS;VIRAL REPLICATION;ABORTION OCCURRED;ACTIVATED PHENOTYPE;ADVERSE OUTCOME;ALTERED DIFFERENTIATION;ART CYCLES;ASSISTED REPRODUCTION","10;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2",7,0.14,3,1,0,0,0,0,3.5,0,1,1,0,1,1,0,1,0,0,1,0,0,0,68.5,68.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4.75,217.33,4.71,0,0,2.5,0,0,0,0,1,0,0,3,0,3,0,0,0,0,0,0,0,2,2,0,3,1,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY;4206 PUBLIC HEALTH;44 HUMAN SOCIETY;4403 DEMOGRAPHY","4;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;AUTOIMMUNE DISEASE;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CONTRACEPTION/REPRODUCTION;DIGESTIVE DISEASES;INFERTILITY;NUTRITION;PAIN RESEARCH;PATIENT SAFETY;PREVENTION","3;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","CERVICAL CANCER","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",1,539700,107940,4,5,1,1,10,26985,1.81582360570687,"ENTE OSPEDALIERO OSPEDALI GALLIERA;IRCCS MATERNO INFANTILE BURLO GAROFOLO;THE SAN RAFFAELE TELETHON INSTITUTE FOR GENE THERAPY;UNIVERSITY OF BRESCIA;UNIVERSITY OF FLORENCE","1;1;1;1;1","TELETHON FOUNDATION","1",NA,NA,"TELETHON GRANT PROJECTS - 2007 (PROGRAM)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY","1;1","AUTOIMMUNE DISEASE;CLINICAL RESEARCH;GENETICS","1;1;1","INFLAMMATORY AND IMMUNE SYSTEM","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2008,102,8.13725490196078,2.7156862745098,0.5,0.480392156862745,0.490196078431373,1.85906040268456,1.24390243902439,1.75,1.25,0.362745098039216,0,45,36,6,10,0.44,0.35,0.06,0.1,40.77,0.743085834193569,NA,0.441176470588235,0.794117647058823,0.457,0.362,0.481,0.375,"ALESSANDRO VENTURA;SÉRGIO CROVELLA;LUDOVICA SEGAT;MICHELE MILANESE;STEFANO MARTELOSSI;BRUNO BEMBI;PAOLO GASPARINI;TARCISIO NOT;LOREDANA LEPORE;PIO D’ADAMO;GLÓRIA PELIZZO;ALBERTO TOMMASINI;FLORIANA ZENNARO;MIRELLA FILOCAMO;GABRIELE STOCCO;ADRIANO CATTANEO;FRANCESCO DE SETA;DANIELA CODRICH;ANNALISA FABRIS;GIULIANA DECORTI","16;11;10;8;8;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4","ALESSANDRO VENTURA;SÉRGIO CROVELLA;LUDOVICA SEGAT;ADRIANO CATTANEO;STEFANO MARTELOSSI;MICHELE MILANESE;LOREDANA LEPORE;GLÓRIA PELIZZO;FLORIANA ZENNARO;FEDERICO MARCHETTI;DANIELA CODRICH;ZEMIRA CANNIOTO;GIUSEPPE RICCI;VALTER SERGO;CHRISTOPH KRAFFT;LAURA TRAVAN;BRUNO BEMBI;TARCISIO NOT;EGIDIO BARBI;GIULIANA DECORTI","2.82;1.7;1.56;1.29;1.29;1.28;1.25;1.14;1.01;1;0.89;0.89;0.81;0.75;0.75;0.71;0.69;0.68;0.67;0.63","ALESSANDRO VENTURA;SÉRGIO CROVELLA;LUDOVICA SEGAT;MICHELE MILANESE;STEFANO MARTELOSSI;BRUNO BEMBI;PAOLO GASPARINI;TARCISIO NOT;LOREDANA LEPORE;PIO D’ADAMO;GLÓRIA PELIZZO;ALBERTO TOMMASINI;FLORIANA ZENNARO;GABRIELE STOCCO;ADRIANO CATTANEO;FRANCESCO DE SETA;DANIELA CODRICH;ANNALISA FABRIS;FEDERICO MARCHETTI;LUCA RONFANI","16;11;10;8;8;7;6;6;6;6;5;5;5;4;4;4;4;4;3;3","ALESSANDRO VENTURA;SÉRGIO CROVELLA;LUDOVICA SEGAT;ADRIANO CATTANEO;STEFANO MARTELOSSI;MICHELE MILANESE;LOREDANA LEPORE;GLÓRIA PELIZZO;FLORIANA ZENNARO;FEDERICO MARCHETTI;DANIELA CODRICH;ZEMIRA CANNIOTO;GIUSEPPE RICCI;LAURA TRAVAN;BRUNO BEMBI;TARCISIO NOT;EGIDIO BARBI;LUCA RONFANI;ANDREA TADDIO;PAOLO GASPARINI","2.82;1.7;1.56;1.29;1.29;1.28;1.25;1.14;1.01;1;0.89;0.89;0.81;0.71;0.69;0.68;0.67;0.62;0.58;0.57","ALESSANDRO VENTURA;PAOLO GASPARINI;PIO D’ADAMO;BRUNO BEMBI;SÉRGIO CROVELLA;ADRIANO CATTANEO;ALBERTO TOMMASINI;LAURA TRAVAN;LUCA RONFANI;MASSIMO ZEVIANI;ANDREA BORDUGO;L. PERATONER;MARCO PENNESI;SILVIA MINISINI;GABRIELE STOCCO;G CHIUMELLO;LUDOVICA SEGAT;ERIKA FERNÁNDEZ‐VIZARRA;MEYLING CHEOK;WENJIAN YANG","748;554;554;447;409;362;337;333;330;321;320;320;320;320;313;308;294;293;288;288","ALESSANDRO VENTURA;PIO D’ADAMO;PAOLO GASPARINI;BRUNO BEMBI;SÉRGIO CROVELLA;ADRIANO CATTANEO;ALBERTO TOMMASINI;LAURA TRAVAN;ANDREA BORDUGO;L. PERATONER;MARCO PENNESI;SILVIA MINISINI;GABRIELE STOCCO;CARMELA LANZARA;FRANCESCO DE SETA;G. P. MANDRUZZATO;LUDOVICA SEGAT;SHEILA ULIVI;TARCISIO NOT;SECONDO GUASCHINO","689;554;535;419;409;362;337;333;320;320;320;320;313;233;233;208;204;203;201;199","ALESSANDRO VENTURA;SÉRGIO CROVELLA;STEFANO MARTELOSSI;PIO D’ADAMO;BRUNO BEMBI;LOREDANA LEPORE;LUDOVICA SEGAT;TARCISIO NOT;FLORIANA ZENNARO;PAOLO GASPARINI;ADRIANO CATTANEO;ALBERTO TOMMASINI;FRANCESCO DE SETA;GABRIELE STOCCO;NAGUA GIURICI;SILVIA DOMINISSINI;ANDREA DARDIS;ANNALISA FABRIS;DANIELA CODRICH;EGIDIO BARBI","15;11;7;6;6;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;MATERIALS SCIENCE;HISTORY;MATHEMATICS;SOCIOLOGY;BUSINESS;PHILOSOPHY","89;54;13;8;7;5;3;3;2;2;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;SURGERY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;OBSTETRICS;OPTICS;VIROLOGY;MOLECULAR BIOLOGY;ANDROLOGY;CANCER RESEARCH;CELL BIOLOGY;CLINICAL PSYCHOLOGY;DERMATOLOGY;GYNECOLOGY;PHARMACOLOGY;PSYCHIATRY","55;42;25;25;18;16;14;11;9;6;6;6;6;6;5;4;4;4;4;4;4;4;4","DISEASE;GENE;PREGNANCY;ANTIBODY;POPULATION;CANCER;ENZYME;IMMUNE SYSTEM;ODDS RATIO;PATHOGENESIS;RANDOMIZED CONTROLLED TRIAL;TRANSPLANTATION;ARTHRITIS;BODY MASS INDEX;BREASTFEEDING;CYTOKINE;ENDOMETRIUM;FOURIER TRANSFORM INFRARED SPECTROSCOPY;GLUTEN;HEPATOLOGY;INFLAMMATION;LUNG;PROSPECTIVE COHORT STUDY;RAMAN SPECTROSCOPY;VIRUS","28;23;13;9;9;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","GENOTYPE;FETUS;ALLELE;MUTATION;AUTOIMMUNE DISEASE;GESTATIONAL AGE;PHENOTYPE;AZATHIOPRINE;GESTATION;ANTIBIOTIC PROPHYLAXIS;AUTOANTIBODY;AUTOIMMUNITY;CARDIOMYOPATHY;COELIAC DISEASE;COLORECTAL CANCER;CYTOCHROME C OXIDASE;FOXP3;GENE EXPRESSION;GENERAL HEALTH QUESTIONNAIRE;GENOME;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATITIS B VIRUS;HEPATITIS C VIRUS;INFERTILITY;INFLIXIMAB;LOCUS (GENETICS);MITOCHONDRIAL DNA;NEUTROPENIA;PROTEIN SUBUNIT;PSYCHOLOGICAL DISTRESS;REFLUX;TISSUE TRANSGLUTAMINASE;ULCERATIVE COLITIS","11;7;6;6;5;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HAPLOTYPE;GENE POLYMORPHISM;PLACENTA;POLYMORPHISM (COMPUTER SCIENCE);COLONOSCOPY;COPY-NUMBER VARIATION;MISSENSE MUTATION;MITOCHONDRIAL ENCEPHALOMYOPATHY;SINGLE-NUCLEOTIDE POLYMORPHISM;VESICOURETERAL REFLUX;ACUTE LYMPHOCYTIC LEUKEMIA;ALLELE FREQUENCY;ANTI-THYROID AUTOANTIBODIES;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;AUTOIMMUNE THYROIDITIS;BREAKPOINT;CARBOHYDRATE DEFICIENT TRANSFERRIN;CARBOPLATIN;CEREBRAL VASCULITIS;CHLAMYDOPHILA PNEUMONIAE;CHOLESTASIS OF PREGNANCY;COLECTOMY;COMPOUND HETEROZYGOSITY;CONGENITAL HEARING LOSS;CONNECTIVE TISSUE DISEASE;CONSERVED SEQUENCE;DOMESTIC VIOLENCE;EVANS SYNDROME;FARNESYL PYROPHOSPHATE;FAS LIGAND;FAS RECEPTOR;FERROPORTIN;FILGRASTIM;FRAMESHIFT MUTATION;GAMMA SUBUNIT;GENE DOSAGE;GENE FAMILY;GENOTYPE-PHENOTYPE DISTINCTION;GENOTYPING;GERANYLGERANYL PYROPHOSPHATE;GESTATIONAL DIABETES;HERPESVIRIDAE;HPV INFECTION;HYDROPS FETALIS;HYPERTRIGLYCERIDEMIA;HYSTEROSALPINGOGRAPHY;IL-2 RECEPTOR;IN UTERO;INSULIN-LIKE GROWTH FACTOR;INTRAUTERINE GROWTH RESTRICTION;LEUKAPHERESIS;MALE INFERTILITY;MECONIUM;MEVALONATE PATHWAY;MICROSATELLITE;NPC1;PERIPHERAL TOLERANCE;PHARMACOGENETICS;PLEXIFORM NEUROFIBROMA;POINT MUTATION;POLYHYDRAMNIOS;PREMATURE BIRTH;PRENATAL DIAGNOSIS;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;PROMOTER;RAMAN MICROSCOPE;RIBAVIRIN;RNA SPLICING;SEMEN ANALYSIS;SMALL FOR GESTATIONAL AGE;SPERM WASHING;STEREOELECTROENCEPHALOGRAPHY;THIOPURINE METHYLTRANSFERASE;UNDERWEIGHT;VINCRISTINE","6;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;ADOLESCENT;CHILD;INFANT;CHILD, PRESCHOOL;INFANT, NEWBORN;MIDDLE AGED;ITALY;MANNOSE-BINDING LECTIN;POLYMORPHISM, GENETIC;CARDIOVASCULAR DISEASES;COLITIS, ULCERATIVE;CELIAC DISEASE;DNA MUTATIONAL ANALYSIS;GENETIC PREDISPOSITION TO DISEASE;GENOTYPE","73;48;41;28;24;22;20;20;16;16;14;13;10;10;9;9;8;8;8;8","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PEDIATRIC URINARY TRACT INFECTIONS;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;MALE REPRODUCTIVE HEALTH;MATERNAL AND CHILD NUTRITION IN DEVELOPING COUNTRIES;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;PSYCHOLOGICAL IMPACT OF BEREAVEMENT AND GRIEF;REGULATION OF IRON METABOLISM AND ANEMIA;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;AMINO ACID TRANSPORT AND METABOLISM IN HEALTH AND DISEASE","5;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","GENE POLYMORPHISM;PATHOGENESIS;ENDOMETRIAL RECEPTIVITY;CELIAC DISEASE;CHILD DEVELOPMENT;DECIDUA;ETIOLOGY;FETAL GROWTH RESTRICTION;GENERAL HEALTH QUESTIONNAIRE;GLUCOCEREBROSIDASE MUTATIONS;GLUTEN SENSITIVITY;HYSTEROSCOPIC TREATMENT;INFANT HEALTH;INFLAMMATION;MALNUTRITION IMPACTS;MATERNAL AND CHILD UNDERNUTRITION;MICROWAVE IMAGING;MITOCHONDRIAL ENCEPHALOMYOPATHY;NEUROFIBROMATOSIS;NIEMANN-PICK DISEASE","4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CELIAC DISEASE;GENE POLYMORPHISMS;STEM CELL;ACUTE LYMPHOBLASTIC;ANTIBIOTIC PROPHYLAXIS;BRAZILIAN CHILDREN;CELL TRANSPLANTATION;CONTROLLED TRIAL;DECIDUAL ENDOTHELIAL;DISEASE TYPE;ENDOTHELIAL CELLS;FTIR IMAGING;HEPATOCELLULAR CARCINOMA;LUNG TISSUE;LYMPHOBLASTIC LEUKEMIA;MASP GENE;MBL GENE;NIEMANN-PICK DISEASE;PREVENTING PYELONEPHRITIS;RANDOMIZED CONTROLLED;REFLUX EFFECTIVE;RENAL SCARS;VESICOURETERAL REFLUX;ABCB MDR;ABSTRACTS PHENOTYPE;ACID THERAPY;ACIDS EXCRETION;ACTION PROJECT;ACTIVE METABOLITES;ACUTE MALNUTRITION","4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;LIVER DISEASE;CELIAC DISEASE;MALATTIE METABOLICHE;METABOLICHE IRCCS;AUTOIMMUNE LIVER;UTERINE CAVITY;BALLOON CATHETER;IMMUNOSUPPRESSIVE THERAPY;LIVER DAMAGE;BURLO GAROFOLO;CERVICAL VACUUM;COELIAC DISEASE;CONTRACEPTIVE USERS;DI MALATTIE;DIAGNOSI PRE-POSTNATALE;ENDOCERVICAL CANAL;GENOVA ITALYSEARCH;GGASLINI GENOVA;IRCCS BURLO;IRCCS GGASLINI;PRE-POSTNATALE MALATTIE;PROSPECTIVE RANDOMIZED;PROTEIN EXPRESSION;RANDOMIZED SINGLE-BLINDED;SINGLE-BLINDED STUDYFERTIL;STUDYFERTIL STERIL;UNITÀ DI;VACUUM CUP","41;25;24;23;20;18;17;14;12;12;12;10;10;10;10;10;10;10;10;10;10;10;10;10;10;10;10;10;10;10",21,0.21,5.08,2,1,1,0,1,2,0,1,2,1,1,3,2,1.5,1,0,4,2,0,0,107,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,2.33,107.33,7.64,0,0,2.45,0,0,0,0,10,0,1,0,0,3,0,0,0,0,0,0,0,9,1,1,3,8,0,0,0,0,0,0,0,0,"Italy","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;4204 MIDWIFERY;4206 PUBLIC HEALTH;44 HUMAN SOCIETY;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","7;6;4;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COMPARATIVE EFFECTIVENESS RESEARCH;PEDIATRIC;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;CHRONIC PAIN;CROHN'S DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;PAIN RESEARCH;PREVENTION;RARE DISEASES","3;3;2;2;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;ORAL AND GASTROINTESTINAL;INFLAMMATORY AND IMMUNE SYSTEM;INJURIES AND ACCIDENTS","2;2;1;1","6.1 PHARMACEUTICALS;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;5.1 PHARMACEUTICALS;6.4 SURGERY;7.3 MANAGEMENT AND DECISION MAKING","4;1;1;1;1",NA,NA,NA,NA,1,53900,53900,2,1,1,0,0,53935,1.89116529155465,"IRCCS MATERNO INFANTILE BURLO GAROFOLO","1","TELETHON FOUNDATION","1",NA,NA,"TELETHON GRANT PROJECTS - 2008 (PROGRAM)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE","1;1","AGING;CONTRACEPTION/REPRODUCTION;ESTROGEN;GENETIC TESTING;GENETICS;OSTEOPOROSIS;PREVENTION","1;1;1;1;1;1;1",NA,NA,"2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2009,90,10.4,2.6,0.377777777777778,0.422222222222222,0.422222222222222,1.8,1.09677419354839,1.65217391304348,1.15151515151515,0.333333333333333,2,29,24,12,15,0.32,0.27,0.13,0.17,33.57,0.725652450668364,NA,0.377777777777778,0.888888888888889,0.409,0.361,0.383,0.42,"SÉRGIO CROVELLA;LUDOVICA SEGAT;ALESSANDRO VENTURA;PAOLO GASPARINI;VANNA PECILE;DOMENICO LEONARDO GRASSO;LUCA RONFANI;ANTONIO AMOROSO;MARCO CARROZZI;ANNA SAVOIA;PIO D’ADAMO;GIULIANA DECORTI;GABRIELE STOCCO;FEDERICO MARCHETTI;LUCAS ANDRÉ CAVALCANTI BRANDÃO;BRUNO BEMBI;ANDREA DARDIS;SARA DE IUDICIBUS;EGIDIO BARBI;DANIELA DE ROCCO","12;9;7;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","SÉRGIO CROVELLA;LUCA RONFANI;IRENE BERTI;LUDOVICA SEGAT;MARZIA LAZZERINI;IRCCS BURLO;FULVIO PARENTIN;STEFANO PENSIERO;ALESSANDRO VENTURA;MARCO CARROZZI;GIANLUCA TORNESE;GIULIANA DECORTI;DOMENICO LEONARDO GRASSO;FEDERICO MARCHETTI;GABRIELE STOCCO;SARA DE IUDICIBUS;FIORA BARTOLI;ANNA SAVOIA;EGIDIO BARBI;FRANCESCO DE SETA","1.53;1.42;1.2;1.15;1.08;1;0.81;0.81;0.71;0.69;0.68;0.65;0.65;0.61;0.51;0.51;0.51;0.49;0.49;0.45","SÉRGIO CROVELLA;LUDOVICA SEGAT;ALESSANDRO VENTURA;PAOLO GASPARINI;VANNA PECILE;DOMENICO LEONARDO GRASSO;LUCA RONFANI;MARCO CARROZZI;ANNA SAVOIA;PIO D’ADAMO;FEDERICO MARCHETTI;ANDREA DARDIS;SARA DE IUDICIBUS;EGIDIO BARBI;DANIELA DE ROCCO;FIORA BARTOLI;TARCISIO NOT;FULVIO PARENTIN;FRANCESCO DE SETA;GIOVANNI CIANA","12;9;7;6;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3","SÉRGIO CROVELLA;LUCA RONFANI;IRENE BERTI;LUDOVICA SEGAT;IRCCS BURLO;FULVIO PARENTIN;STEFANO PENSIERO;ALESSANDRO VENTURA;MARCO CARROZZI;GIANLUCA TORNESE;DOMENICO LEONARDO GRASSO;FEDERICO MARCHETTI;SARA DE IUDICIBUS;FIORA BARTOLI;ANNA SAVOIA;EGIDIO BARBI;FRANCESCO DE SETA;SERGIO PARCO;MICHELA DONATO;FEDERICA SCRIMIN","1.53;1.42;1.2;1.15;1;0.81;0.81;0.71;0.69;0.68;0.65;0.61;0.51;0.51;0.49;0.49;0.45;0.45;0.45;0.45","PAOLO GASPARINI;PIO D’ADAMO;DANIELA TONIOLO;ALBERTO MARTINI;ELISABETTA CORTIS;FRANCESCO ZULIAN;ALEXANDER ZIMPRICH;ANDRES METSPALU;ANDREY KHRUNIN;ANTONIO JULIÀ;ARNE PFEUFER;BÉLA MELEGH;CHRISTELLE BOREL;EVELIINA JAKKULA;FRITZ ZIMPRICH;HOMA ATTAR;H‐ERICH WICHMANN;IVAN BALAŠČÁK;JAN LUBIŃSKI;JĀNIS KLOVIŅŠ","781;728;430;401;401;401;385;385;385;385;385;385;385;385;385;385;385;385;385;385","PAOLO GASPARINI;PIO D’ADAMO;LOREDANA LEPORE;VANNA PECILE;SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALBERTO TOMMASINI;GIUSEPPE TONINI;ANNA SAVOIA;FABIANA ZIBERNA;SERENA VATTA;TARCISIO NOT;ADRIANO CATTANEO;TEA BURMAZ;LUDOVICA SEGAT;MARCO PENNESI;M ANDOLINA;SHEILA ULIVI;VERONICA GUERCI;ANNALISA FABRIS","781;728;241;186;177;173;171;143;142;131;131;131;118;118;90;87;86;85;76;75","SÉRGIO CROVELLA;LUDOVICA SEGAT;ALESSANDRO VENTURA;PAOLO GASPARINI;ANNA SAVOIA;DOMENICO LEONARDO GRASSO;MARCO CARROZZI;PIO D’ADAMO;VANNA PECILE;LUCA RONFANI;DANIELA DE ROCCO;FEDERICO MARCHETTI;GIANLUCA TORNESE;GIOVANNI CIANA;SARA DE IUDICIBUS;EGIDIO BARBI;ELISABETTA ZOCCONI;FULVIO PARENTIN;STEFANO PENSIERO;FRANCESCO DE SETA","11;7;6;6;5;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;SOCIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;POLITICAL SCIENCE;ENGINEERING;PSYCHOLOGY;MATHEMATICS;PHILOSOPHY;ART;BUSINESS;ECONOMICS;GEOGRAPHY;GEOLOGY","76;55;8;7;6;6;5;3;3;2;2;1;1;1;1;1","GENETICS;INTERNAL MEDICINE;IMMUNOLOGY;PATHOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;SURGERY;ENDOCRINOLOGY;BIOCHEMISTRY;PSYCHIATRY;VIROLOGY;ANATOMY;DEMOGRAPHY;OBSTETRICS;AUDIOLOGY;DERMATOLOGY;GASTROENTEROLOGY;LAW;PROGRAMMING LANGUAGE;CELL BIOLOGY;GYNECOLOGY;MOLECULAR BIOLOGY;ONCOLOGY;OPTICS","46;46;25;20;15;14;14;12;10;8;8;6;6;6;5;5;5;5;5;4;4;4;4;4","GENE;POPULATION;DISEASE;PREGNANCY;CANCER;VIRUS;ANTIGEN;ALTERNATIVE MEDICINE;ANTIBODY;DIABETES MELLITUS;HEARING LOSS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IMMUNOHISTOCHEMISTRY;ABNORMALITY;ASYMPTOMATIC;CONFIDENCE INTERVAL;ENZYME;EPIDEMIOLOGY;EPILEPSY;INCIDENCE (GEOMETRY);MEDLINE;MITOCHONDRION;PLATELET","39;17;14;11;7;7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","GENOTYPE;ALLELE;MUTATION;PHENOTYPE;EXON;HUMAN LEUKOCYTE ANTIGEN;CERVICAL CANCER;CHROMOSOME;COCHRANE LIBRARY;FETUS;LOCUS (GENETICS);MITOCHONDRIAL DNA;NEPHROPATHY;POLYMERASE CHAIN REACTION;AUTOIMMUNE DISEASE;COELIAC DISEASE;DEFENSIN;ENDOMETRITIS;EPSTEIN–BARR VIRUS;GENE DUPLICATION;GENETIC VARIATION;GROWTH HORMONE;HEPATITIS B VIRUS;INFERTILITY;INTRON;MULTIPLE DRUG RESISTANCE;MUTANT;PERIPHERAL BLOOD MONONUCLEAR CELL;RNA;SENSORINEURAL HEARING LOSS;SYSTEMATIC REVIEW;TISSUE TRANSGLUTAMINASE;VIRAL DISEASE;VIRAL LOAD","16;10;10;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SINGLE-NUCLEOTIDE POLYMORPHISM;MISSENSE MUTATION;HAPLOTYPE;POLYMORPHISM (COMPUTER SCIENCE);KARYOTYPE;ALLELE FREQUENCY;COCHRANE COLLABORATION;FRAMESHIFT MUTATION;GENOTYPING;HPV INFECTION;P-GLYCOPROTEIN;ADENOID HYPERTROPHY;ALPORT SYNDROME;AMNIOTIC FLUID;ANTIRETROVIRAL THERAPY;BETA DEFENSIN;BLOOD PLATELET DISORDERS;BREAKPOINT;CD3;CHROMOSOME 7 (HUMAN);CHROMOSOME INSTABILITY;CONGENITAL CYSTIC ADENOMATOID MALFORMATION;CONGENITAL DIAPHRAGMATIC HERNIA;COPY-NUMBER VARIATION;CYTOGENETICS;CYTOREDUCTIVE SURGERY;DEMOGRAPHIC HISTORY;DNA METHYLATION;DOMESTIC VIOLENCE;EXTERNAL OPHTHALMOPLEGIA;FACTOR V LEIDEN;GENETIC HETEROGENEITY;GENETIC STRUCTURE;GROWTH HORMONE DEFICIENCY;HAPLOINSUFFICIENCY;HERPESVIRIDAE;HLA-A;HLA-G;HUMAN GROWTH HORMONE;LAMIVUDINE;LIPOPROTEIN(A);LOSS OF HETEROZYGOSITY;MALE INFERTILITY;MECP2;MEGAKARYOCYTE;METHYLENETETRAHYDROFOLATE REDUCTASE;MICRODELETION SYNDROME;NESTED POLYMERASE CHAIN REACTION;NPC1;PRENATAL DIAGNOSIS;PSYCHOMOTOR DISORDER;RNA SPLICING;SEMEN ANALYSIS;SENTINEL NODE;SPERM WASHING;STAPHYLOCOCCAL SCALDED SKIN SYNDROME;SYBR GREEN I;TRANSFER RNA;UNTRANSLATED REGION;ZIDOVUDINE","7;6;4;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;ADULT;ITALY;;ADOLESCENT;CELIAC DISEASE;CHILD, PRESCHOOL;MIDDLE AGED;GENETIC PREDISPOSITION TO DISEASE;INFANT;POLYMORPHISM, SINGLE NUCLEOTIDE;YOUNG ADULT;AUTOIMMUNE DISEASES;MOLECULAR MOTOR PROTEINS;MYOSIN HEAVY CHAINS;BLOOD PLATELETS;HIV INFECTIONS","67;53;42;28;25;22;21;18;18;18;17;14;14;11;11;10;10;10;9;9","INTEGRIN SIGNALING IN INFLAMMATION AND CANCER;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;COPPER AND ZINC IN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;GENOMIC STUDIES AND ASSOCIATION ANALYSES;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;VIRAL-RELATED CANCERS IN IMMUNOCOMPROMISED PATIENTS;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN TRANSPLANTATION PROCEDURES AND OUTCOMES;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;AUTISM SPECTRUM DISORDERS;BIOLOGICAL AND SYNTHETIC HYDROGENASES: MECHANISMS AND APPLICATIONS;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES","5;4;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","ABNORMALITY;IGA NEPHROPATHY;ZINC;AGE-RELATED HEARING LOSS;BREASTFEEDING SUPPORT;COCHRANE COLLABORATION;DIAGNOSIS;ENDOMETRITIS;GLUTEN SENSITIVITY;INFLAMMATION;MECKEL'S DIVERTICULUM;METABOLIC REGULATION;MICROCEPHALY;P-GLYCOPROTEIN;POPULATION GENETICS;SNP;TISSUE TRANSGLUTAMINASE;TRAIT;ACETAZOLAMIDE;ACTION PLAN","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","GENE POLYMORPHISMS;ORAL ZINC;TREATING DIARRHOEA;BRAZILIAN CHILDREN;CELIAC DISEASE;CERVICAL CANCER;DIVERTICULUM MASKED;FINNISH HUNGARIAN;GROWTH HORMONE;INTERMITTENT RECURRENT;ITALIAN PATIENTS;ITALIAN POPULATIONS;MBL GENE;MECKELS DIVERTICULUM;MOLECULAR ANALYSIS;MOLECULAR FINDINGS;MYOCLONIC EPILEPSY;RECURRENT SUBOCCLUSIVE;SUBOCCLUSIVE EPISODES;ABCB GENE;ACQUIRED CHROMOSOME;ACUTE LYMPHOBLASTIC;ADENOMATOID MALFORMATIONS;ADVERSE DRUG;AGE-RELATED HEARING;AGEING KARYOTYPE;AIRWAY RECURRENT;ALAASP MUTATION;ALGLUCOSIDASE ALFA;ALLOGENEIC HEMATOPOIETIC","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","ANTI-TRANSGLUTAMINASE ANTIBODIES;AUTOSOMAL DOMINANT;OVARIAN CANCER;CELIAC DISEASE;COELIAC DISEASE;GH DEFICIENCY;ALPORT SYNDROME;ANALYSIS REVEALED;EPIDERMAL THICKNESS;FLOW CYTOMETRY;GROWTH HORMONE;ILR REGION;APL ANTIBODIES;COELIAC PATIENTS;CORNEAL THICKNESS;DENSITY-GRADIENT CENTRIFUGATION;FII MUT;HEARING LOSS;HIV INFECTION;INTRACRANIAL HYPERTENSION;ITGBBP GENE;LEUKOCYTE CONCENTRATION;OBESE CHILDREN;OPTICAL MICROSCOPY;PEROXIDASE TEST;PSYCHOLOGICAL DISTRESS;SPERM PREPARATION;STANDARD METHOD;SWEDISH PATIENTS;VERTICAL TRANSMISSION","7;7;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",14,0.16,7.7,3.75,1,1.75,0,8,3,0,1.75,4.5,0,1,1,1,1.5,0,0,1,0,0.75,0,109.75,109.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,4.86,145.25,5.74,0,0,7.71,0,0,1,1,5,0,0,0,0,5,0,0,0,0,0,0,0,5,2,0,5,2,0,0,0,0,0,0,0,0,"Italy","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","7;5;2;2;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;PEDIATRIC RESEARCH INITIATIVE;RARE DISEASES;STEM CELL RESEARCH;BIOTECHNOLOGY;CHRONIC PAIN;CONDITIONS AFFECTING THE EMBRYONIC AND FETAL PERIODS;HEADACHES;INFECTIOUS DISEASES;KIDNEY DISEASE;MIGRAINES;NEUROSCIENCES;PAIN RESEARCH;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREVENTION","5;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;RENAL AND UROGENITAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","2;1;1;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT","6;2;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LUNG CANCER;SARCOMA","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","2;1",1,257000,257000,4,1,1,0,9,118185,0.76151795913187,"IRCCS MATERNO INFANTILE BURLO GAROFOLO","1","TELETHON FOUNDATION","1",NA,NA,"TELETHON GRANT PROJECTS - 2009 (PROGRAM)","1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","1;1;1;1;1;1","BIOTECHNOLOGY;CLINICAL RESEARCH;GENETICS;HUMAN GENOME;NEUROSCIENCES;PREVENTION;REHABILITATION","1;1;1;1;1;1;1","EAR","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;4202 EPIDEMIOLOGY;3105 GENETICS;3208 MEDICAL PHYSIOLOGY","3;3;2;2;1;1","CLINICAL RESEARCH;CARDIOVASCULAR;GENETICS;HEMATOLOGY;HUMAN GENOME","3;1;1;1;1","GENERIC HEALTH RELEVANCE","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION","1;1","POPULATION & SOCIETY","1","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","2;1",NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2010,99,9.44444444444444,2.80808080808081,0.454545454545455,0.454545454545455,0.535353535353535,1.78205128205128,1.18421052631579,1.875,1.325,0.404040404040404,2,57,21,9,8,0.58,0.21,0.09,0.08,40.59,0.89810412591813,NA,0.434343434343434,0.909090909090909,0.477,0.436,0.48,0.465,"SÉRGIO CROVELLA;ALESSANDRO VENTURA;LUDOVICA SEGAT;PAOLO GASPARINI;ALESSANDRA PONTILLO;PAOLA SECCHIERO;LOREDANA LEPORE;RAFAEL LIMA GUIMARÃES;GIULIANA DECORTI;TARCISIO NOT;EMMANOUIL ATHANASAKIS;LUCAS ANDRÉ CAVALCANTI BRANDÃO;FEDERICA CORALLINI;GIORGIO ZAULI;MARGHERITA LONDERO;ANNA SAVOIA;ALBERTO TOMMASINI;MARCELLO MORGUTTI;FEDERICO MARCHETTI;ADRIANO CATTANEO","16;15;11;9;8;7;6;6;6;5;5;5;5;5;5;5;5;4;4;4","SÉRGIO CROVELLA;ALESSANDRO VENTURA;LUDOVICA SEGAT;ALESSANDRA PONTILLO;PAOLA SECCHIERO;ÖZCAN ÇENELİ;SERGIO PARCO;PAOLO GASPARINI;GIULIANA DECORTI;ALBERTO TOMMASINI;RAFAEL LIMA GUIMARÃES;FEDERICO MARCHETTI;GIORGIO ZAULI;MARGHERITA LONDERO;FEDERICA CORALLINI;SERENA PASTORE;LOREDANA LEPORE;CESARE CAMPELLO;ANGELA DE CUNTO;LAURA TRAVAN","2.65;2.35;1.59;1.49;1.06;1;1;0.97;0.9;0.9;0.76;0.76;0.75;0.74;0.73;0.71;0.7;0.68;0.67;0.67","SÉRGIO CROVELLA;ALESSANDRO VENTURA;LUDOVICA SEGAT;PAOLO GASPARINI;ALESSANDRA PONTILLO;LOREDANA LEPORE;TARCISIO NOT;EMMANOUIL ATHANASAKIS;GIORGIO ZAULI;MARGHERITA LONDERO;ANNA SAVOIA;ALBERTO TOMMASINI;MARCELLO MORGUTTI;FEDERICO MARCHETTI;ADRIANO CATTANEO;ANDREA TADDIO;SERENA PASTORE;CESARE CAMPELLO;GRAZIA DI LEO;GIULIO ANDREA ZANAZZO","16;15;11;9;8;6;5;5;5;5;5;5;4;4;4;4;4;4;3;3","SÉRGIO CROVELLA;ALESSANDRO VENTURA;LUDOVICA SEGAT;ALESSANDRA PONTILLO;ÖZCAN ÇENELİ;SERGIO PARCO;PAOLO GASPARINI;ALBERTO TOMMASINI;FEDERICO MARCHETTI;GIORGIO ZAULI;MARGHERITA LONDERO;SERENA PASTORE;LOREDANA LEPORE;CESARE CAMPELLO;ANGELA DE CUNTO;LAURA TRAVAN;TARCISIO NOT;EMMANOUIL ATHANASAKIS;ANNALISA MARCUZZI;ANDREA TADDIO","2.65;2.35;1.59;1.49;1;1;0.97;0.9;0.76;0.75;0.74;0.71;0.7;0.68;0.67;0.67;0.63;0.63;0.62;0.61","ADRIANO CATTANEO;SÉRGIO CROVELLA;ALESSANDRO VENTURA;RICCARDO DAVANZO;A‐M WIDSTRÖM;C PALLÁS‐ALLONSO;JACQUES SIZUN;JUAN GABRIEL RUÍZ;KH NYQVIST;NATHALIE CHARPAK;NILS BERGMAN;SOCORRO MENDOZA;SUSAN M. LUDINGTON‐HOE;UWE EWALD;ALESSANDRA PONTILLO;ANNA SAVOIA;LUDOVICA SEGAT;ALESSANDRO PECCI;VALERIA BOZZI;PATRIZIA NORIS","552;501;481;435;432;432;432;432;432;432;432;432;432;432;431;354;346;332;332;325","ADRIANO CATTANEO;SÉRGIO CROVELLA;ALESSANDRO VENTURA;RICCARDO DAVANZO;ALESSANDRA PONTILLO;LUDOVICA SEGAT;LOREDANA LEPORE;TARCISIO NOT;G. D’OTTAVIO;LAURA BLASON;MARIA BULGHERONI;STEFANIA ZOIA;ALBERTO TOMMASINI;PAOLO GASPARINI;DANIELA DE ROCCO;ANNA SAVOIA;CARMELA LANZARA;ANDREA TADDIO;GIULIO ANDREA ZANAZZO;VERONICA ILEANA GUERCI","552;501;459;435;417;346;295;264;262;262;262;262;207;197;184;170;151;142;141;133","SÉRGIO CROVELLA;ALESSANDRO VENTURA;LUDOVICA SEGAT;PAOLO GASPARINI;ALESSANDRA PONTILLO;LOREDANA LEPORE;TARCISIO NOT;GIORGIO ZAULI;ADRIANO CATTANEO;ANDREA TADDIO;MARCELLO MORGUTTI;ALBERTO TOMMASINI;EMMANOUIL ATHANASAKIS;CESARE CAMPELLO;FEDERICO MARCHETTI;GIULIO ANDREA ZANAZZO;GRAZIA DI LEO;SALVATORE ALBERICO;SERENA PASTORE;STEFANO MARTELOSSI","16;14;11;9;7;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;GEOGRAPHY;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY;ECONOMICS;ART;ENGINEERING;MATHEMATICS;POLITICAL SCIENCE","79;60;18;9;6;3;3;3;3;3;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;SURGERY;PEDIATRICS;ENDOCRINOLOGY;GASTROENTEROLOGY;PATHOLOGY;INTENSIVE CARE MEDICINE;NURSING;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;PHARMACOLOGY;VIROLOGY;MOLECULAR BIOLOGY;OPTICS;DEVELOPMENTAL PSYCHOLOGY;PSYCHIATRY","48;45;21;21;17;15;14;12;12;10;9;8;8;8;8;7;6;6;4;4","GENE;DISEASE;PREGNANCY;POPULATION;CANCER;ANTIBODY;CHEMOTHERAPY;ENZYME;IN VITRO;INCIDENCE (GEOMETRY);INFLAMMATION;STEM CELL;BREASTFEEDING;DIABETES MELLITUS;EPIDEMIOLOGY;IMMUNE SYSTEM;RECEPTOR;VIRUS;ANTIGEN;APOPTOSIS;BIOPSY;CENTRAL NERVOUS SYSTEM;COHORT;COHORT STUDY;HEARING LOSS;IMMUNOHISTOCHEMISTRY;INSULIN;INTENSIVE CARE;LYMPHOMA;MESENCHYMAL STEM CELL;PATHOGENESIS;PLATELET;QUALITY OF LIFE (HEALTHCARE);TUMOR NECROSIS FACTOR ALPHA","34;12;10;8;6;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","GENOTYPE;ALLELE;MUTATION;FETUS;GESTATIONAL AGE;PHENOTYPE;GESTATION;POLYMERASE CHAIN REACTION;BIOSYNTHESIS;COLORECTAL CANCER;DOWNREGULATION AND UPREGULATION;HAEMATOPOIESIS;HUMAN LEUKOCYTE ANTIGEN;ACTIVATOR (GENETICS);BASAL (MEDICINE);BLEEDING DIATHESIS;BREAST CANCER;CYTOTOXICITY;DEFENSIN;EXON;GENOME;GERANYLGERANIOL;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNE THROMBOCYTOPENIA;IN SILICO;INFLAMMASOME;INFLAMMATORY BOWEL DISEASE;INNATE IMMUNE SYSTEM;ISLET;LIVER BIOPSY;LOCUS (GENETICS);MYOSIN LIGHT-CHAIN KINASE;PERIPHERAL BLOOD MONONUCLEAR CELL;SENSORINEURAL HEARING LOSS;SYSTEMIC DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS;TYPE 1 DIABETES;UNIVARIATE ANALYSIS","16;10;10;6;6;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SINGLE-NUCLEOTIDE POLYMORPHISM;HAPLOTYPE;ALLELE FREQUENCY;MEVALONATE PATHWAY;MISSENSE MUTATION;ELTROMBOPAG;GENOTYPING;HLA-G;OSTEOPROTEGERIN;PANCREATIC ISLETS;THROMBOPOIETIN;ABATACEPT;ANTHOCYANIDINS;ASPARTATE TRANSAMINASE;BK VIRUS;CASPASE;CHIARI MALFORMATION;COLONOSCOPY;CONNEXIN;CORONAVIRUS DISEASE 2019 (COVID-19);CTGF;DASATINIB;DELPHINIDIN;DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;DORSOLATERAL PREFRONTAL CORTEX;ESOPHAGEAL VARICES;EXPECTANT MANAGEMENT;FARNESYL PYROPHOSPHATE;FRAMESHIFT MUTATION;GENETIC STRUCTURE;GERMLINE MUTATION;GESTATIONAL DIABETES;GLIOGENESIS;GLYCEMIC INDEX;GLYCOGEN STORAGE DISEASE TYPE II;HBSAG;HISTOCOMPATIBILITY;HYDROPS FETALIS;IMMATURE TERATOMA;IMPAIRED GLUCOSE TOLERANCE;IN UTERO;KRAS;LAMIVUDINE;LENTIVIRUS;LYMPHEDEMA;MALVIDIN;MAMMOGRAPHY;MEGAKARYOCYTE;MOLECULAR EPIDEMIOLOGY;MUTAGENESIS;MYH7;NALP3;NON-MENDELIAN INHERITANCE;NULL ALLELE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PARACELLULAR TRANSPORT;PELARGONIDIN;PLATELET GLYCOPROTEIN GPIB-IX COMPLEX;POLYHYDRAMNIOS;POLYMORPHISM (COMPUTER SCIENCE);POLYPLOID;PORTAL VENOUS PRESSURE;PRENATAL DIAGNOSIS;RANKL;RETINAL VASCULITIS;RISTOCETIN;RNA SPLICING;RUBELLA;SIDA;TAQMAN;THIOPURINE METHYLTRANSFERASE;TOBRAMYCIN;VENTROLATERAL PREFRONTAL CORTEX;VESICOURETERAL REFLUX;VON WILLEBRAND DISEASE;WANDERING SPLEEN","11;5;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADOLESCENT;CHILD;CHILD, PRESCHOOL;ITALY;ADULT;YOUNG ADULT;;ANIMALS;ANTINEOPLASTIC AGENTS;INFANT, NEWBORN;MICE;INFANT;GENETIC PREDISPOSITION TO DISEASE;HIV INFECTIONS;INFLAMMATION;MEVALONATE KINASE DEFICIENCY;MIDDLE AGED","77;53;51;31;29;24;23;21;20;15;15;14;13;13;12;11;11;11;11;11","MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;BIOSYNTHESIS AND ENGINEERING OF TERPENOIDS;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING;MORTALITY AND SEQUELAE OF PRETERM BIRTH;MULTIPOTENT MESENCHYMAL STEM CELLS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;SWEETENERS' TASTE AND IMPACT ON HEALTH;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;ANESTHESIA AND SEDATION MANAGEMENT;APPLICATIONS OF QUANTUM DOTS IN NANOTECHNOLOGY;ATOPIC DERMATITIS AND SKIN MICROBIOME","4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","SNP;GLUTEN SENSITIVITY;HIV;MEVALONATE PATHWAY;PATHOGENESIS;BASAL (MEDICINE);BITTER TASTE;BLEEDING DIATHESIS;CANCER THERAPY;ELTROMBOPAG;ENZYME REPLACEMENT THERAPY;GERANYLGERANIOL;GLYCOGEN STORAGE DISEASES;HEARING LOSS;HLA-G;IMMUNE RESPONSES;INFLAMMATION;INNATE IMMUNITY;KANGAROO CARE;KANGAROO MOTHER CARE","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CELIAC DISEASE;KINASE DEFICIENCY;MEVALONATE KINASE;MOTHER CARE;CASECONTROL STUDY;CELL TRANSPLANTATION;COHORT STUDY;COLON CANCER;CYSTIC FIBROSIS;FIBROSIS PATIENTS;HEARING LOSS;HEMATOPOIETIC STEM;INHERITED THROMBOCYTOPENIA;INTENSIVE CARE;KANGAROO MOTHER;LUPUS ERYTHEMATOSUS;MYH MUTATIONS;NEONATAL INTENSIVE;NORTHEAST BRAZIL;NORTHEAST ITALY;NORTHEASTERN ITALY;PEDIATRIC PATIENTS;STEM CELL;STROMAL CELLS;SYSTEMIC LUPUS;THROMBOCYTOPENIA DERIVING;TYPE II;AA INCREASES;ABATACEPT IMPROVES;ACCELERATION INDUCTION","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","BITTER TASTE;CROSSREF PUBMED;PUBMED SCOPUS;COLON CANCER;HIV- INFECTION;INFLAMMATORY MARKERS;RECEPTOR ACTIVATION;SPLICING PROCESS;STICKLER SYNDROME;ACID Α-GLUCOSIDASE;BLOODY DIARRHEA;CHILD HEALTH;CROHN DISEASE;HEPATIC GLYCOGENOSIS;MALAR RASH;MG KG;PRETERM CHILDREN;PRETERM CHILDRENS;RECOMBINANT TRAIL;VASCULITIC REACTIONS;AB HEPATOMEGALY;ABDOMINAL PAIN;ABNORMAL LIVER;ANA ANTI-DNA;ANALYSIS REVEALED;BALITIMORE -CROSSREF;BETA CELL;BODY WEIGHT;CELL DYSFUNCTION;CFJ MCCROSSIN","6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3",19,0.19,5,2,4,4,0,20,2,0,1.5,2,0,1,24.25,2,2,2,1,66.25,2.5,0,0,113.5,113.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,7.5,3280.5,2.04,1,0.33,49.33,0,0,0,0,2,0,0,1,0,2,0,0,0,0,0,0,0,2,1,0,2,1,0,0,0,0,0,0,0,0,"Germany","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;4204 MIDWIFERY","3;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;CANCER;CONDITIONS AFFECTING THE EMBRYONIC AND FETAL PERIODS;DIABETES;HEMATOLOGY;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;RARE DISEASES","2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1;1","6.1 PHARMACEUTICALS","2","LEUKEMIA / LEUKAEMIA","1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","2;2;2;1;1;1;1","DENTAL/ORAL AND CRANIOFACIAL DISEASE;NUTRITION","1;1",NA,NA,"1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
"IRCCS_BURLOGAROFOLO",2011,124,8.99193548387097,2.45967741935484,0.451612903225806,0.338709677419355,0.5,1.82634730538922,1.30232558139535,1.55555555555556,1.37777777777778,0.524193548387097,2,53,37,16,7,0.43,0.3,0.13,0.06,30.84,0.725031777143383,NA,0.411290322580645,0.911290322580645,0.447,0.375,0.42,0.386,"SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALESSANDRA PONTILLO;LOREDANA LEPORE;PAOLO GASPARINI;MARCO GATTORNO;ANNA SAVOIA;TARCISIO NOT;PATRIZIA NORIS;FEDERICO MARCHETTI;ANDREA TADDIO;STEFANO PENSIERO;SERGIO DEMARINI;FRANCESCO ZULIAN;PAOLA SECCHIERO;FRANCESCO TEDESCO;ALESSANDRO PECCI;ALBERTO TOMMASINI;CARLO L. BALDUINI;MARIA GRAZIA DI IASIO","15;10;8;8;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5","SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALESSANDRA PONTILLO;ADRIANO CATTANEO;LOREDANA LEPORE;SERGIO PARCO;STEFANO PENSIERO;EPAMEINONDAS V. TSIANOS;SERGIO DEMARINI;FEDERICO MARCHETTI;NAGUA GIURICI;MARIA GRAZIA DI IASIO;ANNALISA MARCUZZI;PAOLA SECCHIERO;TAMARO;PAOLO GASPARINI;TARCISIO NOT;REBECCA VOLTAN;FULVIO PARENTIN;GIULIO ANDREA ZANAZZO","2.55;1.75;1.42;1.37;1.16;1.08;1;1;0.98;0.94;0.9;0.85;0.84;0.77;0.75;0.75;0.71;0.68;0.67;0.63","SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALESSANDRA PONTILLO;LOREDANA LEPORE;PAOLO GASPARINI;ANNA SAVOIA;TARCISIO NOT;FEDERICO MARCHETTI;ANDREA TADDIO;STEFANO PENSIERO;SERGIO DEMARINI;PAOLA SECCHIERO;ALBERTO TOMMASINI;MARIA GRAZIA DI IASIO;CHIARA AGOSTINIS;ORIANO RADILLO;LUCA RONFANI;FULVIO PARENTIN;ADRIANO CATTANEO;GIORGIO ZAULI","15;10;8;8;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4","SÉRGIO CROVELLA;ALESSANDRO VENTURA;ALESSANDRA PONTILLO;ADRIANO CATTANEO;LOREDANA LEPORE;SERGIO PARCO;STEFANO PENSIERO;EPAMEINONDAS V. TSIANOS;SERGIO DEMARINI;FEDERICO MARCHETTI;NAGUA GIURICI;MARIA GRAZIA DI IASIO;ANNALISA MARCUZZI;PAOLA SECCHIERO;TAMARO;PAOLO GASPARINI;TARCISIO NOT;REBECCA VOLTAN;FULVIO PARENTIN;GIULIO ANDREA ZANAZZO","2.55;1.75;1.42;1.37;1.16;1.08;1;1;0.98;0.94;0.9;0.85;0.84;0.77;0.75;0.75;0.71;0.68;0.67;0.63","ALESSANDRA PONTILLO;SÉRGIO CROVELLA;MARCO RABUSIN;C J HAWKEY;CHRISTINA PETERS;CHRISTOPHER P. DENTON;DOMINIQUE FARGE;GIANLUIGI MANCARDI;JACOB M. VAN LAAR;JAKOB PASSWEG;JOHN A. SNOWDEN;JOHN J. MOORE;MATTHIEU ALLEZ;MONTSERRAT ROVIRA;MYRIAM LABOPIN;R. ARNOLD;RICARD CERVERA;RICCARDO SACCARDI;ROLAND MARTINꝈ;SANDRO ARDIZZONE","614;473;359;297;297;297;297;297;297;297;297;297;297;297;297;297;297;297;297;297","ALESSANDRA PONTILLO;SÉRGIO CROVELLA;MARCO RABUSIN;ANNA SAVOIA;DANIELA DE ROCCO;ALBERTO TOMMASINI;ALESSANDRO VENTURA;GIORGIO TAMBURLINI;MARCO PENNESI;BARBARA TOFFOLI;CHIARA AGOSTINIS;ORIANO RADILLO;ADRIANO CATTANEO;EGIDIO BARBI;GIORGIO ZAULI;PAOLO GASPARINI;STEFANO MARTELOSSI;ANNALISA FABRIS;ANNA VENDRAMIN;EULALIA CATAMO","503;409;359;295;292;217;211;184;163;152;145;124;119;118;109;109;104;99;95;95","SÉRGIO CROVELLA;ALESSANDRO VENTURA;LOREDANA LEPORE;ANNA SAVOIA;PAOLO GASPARINI;ALBERTO TOMMASINI;ALESSANDRA PONTILLO;STEFANO PENSIERO;ANDREA TADDIO;TARCISIO NOT;ADRIANO CATTANEO;ANNALISA MARCUZZI;CHIARA AGOSTINIS;GIORGIO ZAULI;MARIACRISTINA FERTZ;SERGIO DEMARINI;FULVIO PARENTIN;MARCO RABUSIN;FLAVIO FALETRA;STEFANO MARTELOSSI","12;9;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;SOCIOLOGY;COMPUTER SCIENCE;ECONOMICS;GEOGRAPHY;POLITICAL SCIENCE;BUSINESS;ENGINEERING;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;GEOLOGY","110;70;16;8;5;4;3;3;3;2;2;2;2;2;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;SURGERY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;ENDOCRINOLOGY;ANESTHESIA;CANCER RESEARCH;CELL BIOLOGY;DERMATOLOGY;FAMILY MEDICINE;OBSTETRICS;PSYCHIATRY;NURSING;VIROLOGY","65;54;34;29;20;19;18;11;10;10;9;8;8;7;7;7;7;7;6;6","GENE;DISEASE;PREGNANCY;POPULATION;INFLAMMATION;RHEUMATOLOGY;ADVERSE EFFECT;ALTERNATIVE MEDICINE;CANCER;ENZYME;TRANSPLANTATION;ANTIBODY;CHEMOTHERAPY;IMMUNE SYSTEM;LEUKEMIA;RANDOMIZED CONTROLLED TRIAL;BREASTFEEDING;CLINICAL TRIAL;COGNITION;IN VIVO;INCIDENCE (GEOMETRY);ODDS RATIO;STEM CELL","39;22;16;9;8;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4","GENOTYPE;MUTATION;ALLELE;FETUS;DOWNREGULATION AND UPREGULATION;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;BERNARD–SOULIER SYNDROME;BIOSYNTHESIS;CROHN'S DISEASE;FAMILIAL MEDITERRANEAN FEVER;GENE EXPRESSION;HUMAN LEUKOCYTE ANTIGEN;INFLAMMASOME;INFLAMMATORY BOWEL DISEASE;MITOCHONDRIAL DNA;PSYCHOMOTOR LEARNING;TRANSFECTION;CAESAREAN SECTION;CELL CYCLE;CHILDHOOD CANCER;CHRONIC LYMPHOCYTIC LEUKEMIA;CLINICAL ENDPOINT;COELIAC DISEASE;COLORECTAL CANCER;EX VIVO;FOXP3;GENE KNOCKDOWN;GENETIC PREDISPOSITION;HAEMATOPOIESIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLIXIMAB;KAWASAKI DISEASE;KIDNEY TRANSPLANTATION;LYMPHOBLASTIC LEUKEMIA;MANNAN-BINDING LECTIN;NEUROPSYCHOLOGY;NEUTROPENIA;PEDIGREE CHART;PHENOTYPE;PLACEBO;PLATELET MEMBRANE GLYCOPROTEIN;RENIN–ANGIOTENSIN SYSTEM;REPRODUCTIVE MEDICINE;THROMBOPHILIA;VENOUS THROMBOSIS","13;11;10;6;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SINGLE-NUCLEOTIDE POLYMORPHISM;HAPLOTYPE;PLACENTA;GENOTYPING;MEVALONATE PATHWAY;MISSENSE MUTATION;ACUTE LYMPHOCYTIC LEUKEMIA;ALLELE FREQUENCY;BAYLEY SCALES OF INFANT DEVELOPMENT;BK VIRUS;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);FACTOR V LEIDEN;FEBRILE NEUTROPENIA;GENE MUTATION;NALP3;PLATELET GLYCOPROTEIN GPIB-IX COMPLEX;POLYMORPHISM (COMPUTER SCIENCE);TRANSCRIPTOME;UNTRANSLATED REGION","5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;;ADOLESCENT;CHILD, PRESCHOOL;ADULT;INFANT;ITALY;CELIAC DISEASE;MIDDLE AGED;MUTATION;YOUNG ADULT;ENDOTHELIAL CELLS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;INFANT, NEWBORN;GENETIC PREDISPOSITION TO DISEASE;MONOCYTES;PIPERAZINES","82;58;53;36;35;28;28;25;23;20;19;15;15;13;12;12;12;11;11;11","MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EPILEPSY AND SEIZURES;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;GLOBAL MATERNAL AND CHILD HEALTH OUTCOMES;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS;NATURAL KILLER CELLS IN IMMUNITY;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PEDIATRIC CANCER AND QUALITY OF LIFE","9;7;6;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","DIAGNOSIS;INFLAMMATION;BERNARD–SOULIER SYNDROME;CELIAC DISEASE;CROHN'S DISEASE;DECIDUA;HEARING LOSS;HEMATOLOGY;MEVALONATE PATHWAY;PRETERM INFANTS;THROMBOSIS;TROPHOBLAST;;ACUTE LYMPHOCYTIC LEUKEMIA;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ANGIOTENSIN;ANGIOTENSIN-CONVERTING ENZYME 2;BILIRUBIN MEASUREMENT;BILIRUBIN METABOLISM;BREASTFEEDING","4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","INHERITED THROMBOCYTOPENIA;CELIAC DISEASE;KINASE DEFICIENCY;LEUKEMIC CELLS;MEVALONATE KINASE;NORTHEASTERN BRAZIL;NORTHEASTERN ITALY;PRETERM INFANTS;ACUTE LYMPHOBLASTIC;ALAVAL MUTATION;BOLZANO MUTATION;CHRONIC LYMPHOCYTIC;COHORT STUDY;CROHNS DISEASE;CRYOPYRIN-ASSOCIATED PERIODIC;ENDOTHELIAL CELLS;HEARING LOSS;HEMATOPOIETIC STEM;ITALIAN FAMILIES;LABORATORY FEATURES;LECTIN GENE;LYMPHOBLASTIC LEUKEMIA;MONOALLELIC ALAVAL;PATHWAY INDUCES;PHASE II;RANDOMIZED CONTROLLED;THROMBOCYTOPENIA DERIVED;THROMBOCYTOPENIA THC;ABACAVIR TREATED-HIV;ABSENCE EPILEPSY","4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","PUBMED SCOPUS;CROSSREF PUBMED;AUTOSOMAL DOMINANT;DOMINANT THROMBOCYTOPENIA;ANKRD MUTATIONS;BOLZANO MUTATION;CELIAC DISEASE;CELL LINES;CORD BLOOD;PEDIATRIC PATIENTS;UGI PATIENTS;CD PATIENTS;ENDOTHELIAL CELLS;ESOPHAGEAL ATRESIA;NECROTIZING TRACHEOBRONCHITIS;THC LOCUS;AUTOSOMAL-DOMINANT THROMBOCYTOPENIA;LEUKEMIC CELL;LINKAGE ANALYSIS;PERIODIC FEVER;STRUCTURAL MUTATIONS;TR CELLS;BONFILS FIBERSCOPE;CHIASMAL APLASIA;CHROMOSOMAL REGION;COLON ADENOCARCINOMA;CONFIDENCE INTERVAL;CROHNS DISEASE;DEL VECCHIO;DRACHMAN JG","32;25;16;10;9;9;9;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5",39,0.31,5.92,5,1,1,1,1,3,1,1,6.5,1,1,4.75,0,1,1,2,3,2.25,0,0,75,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,2,372.25,2.58,2,0.5,30.25,0,0,0,0,3,0,0,1,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy;France","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;36 CREATIVE ARTS AND WRITING;3603 MUSIC;39 EDUCATION;3901 CURRICULUM AND PEDAGOGY;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","4;3;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;MENTAL HEALTH;NEUROBLASTOMA;PEDIATRIC RESEARCH INITIATIVE;PREVENTION;RARE DISEASES","4;4;2;2;2;1;1;1;1;1;1;1;1","CANCER;MENTAL HEALTH","1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","3;1","NEUROBLASTOMA","1",NA,NA,1,289000,96333.33,3,3,1,1,25,96361.1111111111,1.28682617469011,"IRCCS MATERNO INFANTILE BURLO GAROFOLO;UNIVERSITY OF BARI ALDO MORO;UNIVERSITY OF BOLOGNA","1;1;1","TELETHON FOUNDATION","1",NA,NA,"TELETHON GRANT PROJECTS - 2011 (PROGRAM)","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS","1;1;1","EYE DISEASE AND DISORDERS OF VISION;GENETICS;NEURODEGENERATIVE;NEUROSCIENCES;PEDIATRIC;RARE DISEASES","1;1;1;1;1;1","EYE;NEUROLOGICAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,8,"PUBLIC LIBRARY OF SCIENCE","8","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3215 REPRODUCTIVE MEDICINE;4206 PUBLIC HEALTH;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4204 MIDWIFERY","10;7;4;2;1;1;1;1","CLINICAL RESEARCH;LUNG","1;1","INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","HEALTH SERVICES & SYSTEMS;POPULATION & SOCIETY","1;1","PUBLIC HEALTH","2",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_BURLOGAROFOLO",2012,122,10.2459016393443,2.90983606557377,0.442622950819672,0.508196721311475,0.540983606557377,2.03448275862069,1.2,1.63157894736842,1.32,0.459016393442623,0,49,31,18,19,0.4,0.25,0.15,0.16,29.72,0.711575206404983,4.82913669064748,0.360655737704918,0.877049180327869,0.455,0.368,0.425,0.426,"SÉRGIO CROVELLA;LUCA RONFANI;LORENZO MONASTA;ALESSANDRO VENTURA;PAOLO GASPARINI;GIORGIO ZAULI;MARCELLA MONTICO;EGIDIO BARBI;MANOLA COMAR;IRENE BERTI;VALENTINA ZANIN;PAOLA SECCHIERO;RICCARDO DAVANZO;FLAVIO FALETRA;ANNALISA MARCUZZI;IVA MAESTRI;MATTEO CECCARELLO;EMMANOUIL ATHANASAKIS;SERGIO DEMARINI;LUDOVICA SEGAT","17;13;11;10;9;8;8;8;7;6;6;6;6;6;6;5;5;5;5;5","SÉRGIO CROVELLA;LUCA RONFANI;GIORGIO ZAULI;LORENZO MONASTA;ALESSANDRO VENTURA;EGIDIO BARBI;IRENE BERTI;PAOLO GASPARINI;RICCARDO DAVANZO;SERGIO PARCO;VASCOTTO;MARCELLA MONTICO;PAOLA SECCHIERO;FLAVIO FALETRA;VALENTINA ZANIN;SERGIO DEMARINI;MANOLA COMAR;ANNALISA MARCUZZI;MARIA GRAZIA DI IASIO;LUDOVICA SEGAT","2.21;1.85;1.61;1.57;1.56;1.16;1.14;1.02;1;1;1;1;0.86;0.84;0.84;0.82;0.82;0.76;0.75;0.73","SÉRGIO CROVELLA;LUCA RONFANI;LORENZO MONASTA;ALESSANDRO VENTURA;PAOLO GASPARINI;GIORGIO ZAULI;MARCELLA MONTICO;EGIDIO BARBI;MANOLA COMAR;IRENE BERTI;VALENTINA ZANIN;RICCARDO DAVANZO;FLAVIO FALETRA;ANNALISA MARCUZZI;MATTEO CECCARELLO;EMMANOUIL ATHANASAKIS;SERGIO DEMARINI;LUDOVICA SEGAT;STEFANO RESTAINO;LIZA VECCHI BRUMATTI","17;13;11;10;9;8;8;8;7;6;6;6;6;6;5;5;5;5;4;4","SÉRGIO CROVELLA;LUCA RONFANI;GIORGIO ZAULI;LORENZO MONASTA;ALESSANDRO VENTURA;EGIDIO BARBI;IRENE BERTI;PAOLO GASPARINI;RICCARDO DAVANZO;VASCOTTO;MARCELLA MONTICO;FLAVIO FALETRA;VALENTINA ZANIN;SERGIO DEMARINI;MANOLA COMAR;ANNALISA MARCUZZI;LUDOVICA SEGAT;GIULIA PALONI;EMMANOUIL ATHANASAKIS;FEDERICO MARCHETTI","2.21;1.85;1.61;1.57;1.56;1.16;1.14;1.02;1;1;1;0.84;0.84;0.82;0.82;0.76;0.73;0.67;0.66;0.64","MARCELLA MONTICO;LUCA RONFANI;TÕNU ESKO;LORENZO MONASTA;ALEXANDER TEUMER;CHRISTA MEISINGER;FEDERICO MURGIA;MAN LI;MATTHIAS NAUCK;SHEILA ULIVI;THOMAS ILLIG;MICHELA TRAGLIA;SARAH E. MEDLAND;NICOLA PIRASTU;MARCO CARROZZI;CHIARA BARBIERO;ISABELLA LONCIARI;ABDEL ABDELLAOUI;ABTEHALE AL-HUSSANI;AFSHIN PARSA","540;478;445;423;382;382;382;382;382;382;382;379;373;365;363;347;347;316;316;316","MARCELLA MONTICO;LUCA RONFANI;LORENZO MONASTA;SHEILA ULIVI;MARCO CARROZZI;CHIARA BARBIERO;ISABELLA LONCIARI;GIORGIA GIROTTO;NICOLA PIRASTU;LAURA BRAVAR;SERGIO DEMARINI;PAOLO GASPARINI;SÉRGIO CROVELLA;RICCARDO DAVANZO;MANOLA COMAR;ALESSANDRO VENTURA;ANNA SAVOIA;FULVIO PARENTIN;EVA ORZAN;LIZA VECCHI BRUMATTI","464;427;423;382;363;347;347;316;316;281;238;198;196;185;162;154;153;150;148;145","SÉRGIO CROVELLA;LORENZO MONASTA;LUCA RONFANI;MANOLA COMAR;ALESSANDRO VENTURA;PAOLO GASPARINI;GIORGIO ZAULI;EGIDIO BARBI;IRENE BERTI;VALENTINA ZANIN;RICCARDO DAVANZO;ANNALISA MARCUZZI;LUDOVICA SEGAT;SERGIO DEMARINI;ANNA SAVOIA;EMMANOUIL ATHANASAKIS;FLAVIO FALETRA;FRANCESCO DE SETA;LIZA VECCHI BRUMATTI;MARCELLA MONTICO","14;11;11;9;8;8;8;7;6;6;5;5;5;5;4;4;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;SOCIOLOGY;MATERIALS SCIENCE;COMPUTER SCIENCE;ENGINEERING;PHILOSOPHY;POLITICAL SCIENCE;ECONOMICS;GEOGRAPHY;MATHEMATICS","99;69;12;9;9;7;6;5;4;4;4;3;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;SURGERY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;OBSTETRICS;DERMATOLOGY;ENDOCRINOLOGY;GYNECOLOGY;MOLECULAR BIOLOGY;DEMOGRAPHY;METALLURGY;MICROBIOLOGY;RADIOLOGY;ANATOMY;ANESTHESIA;CANCER RESEARCH;INTENSIVE CARE MEDICINE;OPTICS;PSYCHIATRY;VIROLOGY","63;51;31;26;24;23;13;12;11;11;10;9;9;9;6;6;6;6;5;5;5;5;5;5;5","GENE;DISEASE;PREGNANCY;POPULATION;ANTIBODY;APOPTOSIS;CANCER;BREASTFEEDING;IMMUNE SYSTEM;ADVERSE EFFECT;ANTIBIOTICS;COHORT;ENZYME;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IN VITRO;INCIDENCE (GEOMETRY);INFLAMMATION;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;ASBESTOS;BACTERIAL VAGINOSIS;JAUNDICE;LEUKEMIA;MESOTHELIOMA;TUMOR NECROSIS FACTOR ALPHA","33;13;13;10;7;7;7;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4","GENOTYPE;MUTATION;PHENOTYPE;ALLELE;EXON;CHROMOSOME;FETUS;GESTATIONAL AGE;PERIPHERAL BLOOD MONONUCLEAR CELL;AUTOIMMUNE DISEASE;BIRTH WEIGHT;CANDIDATE GENE;CHRONIC LYMPHOCYTIC LEUKEMIA;DYSLEXIA;GESTATION;INSULIN RESISTANCE;VAGINAL FLORA;ACTIVATOR (GENETICS);AUTOANTIBODY;BERNARD–SOULIER SYNDROME;CERVICAL CANCER;COLOSTRUM;CYTOPENIA;DENDRITIC CELL;GENETIC VARIATION;GENOME;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HYPOHIDROTIC ECTODERMAL DYSPLASIA;INFLAMMASOME;INJURY PREVENTION;MERKEL CELL CARCINOMA;PLACEBO;PLATELET DISORDER;POLYMERASE CHAIN REACTION;PREECLAMPSIA;PROGRAMMED CELL DEATH;RANDOMIZATION;REDUCTASE;RESPIRATORY DISEASE;RIFAXIMIN;RNA;TOLERABILITY;VIRAL DISEASE","14;12;9;8;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SINGLE-NUCLEOTIDE POLYMORPHISM;FRAMESHIFT MUTATION;GENOTYPING;HAPLOTYPE;MEVALONATE PATHWAY;COMPOUND HETEROZYGOSITY;EXOME SEQUENCING;GENE MUTATION;GENETIC HETEROGENEITY;HPV INFECTION;MERKEL CELL POLYOMAVIRUS;PENETRANCE;PLACENTA;PLEURAL DISEASE;PROBAND;RNA SPLICING;UTERINE ARTERY;ABSOLUTE NEUTROPHIL COUNT;ADIPOKINE;AIM2;ALLELE FREQUENCY;ALTERNATIVE SPLICING;ANEUPLOIDY;AUTOIMMUNE REGULATOR;BAYLEY SCALES OF INFANT DEVELOPMENT;BLOOD PLATELET DISORDERS;BRADYCARDIA;CARDIOTOCOGRAPHY;CASPASE;CASPASE 1;CD38;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHILD ABUSE;CHILDHOOD OBESITY;CONDITIONING REGIMEN;CORONAVIRUS DISEASE 2019 (COVID-19);CROHN DISEASE;DC-SIGN;DEVELOPMENTAL DYSLEXIA;DOMESTIC VIOLENCE;E2F1;ELIMINATION DIET;FAMILY PLANNING;FARNESYL PYROPHOSPHATE;FETAL HEART RATE;FINASTERIDE;GENETIC ARCHITECTURE;GENETIC SCREEN;GERANYLGERANYL PYROPHOSPHATE;GLUTATHIONE S-TRANSFERASE;HERPESVIRIDAE;HMG-COA REDUCTASE;HUMAN BREAST;HUMAN PAPILLOMA VIRUS;HYPERINSULINISM;IGHV@;INVOLUCRIN;JC VIRUS;LEBER'S HEREDITARY OPTIC NEUROPATHY;LENTIVIRUS;LONG ARM;LYME BORRELIOSIS;MALE INFERTILITY;MAMMARY GLAND;MASSIVE PARALLEL SEQUENCING;MERKEL CELL;MEVALONIC ACID;MISSENSE MUTATION;MONOOXYGENASE;MULTIPLEX POLYMERASE CHAIN REACTION;NEUROBORRELIOSIS;NOGGIN;ORAL FOOD CHALLENGE;PAPILLOMAVIRIDAE;PERFORIN;PLATELET GLYCOPROTEIN GPIB-IX COMPLEX;PRENATAL DIAGNOSIS;RANKL;SULFONYLUREA RECEPTOR;TEMPERATURE GRADIENT GEL ELECTROPHORESIS;TESTIS DETERMINING FACTOR;WHOLE GENOME SEQUENCING;WILD TYPE","9;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ADULT;ITALY;INFANT;;MIDDLE AGED;POLYMORPHISM, SINGLE NUCLEOTIDE;INFANT, NEWBORN;MUTATION;YOUNG ADULT;GENETIC PREDISPOSITION TO DISEASE;MESOTHELIOMA;THROMBOCYTOPENIA;HIV INFECTIONS;ABNORMALITIES, MULTIPLE","100;65;52;39;32;27;26;26;24;20;16;16;15;15;15;13;11;11;10;9","MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;DEVELOPMENT OF READING SKILLS AND DYSLEXIA;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;BIOLOGY AND PATHOLOGY OF KERATINS AND RELATED DISORDERS;BIOSYNTHESIS AND ENGINEERING OF TERPENOIDS;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;GENOMIC STUDIES AND ASSOCIATION ANALYSES;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR MECHANISMS OF TOOTH DEVELOPMENT AND MORPHOGENESIS;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2","4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","BREASTFEEDING;BREASTFEEDING SUPPORT;ASBESTOS EXPOSURE;BREASTFEEDING DURATION;CANDIDATE GENE;GENETIC ASSOCIATION;GIRL;HIV;MALIGNANT PLEURAL MESOTHELIOMA;MEVALONATE PATHWAY;SNP;VAGINAL FLORA;BERNARD–SOULIER SYNDROME;BILIRUBIN MEASUREMENT;BILIRUBIN METABOLISM;CELIAC DISEASE;COMPOUND HETEROZYGOSITY;CYTOPENIA;DECIDUA;DECIDUAL CELLS","4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","CELIAC DISEASE;LYMPHOCYTIC LEUKEMIA;MALIGNANT PLEURAL;PATIENTS AFFECTED;PLEURAL MESOTHELIOMA;ABCC MUTATIONS;APOPTOSIS-INDUCING LIGAND;ARTERY DOPPLER;B-CHRONIC LYMPHOCYTIC;BACTERIAL VAGINOSIS;CELL TRANSPLANTATION;ECTODERMAL DYSPLASIA;FREE Β-HCG;HUMAN COLOSTRUM;HUMAN PAPILLOMAVIRUS;ITALIAN PATIENT;KINASE DEFICIENCY;LETTER SPACING;MATERNAL HISTORY;MATERNAL SERUM;MERKEL-CELL POLYOMAVIRUS;MEVALONATE KINASE;MYH-RELATED DISEASE;NATURAL HISTORY;NORTH-EASTERN ITALY;OBSERVATIONAL STUDY;OCCURS LATE;PAPP-A PP-;PP- UTERINE;STEM CELL","3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ISOLATED MESENTERIC;MESENTERIC CASTLEMANS;PUBMED SCOPUS;ABDOMINAL MASS;PUBMED GOOGLE;ALA RARE;CASTLEMANS DISEASE;CASTLEMANS DISEASEJ;DIS -PUBMED;DISEASEJ GASTROINTEST;GASTROINTEST LIVER;LIVER DIS;MASS ISOLATED;RARE FORM;CASTLEMAN DISEASE;BLOOD CELL;CASTLEMAN DISEASEJ;RED BLOOD;CROSSREF PUBMED;MG DAYS;PERIPHERAL BLOOD;CELL TRANSPLANTATION;CENTERS REGISTRY;CENTRAL EUROPEAN;CLINICAL IMMUNOLOGYPRIMARY;CLINICAL PRESENTATIONS;COMPLEX CLINICAL;CONGENITAL HEMANGIOMA;DATA BRING;DIFFERENTIAL DIAGNOSIS","24;24;16;13;13;12;12;12;12;12;12;12;12;12;10;9;9;9;8;7;7;6;6;6;6;6;6;6;6;6",52,0.43,6.36,4,3,2.5,2,5,2,0,1,5.25,2,1,4.25,0,2.5,1.75,3.5,3,2.75,0,0,78,78.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,7,82,1.25,0,0,8.5,0,0,1,0,1,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","2;1;1","PEDIATRIC;CANCER;CHILDHOOD LEUKEMIA;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEALTH SERVICES;HEMATOLOGY;INFECTIOUS DISEASES;LUNG;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;RARE DISEASES","2;1;1;1;1;1;1;1;1;1;1;1;1;1","RESPIRATORY","1","5.1 PHARMACEUTICALS;6.7 PHYSICAL","1;1","LEUKEMIA / LEUKAEMIA","1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,"PUBLIC LIBRARY OF SCIENCE","17","31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;47 LANGUAGE, COMMUNICATION AND CULTURE;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;4202 EPIDEMIOLOGY;3202 CLINICAL SCIENCES;4206 PUBLIC HEALTH;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;4701 COMMUNICATION AND MEDIA STUDIES;4704 LINGUISTICS","17;11;8;7;4;3;3;2;2;1;1;1","GENETICS;HUMAN GENOME;BRAIN DISORDERS;PEDIATRIC;PREVENTION;AGING;BIOTECHNOLOGY;BURDEN OF ILLNESS;CLINICAL RESEARCH;DIABETES;EYE DISEASE AND DISORDERS OF VISION;GENETIC TESTING;INFECTIOUS DISEASES;KIDNEY DISEASE;MENTAL HEALTH;OTITIS MEDIA;RARE DISEASES","6;5;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL","2;1;1","2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","3;3;2;1;1","BIOMEDICAL;CLINICAL;POPULATION & SOCIETY","3;1;1","PUBLIC HEALTH;CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","6;5;2","NOT SITE-SPECIFIC CANCER","1","3 GOOD HEALTH AND WELL BEING","3"
"IRCCS_BURLOGAROFOLO",2013,159,9.85534591194969,3.0125786163522,0.364779874213836,0.465408805031447,0.553459119496855,2.12444444444444,1.28888888888889,1.94736842105263,1.41935483870968,0.515723270440252,2,66,57,13,15,0.42,0.36,0.08,0.09,28.58,0.81922627109683,4.45209580838323,0.314465408805031,0.849056603773585,0.538,0.382,0.422,0.416,"ALESSANDRO VENTURA;LORENZO MONASTA;SÉRGIO CROVELLA;LOREDANA LEPORE;GIORGIO ZAULI;SERGIO DEMARINI;PAOLO GASPARINI;STEFANO MARTELOSSI;LUCA RONFANI;FEDERICA PEDERIVA;ANDREA TADDIO;PAOLA SECCHIERO;LAURA TRAVAN;MANOLA COMAR;TARCISIO NOT;ALBERTO MARTINI;GIULIO ANDREA ZANAZZO;LUDOVICA SEGAT;ANGELA DE CUNTO;RICCARDO DAVANZO","16;15;13;11;11;10;9;9;8;8;8;8;7;6;6;6;6;6;6;6","ALESSANDRO VENTURA;FEDERICA PEDERIVA;LORENZO MONASTA;LOREDANA LEPORE;SÉRGIO CROVELLA;GIORGIO ZAULI;SERGIO DEMARINI;SERENA PASTORE;ANDREA TADDIO;STEFANO MARTELOSSI;ADRIANO CATTANEO;IRENE BERTI;ANGELA DE CUNTO;PAOLA SECCHIERO;PAOLO GASPARINI;STEFANO PENSIERO;GIULIA PALONI;AGOSTINO ACCARDO;LUCA RONFANI;RICCARDO DAVANZO","2.47;2.34;2.15;1.84;1.82;1.61;1.58;1.45;1.43;1.38;1.35;1.17;1.13;1.12;0.97;0.96;0.92;0.92;0.88;0.88","ALESSANDRO VENTURA;LORENZO MONASTA;SÉRGIO CROVELLA;LOREDANA LEPORE;GIORGIO ZAULI;SERGIO DEMARINI;PAOLO GASPARINI;STEFANO MARTELOSSI;LUCA RONFANI;FEDERICA PEDERIVA;ANDREA TADDIO;PAOLA SECCHIERO;LAURA TRAVAN;MANOLA COMAR;TARCISIO NOT;GIULIO ANDREA ZANAZZO;LUDOVICA SEGAT;ANGELA DE CUNTO;RICCARDO DAVANZO;IRENE BERTI","16;15;13;11;11;10;9;9;8;8;8;8;7;6;6;6;6;6;6;5","ALESSANDRO VENTURA;FEDERICA PEDERIVA;LORENZO MONASTA;LOREDANA LEPORE;SÉRGIO CROVELLA;GIORGIO ZAULI;SERGIO DEMARINI;SERENA PASTORE;ANDREA TADDIO;STEFANO MARTELOSSI;ADRIANO CATTANEO;IRENE BERTI;ANGELA DE CUNTO;PAOLA SECCHIERO;PAOLO GASPARINI;STEFANO PENSIERO;GIULIA PALONI;LUCA RONFANI;RICCARDO DAVANZO;MANOLA COMAR","2.47;2.34;2.15;1.84;1.82;1.61;1.58;1.45;1.43;1.38;1.35;1.17;1.13;1.12;0.97;0.96;0.92;0.88;0.88;0.85","PAOLO GASPARINI;LORENZO MONASTA;GIORGIO ZAULI;PIO D’ADAMO;CARLO L. BALDUINI;ANNALISA MARCUZZI;GIULIO KLEINER;VALENTINA ZANIN;GIOVANNA RUSSO;MARIA PIA CICALESE;MASSIMO ZEVIANI;A. DE NEGRI;ADRIANA BEREZOVSKY;ALESSANDRA MARESCA;ALFREDO A. SADUN;ANDREA TANCREDI;ANGELA PYLE;ANNALINDA PISANO;CARLA GIORDANO;DORA FIX VENTURA","550;537;528;424;392;355;355;349;289;278;273;251;251;251;251;251;251;251;251;251","PAOLO GASPARINI;GIORGIO ZAULI;LORENZO MONASTA;GIULIO KLEINER;ANNALISA MARCUZZI;VALENTINA ZANIN;PIO D’ADAMO;ANNA SAVOIA;LUCA RONFANI;NICOLA PIRASTU;SHEILA ULIVI;ALBERTO TOMMASINI;RICCARDO DAVANZO;SERGIO DEMARINI;ALESSANDRO VENTURA;FRANCESCO FANFANI;LOREDANA LEPORE;FLAVIO FALETRA;LAURA TRAVAN;ANGELA DE CUNTO","550;521;513;355;349;349;273;244;244;228;228;199;187;185;171;171;169;168;162;145","ALESSANDRO VENTURA;LORENZO MONASTA;LOREDANA LEPORE;GIORGIO ZAULI;SERGIO DEMARINI;PAOLO GASPARINI;STEFANO MARTELOSSI;LUCA RONFANI;FEDERICA PEDERIVA;ANDREA TADDIO;ANGELA DE CUNTO;GIULIO ANDREA ZANAZZO;LAURA TRAVAN;RICCARDO DAVANZO;SÉRGIO CROVELLA;LUDOVICA SEGAT;GIORGIO TAMBURLINI;GIULIO KLEINER;TARCISIO NOT;MANOLA COMAR","14;14;10;10;10;9;9;8;7;6;6;6;6;6;6;6;5;5;5;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;SOCIOLOGY;MATHEMATICS;COMPUTER SCIENCE;POLITICAL SCIENCE;MATERIALS SCIENCE;ECONOMICS;PHILOSOPHY;ENGINEERING;ART;GEOGRAPHY;GEOLOGY","136;88;19;17;13;11;9;5;5;4;3;3;2;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;BIOCHEMISTRY;PATHOLOGY;SURGERY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;CANCER RESEARCH;GASTROENTEROLOGY;OBSTETRICS;PSYCHIATRY;VIROLOGY;DEMOGRAPHY;PHARMACOLOGY;INTENSIVE CARE MEDICINE;DERMATOLOGY;ANESTHESIA;MICROBIOLOGY;OPTICS;PALEONTOLOGY","85;58;48;32;25;25;24;14;14;12;12;11;11;11;10;10;9;8;7;7;7;7","GENE;DISEASE;PREGNANCY;POPULATION;ANTIBODY;IMMUNE SYSTEM;INFLAMMATION;RHEUMATOLOGY;BREASTFEEDING;CANCER;VIRUS;COHORT;IN VITRO;TUMOR NECROSIS FACTOR ALPHA;CHEMOTHERAPY;COGNITION;BACTERIA;DIABETES MELLITUS;IN VIVO;ALTERNATIVE MEDICINE;APOPTOSIS;BREAST FEEDING;CONFIDENCE INTERVAL;CYTOKINE;ENZYME;IMMUNOHISTOCHEMISTRY;LEUKEMIA;RANDOMIZED CONTROLLED TRIAL","37;28;15;14;13;10;9;9;8;8;8;7;7;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4","MUTATION;GENOTYPE;PHENOTYPE;AUTOANTIBODY;GESTATION;GESTATIONAL AGE;INFLAMMATORY BOWEL DISEASE;RITUXIMAB;AUTOIMMUNITY;CERVICAL CANCER;FETUS;PSYCHOMOTOR LEARNING;ALLELE;ANAKINRA;AZATHIOPRINE;BREAST CANCER;CD20;CHEMOKINE;CHRONIC LYMPHOCYTIC LEUKEMIA;CUMULATIVE INCIDENCE;EXON;INFLIXIMAB;LOCUS (GENETICS);MONOCLONAL ANTIBODY;TYPE 1 DIABETES","14;12;11;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","SINGLE-NUCLEOTIDE POLYMORPHISM;EXOME SEQUENCING;CANAKINUMAB;GENETIC HETEROGENEITY;PENETRANCE;BAYLEY SCALES OF INFANT DEVELOPMENT;BK VIRUS;CHLORAMBUCIL;CORONAVIRUS DISEASE 2019 (COVID-19);GENE MUTATION;IL-2 RECEPTOR;MERKEL CELL POLYOMAVIRUS;MEVALONATE PATHWAY;MISSENSE MUTATION;PROBAND;RADICAL HYSTERECTOMY;THIOPURINE METHYLTRANSFERASE;ADAPTIVE RADIATION;ADULT STEM CELL;ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS;AMNIOTIC FLUID;AMPLICON;APGAR SCORE;ARBOVIRUS INFECTIONS;AXILLA;BIOPHYSICAL PROFILE;C DIFFICILE;CARDIOTOCOGRAPHY;CHORIOAMNIONITIS;COLONOSCOPY;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;CRYOGLOBULINEMIA;CXCL10;DEBULKING;DIGITAL IMAGE;DOUBLE BLIND;DUCTAL CARCINOMA;EPITHELIAL OVARIAN CANCER;EVANS SYNDROME;FANCONI ANEMIA;FETAL GROWTH;FICOLIN;FUNCTIONAL NEAR-INFRARED SPECTROSCOPY;GATA1;GENOTYPE-PHENOTYPE DISTINCTION;GENOTYPING;HAPLOTYPE;HETEROZYGOTE ADVANTAGE;HYPERINSULINEMIC HYPOGLYCEMIA;HYPERINSULINISM;IMATINIB MESYLATE;INFLAMMATORY BOWEL DISEASES;INGUINAL CANAL;INTERCELLULAR ADHESION MOLECULE;JC VIRUS;KETOACIDOSIS;LEBER'S HEREDITARY OPTIC NEUROPATHY;LOSS FUNCTION;LOSS OF HETEROZYGOSITY;LOW LEVEL LASER THERAPY;MECONIUM;MERKEL CELL;MEVALONIC ACID;MICROARRAY;MICROVESICLES;MITOCHONDRIAL DISEASE;MOLECULAR EPIDEMIOLOGY;MOLECULAR MEDICINE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NEAR-FIELD SCANNING OPTICAL MICROSCOPE;NEOADJUVANT THERAPY;OMALIZUMAB;ONCOGENE;P-GLYCOPROTEIN;PARAMETRIUM;PAX6;PHARMACOGENETICS;PLACENTA;PODOCYTE;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;PROSTATECTOMY;RAFT;RIBAVIRIN;SCANNING ION-CONDUCTANCE MICROSCOPY;SCORAD;SERINE PROTEASE;STREPTOCOCCUS BOVIS;STREPTOCOCCUS PYOGENES;TAKAYASU'S ARTERITIS;TELEPATHOLOGY;TELERADIOLOGY;TESTIS DETERMINING FACTOR;UMBILICAL ARTERY;UNTRANSLATED REGION","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ITALY;;MIDDLE AGED;INFANT;INFANT, NEWBORN;YOUNG ADULT;AGED;ANIMALS;TNF-RELATED APOPTOSIS-INDUCING LIGAND;PREGNANCY;BREAST FEEDING;GENOTYPE;CYTOKINES","120;89;80;40;36;35;33;33;32;26;24;23;20;19;18;15;14;13;13;12","MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MORTALITY AND SEQUELAE OF PRETERM BIRTH;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;EFFECTIVE STRATEGIES FOR WRITING INSTRUCTION IN EDUCATION;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EVOLUTION OF CHILD HEALTH SERVICES IN EUROPE;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GYNECOLOGIC ONCOLOGY;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH","8;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","BREASTFEEDING SUPPORT;CANAKINUMAB;CHILD HEALTH;CUMULATIVE INCIDENCE;EXOME;HEARING LOSS;INFLAMMATION;INTERLEUKIN-1;JUVENILE IDIOPATHIC ARTHRITIS;PENETRANCE;PRENATAL DIAGNOSIS;TYPE 1 DIABETES;APPENDICITIS;ASBESTOS EXPOSURE;BREASTFEEDING;BREASTFEEDING DURATION;BREASTFEEDING PROMOTION;C-PEPTIDE LEVELS;CANDIDATE GENE;CHLORAMBUCIL","4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","BOWEL DISEASE;INFLAMMATORY BOWEL;TYPE DIABETES;CELIAC DISEASE;GENE POLYMORPHISMS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;KINASE DEFICIENCY;MEVALONATE KINASE;MOUSE MODEL;ANTI-CD NANOPARTICLES;B-CELL MALIGNANCIES;CAESAREAN DELIVERY;CELL TRANSPLANTATION;CHILD HEALTH;CHLORAMBUCILHYDROXYCHLOROQUINE-LOADED ANTI-CD;CHRONIC UVEITIS;CHRONIC VENOUS;CONTROLLED TRIAL;CYSTIC FIBROSIS;DEVELOPMENT MATURATION;DIABETES MELLITUS;ENDOTHELIAL CELLS;FISH CONSUMPTION;HANDWRITING KINEMATICS;HEALTHY SUBJECTS;HEARING LOSS;HUMAN PAPILLOMAVIRUS;LEARNING INFLUENCE;MANNOSE BINDING","4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CD RATES;PUBMED SCOPUS;WILMS TUMOR;ABDOMINAL PAIN;CHILD HEALTH;CROSSREF PUBMED;DIGITAL X-RAY;ENDOTHELIAL CELLS;GESTATIONAL AGE;HEALTH RESEARCH;PHYSICAL EXAMINATION;PLATELET COUNT;RISK FACTORS;SERUM LEVELS;ADA START;FISH INTAKE;LEFT PARADUODENAL;MITOCHONDRIAL DNA;SEROTONIN SERUM;TPHABS PATIENTS;UNCOMPLICATED PREGNANCIES;X-RAY IMAGES;ACUTE PHASE;ACUTE PYELONEPHRITIS;ANTI-CD NANOPARTICLES;BODY COMPOSITION;CLINICAL REMISSION;COMPUTED TOMOGRAPHY;EXAMINATION REVEALED;FA PATIENTS","14;11;7;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4",67,0.42,5.12,3.5,1,1.5,1,2,1.25,0,1.5,4,0,0,3,0,2,1,1,3,1,0,0,83.5,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1.25,1240.5,2,0,0,4.75,0,0,0,1,2,0,0,1,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Switzerland","1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS","3;2;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CANCER;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;NUTRITION;PAIN RESEARCH;PREVENTION","2;2;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;MENTAL HEALTH","1;1;1","6.1 PHARMACEUTICALS;8.1 ORGANISATION AND DELIVERY OF SERVICES","1;1","NOT SITE-SPECIFIC CANCER","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,58,"PUBLIC LIBRARY OF SCIENCE","58","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;3105 GENETICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;4204 MIDWIFERY;44 HUMAN SOCIETY;34 CHEMICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;33 BUILT ENVIRONMENT AND DESIGN;40 ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4206 PUBLIC HEALTH;4403 DEMOGRAPHY;47 LANGUAGE, COMMUNICATION AND CULTURE;49 MATHEMATICAL SCIENCES;52 PSYCHOLOGY;3003 ANIMAL PRODUCTION","48;18;17;9;7;6;4;4;4;3;2;2;2;2;2;2;2;2;2;1","GENETICS;HUMAN GENOME;CLINICAL RESEARCH;HEMATOLOGY;PEDIATRIC;RARE DISEASES;CANCER;LYMPHOMA;NEUROSCIENCES;BIOENGINEERING;BIOTECHNOLOGY;BRAIN DISORDERS;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIGESTIVE DISEASES;INFANT MORTALITY;MENTAL HEALTH;NANOTECHNOLOGY;NUTRITION;ORPHAN DRUG;OSTEOPOROSIS","8;5;4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;GENERIC HEALTH RELEVANCE;ORAL AND GASTROINTESTINAL;BLOOD;CANCER;EAR;REPRODUCTIVE HEALTH AND CHILDBIRTH","2;2;2;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;8.1 ORGANISATION AND DELIVERY OF SERVICES","4;2;2;1;1;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS;POPULATION & SOCIETY","5;3;3;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH;HEALTH SERVICES RESEARCH","9;6;3;2","LEUKEMIA / LEUKAEMIA;LIVER CANCER;NOT SITE-SPECIFIC CANCER;NON-HODGKIN'S LYMPHOMA","3;2;2;1",NA,NA
"IRCCS_BURLOGAROFOLO",2014,171,10.812865497076,2.8187134502924,0.426900584795322,0.409356725146199,0.567251461988304,2.07758620689655,1.25862068965517,1.62790697674419,1.38571428571429,0.514619883040936,1,71,52,19,18,0.42,0.3,0.11,0.11,29.67,0.785159539714269,4.34666666666667,0.327485380116959,0.91812865497076,0.461,0.341,0.384,0.364,"SÉRGIO CROVELLA;PAOLO GASPARINI;ALESSANDRO VENTURA;ANDREA TADDIO;GIORGIO ZAULI;ALBERTO TOMMASINI;STEFANO MARTELOSSI;LUCA RONFANI;ANNA SAVOIA;PAOLA SECCHIERO;MANOLA COMAR;GIOVANNA FERRARA;FRANCESCO FANFANI;LOREDANA LEPORE;LUDOVICA SEGAT;FLAVIO FALETRA;SERENA PASTORE;GIOVANNI SCAMBIA;EGIDIO BARBI;PIO D’ADAMO","12;11;10;9;9;9;9;8;8;8;7;7;7;7;7;7;7;6;6;6","SÉRGIO CROVELLA;ALESSANDRO VENTURA;EGIDIO BARBI;PAOLO GASPARINI;GIOVANNA FERRARA;MARZIA LAZZERINI;ALBERTO TOMMASINI;ANDREA TADDIO;GIORGIO ZAULI;MANOLA COMAR;NATALIA MAXIMOVA;IRENE BERTI;STEFANO MARTELOSSI;LUDOVICA SEGAT;FLAVIO FALETRA;SERENA PASTORE;SAMUELE NAVIGLIO;PAOLA SECCHIERO;LUCA RONFANI;FRANCESCO DE SETA","1.98;1.67;1.36;1.36;1.24;1.22;1.21;1.19;1.09;1.07;1.05;1.04;1.02;0.99;0.96;0.95;0.94;0.92;0.92;0.86","SÉRGIO CROVELLA;PAOLO GASPARINI;ALESSANDRO VENTURA;ANDREA TADDIO;GIORGIO ZAULI;ALBERTO TOMMASINI;STEFANO MARTELOSSI;LUCA RONFANI;ANNA SAVOIA;PAOLA SECCHIERO;MANOLA COMAR;GIOVANNA FERRARA;FRANCESCO FANFANI;LOREDANA LEPORE;LUDOVICA SEGAT;FLAVIO FALETRA;SERENA PASTORE;GIOVANNI SCAMBIA;EGIDIO BARBI;PIO D’ADAMO","12;11;10;9;9;9;9;8;8;8;7;7;7;7;7;7;7;6;6;6","SÉRGIO CROVELLA;ALESSANDRO VENTURA;EGIDIO BARBI;PAOLO GASPARINI;GIOVANNA FERRARA;MARZIA LAZZERINI;ALBERTO TOMMASINI;ANDREA TADDIO;GIORGIO ZAULI;MANOLA COMAR;NATALIA MAXIMOVA;IRENE BERTI;STEFANO MARTELOSSI;LUDOVICA SEGAT;FLAVIO FALETRA;SERENA PASTORE;SAMUELE NAVIGLIO;PAOLA SECCHIERO;LUCA RONFANI;FRANCESCO DE SETA","1.98;1.67;1.36;1.36;1.24;1.22;1.21;1.19;1.09;1.07;1.05;1.04;1.02;0.99;0.96;0.95;0.94;0.92;0.92;0.86","SHEILA ULIVI;PAOLO GASPARINI;PIO D’ADAMO;NICOLA PIRASTU;DANIELA TONIOLO;MICHELA TRAGLIA;NAJAF AMIN;ALAN F. WRIGHT;CAROLINE HAYWARD;DEEPTI GURDASANI;GERSHIM ASIKI;HARRY CAMPBELL;IGOR RUDAN;JAMES F. WILSON;JARED O’CONNELL;JEAN-FRANÇOIS ZAGURY;JENNIFER E. HUFFMAN;JIE HUANG;JONATHAN MARCHINI;KENNETH EKORU","1211;892;754;739;675;675;648;615;615;615;615;615;615;615;615;615;615;615;615;615","SHEILA ULIVI;PAOLO GASPARINI;PIO D’ADAMO;NICOLA PIRASTU;CHIARA AGOSTINIS;ANNA SAVOIA;LORENZO MONASTA;CATERINA BUSINELLI;LUCA RONFANI;STEFANO MARTELOSSI;ANNA ERENBOURG;GIANPAOLO MASO;SALVATORE ALBERICO;VALENTINA BARRESI;VALENTINA SOINI;MARCELLA MONTICO;VANNA PECILE;GIORGIO ZAULI;FRANCESCO FANFANI;SÉRGIO CROVELLA","1211;849;727;712;316;295;278;234;203;203;201;201;201;201;201;171;171;166;160;148","PAOLO GASPARINI;GIORGIO ZAULI;SÉRGIO CROVELLA;ALESSANDRO VENTURA;STEFANO MARTELOSSI;ALBERTO TOMMASINI;LUDOVICA SEGAT;FRANCESCO FANFANI;ANNA SAVOIA;FLAVIO FALETRA;LOREDANA LEPORE;LUCA RONFANI;ANDREA TADDIO;EGIDIO BARBI;MANOLA COMAR;CHIARA AGOSTINIS;DIEGO VOZZI;ELISA PISCIANZ;ERICA VALENCIC;NATALIA MAXIMOVA","10;9;8;8;8;7;7;7;7;7;6;6;6;6;6;5;5;5;5;5","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATHEMATICS;COMPUTER SCIENCE;SOCIOLOGY;PSYCHOLOGY;MATERIALS SCIENCE;ECONOMICS;ENGINEERING;BUSINESS;GEOGRAPHY;POLITICAL SCIENCE;PHILOSOPHY","148;102;15;10;9;8;8;7;6;5;4;2;2;2;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;SURGERY;BIOCHEMISTRY;PATHOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;GASTROENTEROLOGY;OBSTETRICS;VIROLOGY;CELL BIOLOGY;DERMATOLOGY;OPTICS;PHARMACOLOGY;PSYCHIATRY;AUDIOLOGY;CANCER RESEARCH;DEMOGRAPHY;FAMILY MEDICINE","95;70;52;33;28;27;27;25;17;14;11;10;9;9;8;8;8;7;7;7;7","GENE;POPULATION;DISEASE;PREGNANCY;IN VITRO;CANCER;INFLAMMATION;RHEUMATOLOGY;VIRUS;ANTIBODY;COHORT;TRANSPLANTATION;ANTIGEN;IMMUNE SYSTEM;BACTERIA;DIABETES MELLITUS;ENZYME;ARTHRITIS;CHEMOTHERAPY;CYTOKINE;HEARING LOSS;IN VIVO;LAPAROSCOPY;LEUKEMIA;METHOTREXATE","49;25;24;19;13;11;10;10;10;9;8;8;7;7;6;6;6;5;5;5;5;5;5;5;5","GENOTYPE;PHENOTYPE;MUTATION;ALLELE;FETUS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PROINFLAMMATORY CYTOKINE;ULCERATIVE COLITIS;CERVICAL CANCER;GENE EXPRESSION;HEART RATE;HUMAN LEUKOCYTE ANTIGEN;INFLAMMATORY BOWEL DISEASE;OVARIAN CANCER;POLYMERASE CHAIN REACTION;SEROLOGY;CHEMOKINE;CHROMOSOME;CROHN'S DISEASE;DNA REPAIR;EXON;GESTATION;GESTATIONAL AGE;IMMUNOGLOBULIN G;LYMPHOBLASTIC LEUKEMIA;NEPHROPATHY","16;14;12;9;6;6;6;6;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","SINGLE-NUCLEOTIDE POLYMORPHISM;GENOTYPING;HAPLOTYPE;MISSENSE MUTATION;ACUTE LYMPHOCYTIC LEUKEMIA;DEBULKING;FANCONI ANEMIA;FETAL HEART RATE;HAPLOINSUFFICIENCY;IMMUNOGLOBULIN A;COMPOUND HETEROZYGOSITY;CTL*;FRAMESHIFT MUTATION;GENE FLOW;RIBAVIRIN;TORQUE TENO VIRUS;AA AMYLOIDOSIS;ACINETOBACTER BAUMANNII;ALTERNATIVE SPLICING;AMNIOTIC FLUID;AMPEROMETRY;ASCUS (BRYOZOA);BARTONELLA HENSELAE;BK VIRUS;BONE MARROW FAILURE;BREAKPOINT;BURKHOLDERIA CENOCEPACIA;BURKHOLDERIA CEPACIA COMPLEX;CALPROTECTIN;CARDIOTOCOGRAPHY;CELL CYCLE CHECKPOINT;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHILDHOOD LEUKEMIA;CHORIOAMNIONITIS;CHROMOSOMAL CROSSOVER;CHROMOSOME INSTABILITY;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS;CMIN;COLONOSCOPY;CONGENITAL MYOPATHY;CONNEXIN;COW'S MILK ALLERGY;CROHN DISEASE;DERMATAN SULFATE;EOTAXIN;EPITHELIAL OVARIAN CANCER;EXOME SEQUENCING;FAMILY PLANNING;FERTILITY PRESERVATION;FETAL GROWTH;FETAL MONITORING;FOLINIC ACID;GANCICLOVIR;GENETIC HETEROGENEITY;GENETIC STRUCTURE;GERMLINE MUTATION;GESTATIONAL DIABETES;GROEL;GROWTH HORMONE DEFICIENCY;GROWTH HORMONE TREATMENT;HEMOPHAGOCYTOSIS;HEPATIC VENO-OCCLUSIVE DISEASE;HETEROZYGOTE ADVANTAGE;HLA-G;HOMEOBOX;HYPERINSULINISM;HYPOPHOSPHATASIA;INFLAMMATORY BOWEL DISEASES;INTRAUTERINE GROWTH RESTRICTION;JC VIRUS;KARYOTYPE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS PLANTARUM;MERKEL CELL POLYOMAVIRUS;MEVALONATE PATHWAY;MICROARRAY;MICRODELETION SYNDROME;MICROHEMATURIA;MILK ALLERGY;MIXED LYMPHOCYTE REACTION;MUCOPOLYSACCHARIDOSIS I;NEUROPSYCHOLOGICAL ASSESSMENT;NOD2;OLIGOARTHRITIS;OSTEOPROTEGERIN;PDGFRA;PENETRANCE;PNEUMOCOCCAL CONJUGATE VACCINE;POINT MUTATION;PRENATAL DIAGNOSIS;PROMOTER;PSYCHOLOGICAL REPRESSION;PYROPTOSIS;REPLICON;RNA SPLICING;RNA-BINDING PROTEIN;RUBELLA;RUNX2;SDHA;SERUM AMYLOID A PROTEIN;SEXUAL ABUSE;SOX2;T-CELL RECEPTOR;TANDEM REPEAT;TAQMAN;TELERADIOLOGY;THROMBASTHENIA;TICK-BORNE ENCEPHALITIS VIRUS;TOXIC MEGACOLON;TRACHELECTOMY;TRANSLATION (BIOLOGY);TYMPANOMETRY;VANCOMYCIN;VINCRISTINE","10;6;5;5;3;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;CHILD;ADULT;ADOLESCENT;CHILD, PRESCHOOL;ITALY;MIDDLE AGED;INFANT;THROMBOCYTOPENIA;YOUNG ADULT;GENOTYPE;POLYMORPHISM, SINGLE NUCLEOTIDE;PREGNANCY;AGED;INFANT, NEWBORN;ANIMALS;CELIAC DISEASE","124;90;58;42;42;39;36;32;28;28;27;18;18;16;16;16;15;15;14;14","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;MORTALITY AND SEQUELAE OF PRETERM BIRTH;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENOMIC ANALYSIS OF ANCIENT DNA;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY","5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2","PROINFLAMMATORY CYTOKINE;BREASTFEEDING SUPPORT;JUVENILE IDIOPATHIC ARTHRITIS;LACTATION;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;SNP;TREATMENT OUTCOMES;ACUTE LYMPHOCYTIC LEUKEMIA;BREASTFEEDING;BREASTFEEDING PROMOTION;CONTINUOUS BLOOD PRESSURE ESTIMATION;DEBULKING;FANCA;GENETIC ASSOCIATION;GENOME-WIDE ASSOCIATION STUDY;HAPLOINSUFFICIENCY;HEARING LOSS;HEART RATE VARIABILITY;HLA-G;IMMUNOGLOBULIN A","6;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","BONE MARROW;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;HEARING LOSS;HEMATOPOIETIC STEM;STEM CELL;ACUTE LYMPHOBLASTIC;BOWEL DISEASE;CANCER PATIENTS;CELIAC DISEASE;CELL TRANSPLANTATION;HEART RATE;INFLAMMATORY BOWEL;ITALIAN ASSOCIATION;LYMPHOBLASTIC LEUKEMIA;OVARIAN CANCER;PEDIATRIC ONCO-HEMATOLOGY;PREGNANT WOMEN;PRETERM INFANTS;RISK FACTORS;SINGLE-INSTITUTION EXPERIENCE;ULCERATIVE COLITIS;ACTION FOLLOW-UP;ADVANCED OVARIAN;AIRWAY PRESSURE;ALLOGENEIC HEMATOPOIETIC;AMINOIMIDAZOLE--CARBOXAMIDE RIBONUCLEOTIDE-TRANSFORMYLASE;CERVICAL CANCER;CLINICAL SIGNIFICANCE;COGNITIVE IMPAIRMENT","5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","CHILD HEALTH;FANCONI ANEMIA;GASTROINTESTINAL STROMAL;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;SUCCINATE DEHYDROGENASE;SYSTEMIC JIA;PR CI-;WEIGHT GAIN;BP INSERTION;CENTRAL ASIA;CVI PATIENTS;HEALTH RESEARCH;KITPDGFRA WILD-TYPE;PROP PHENOTYPES;SIGNIFICANT ASSOCIATION;STROMAL TUMORS;XMLNSMMLHTTPWWWWORGMATHMATHML IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMNMMLMNMMLMATH;CELL PROLIFERATION;CLINICAL REMISSION;COFFEE LIKING;FM MMLMATH;FOOD LIKING;GENERATION SEQUENCING;HEALTHY SUBJECTS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;PREGNANT WOMEN;RECOMBINATION EVENTS;RISK FACTORS;STRESS GRANULES","15;9;9;9;8;8;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5",75,0.44,4.25,5,1.25,1,1,5.75,3.25,1,1.25,5,0,1,4,1.75,1.5,1,1.5,3,2,0,0,69.5,69.5,2,0,1,2,0,0,0,0,0,0,0,0,3,0,0,1,2.66666666666667,1.66,1.33333333333333,0,1,2,0,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CALLIGARIS LORENZO;GERMANI CLAUDIO;ZANON DAVIDE;MICHIELAN PARIDE;NOT TARCISIO","2;2;2;1;1","IRCCS MATERNO INFANTILE BURLO GAROFOLO OSPEDALE DI ALTA SPECIALIZZAZIONE E DI RILIEVO NAZ PER LA SAL;EASY & GOOD S R L;IRCCS MATERNO-INFANTILE BURLO GAROFOLO - OSPEDALE DI ALTA SPECIALIZZAZIONE E DI RILIEVO NAZIONALE PER LA SALUTE DELLA DONNA E DEL BAMBINO","2;1;1","30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;34 CHEMICAL SCIENCES;3406 PHYSICAL CHEMISTRY;46 INFORMATION AND COMPUTING SCIENCES;3006 FOOD SCIENCES","2;2;2;2;1","PEDIATRIC;NUTRITION","2;1",NA,NA,"A61K47/02;A61K47/26;A61K9/00;A61P7/08;A21D2/02;A23L1/00;A23L1/304;A23L1/308;A23L2/52;A23L5/20","2;2;2;2;1;1;1;1;1;1","A61K31/19;A61K31/198;A61K31/7004;A61K33/14;A61K47/02;A61K47/26;A61K9/0019;A61P7/08;A21D13/064;A21D2/02","2;2;2;2;2;2;2;2;1;1",3,1,200,1.52,0,0,1,0,0,0,0,2,0,0,1,0,1,0,0,0,0,0,0,0,3,0,0,1,2,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES","3;3;1","CHRONIC PAIN;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PAIN RESEARCH;PEDIATRIC","1;1;1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36,"PUBLIC LIBRARY OF SCIENCE","36","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;3203 DENTISTRY;3215 REPRODUCTIVE MEDICINE;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3204 IMMUNOLOGY;44 HUMAN SOCIETY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;38 ECONOMICS;51 PHYSICAL SCIENCES;3006 FOOD SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3107 MICROBIOLOGY;3402 INORGANIC CHEMISTRY;3406 PHYSICAL CHEMISTRY;3801 APPLIED ECONOMICS","34;29;15;9;4;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1","GENETICS;CLINICAL RESEARCH;PREVENTION;HUMAN GENOME;BIOTECHNOLOGY;AUTOIMMUNE DISEASE;DENTAL/ORAL AND CRANIOFACIAL DISEASE;GENETIC TESTING;HIV/AIDS;LUNG;NEUROSCIENCES;NUTRITION;PEDIATRIC;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;TRANSPLANTATION","8;4;4;3;2;1;1;1;1;1;1;1;1;1;1;1","EAR;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;NEUROLOGICAL","2;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","5;1;1;1;1","BIOMEDICAL;CLINICAL","3;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","5;4;1","NOT SITE-SPECIFIC CANCER;THYROID CANCER","4;2",NA,NA
"IRCCS_BURLOGAROFOLO",2015,159,13.4339622641509,2.75471698113207,0.389937106918239,0.320754716981132,0.459119496855346,2.32978723404255,1.31914893617021,1.64516129032258,1.23728813559322,0.559748427672956,4,74,37,18,14,0.47,0.23,0.11,0.09,53.21,1.42786142698854,4.39058823529412,0.264150943396226,0.918238993710692,0.485,0.353,0.343,0.366,"ALESSANDRO VENTURA;PAOLO GASPARINI;SÉRGIO CROVELLA;STEFANO MARTELOSSI;ANDREA TADDIO;LUCA RONFANI;MARCELLA MONTICO;EGIDIO BARBI;ALBERTO TOMMASINI;MASSIMO MEZZAVILLA;LOREDANA LEPORE;GIORGIO ZAULI;GIUSEPPE RICCI;LORENZO MONASTA;ANTONIETTA ROBINO;TAMARA STAMPALIJA;GIULIANA DECORTI;SERENA ARRIGO;MONICA MARTINELLI;TARCISIO NOT","16;13;13;13;10;9;9;8;8;7;6;6;6;6;6;6;6;6;5;5","ALESSANDRO VENTURA;ANDREA TADDIO;SÉRGIO CROVELLA;MASSIMO MEZZAVILLA;EGIDIO BARBI;LUCA RONFANI;PAOLO GASPARINI;RICCARDO DAVANZO;STEFANO MARTELOSSI;DOMENICO CACCIARI;FEDERICA PEDERIVA;LORENZO MONASTA;MARCELLA MONTICO;NATALIA MAXIMOVA;ANTONIETTA ROBINO;ALBERTO TOMMASINI;CHIARA AGOSTINIS;GIUSEPPE RICCI;GIORGIO ZAULI;SAMUELE NAVIGLIO","2.39;2.24;1.86;1.77;1.68;1.4;1.35;1.31;1.25;1;0.98;0.93;0.92;0.92;0.91;0.9;0.89;0.85;0.84;0.83","ALESSANDRO VENTURA;PAOLO GASPARINI;SÉRGIO CROVELLA;STEFANO MARTELOSSI;ANDREA TADDIO;LUCA RONFANI;MARCELLA MONTICO;EGIDIO BARBI;ALBERTO TOMMASINI;MASSIMO MEZZAVILLA;LOREDANA LEPORE;GIORGIO ZAULI;GIUSEPPE RICCI;LORENZO MONASTA;ANTONIETTA ROBINO;TAMARA STAMPALIJA;MONICA MARTINELLI;TARCISIO NOT;FEDERICA PEDERIVA;SARA DE IUDICIBUS","16;13;13;13;10;9;9;8;8;7;6;6;6;6;6;6;5;5;5;5","ALESSANDRO VENTURA;ANDREA TADDIO;SÉRGIO CROVELLA;MASSIMO MEZZAVILLA;EGIDIO BARBI;LUCA RONFANI;PAOLO GASPARINI;RICCARDO DAVANZO;STEFANO MARTELOSSI;DOMENICO CACCIARI;FEDERICA PEDERIVA;LORENZO MONASTA;MARCELLA MONTICO;NATALIA MAXIMOVA;ANTONIETTA ROBINO;ALBERTO TOMMASINI;CHIARA AGOSTINIS;GIUSEPPE RICCI;GIORGIO ZAULI;NICOLA PIRASTU","2.39;2.24;1.86;1.77;1.68;1.4;1.35;1.31;1.25;1;0.98;0.93;0.92;0.92;0.91;0.9;0.89;0.85;0.84;0.83","JIE HUANG;PETR DANECEK;SHANE MCCARTHY;RICHARD DURBIN;MARCELLA MONTICO;INÊS BARROSO;LUCA RONFANI;VALENTINA IOTCHKOVA;AUDREY E. HENDRICKS;YASIN MEMARI;AL ARTAMAN;ALEMAYEHU MEKONNEN;ALIREZA ESTEGHAMATI;AMANDA PAIN;AMI R. MOORE;ANDREA WERDECKER;AZMERAW T. AMARE;BABAK ESHRATI;BENJAMIN C COWIE;BRADEN TE AO","4228;3609;3609;3270;3033;2879;2801;2538;2519;2519;2508;2508;2508;2508;2508;2508;2508;2508;2508;2508","MARCELLA MONTICO;LUCA RONFANI;MASSIMILIANO COCCA;PAOLO GASPARINI;ANTONIETTA ROBINO;MASSIMO MEZZAVILLA;ILARIA GANDIN;CATERINA BARBIERI;DRAGANA VUCKOVIC;MICHELA TRAGLIA;ELENA FLAUGNACCO;STEFANIA ZOIA;LIZA VECCHI BRUMATTI;GIUSEPPE TONINI;ALESSANDRO VENTURA;STEFANO MARTELOSSI;ALESSANDRA KNOWLES;ALBERTO TOMMASINI;SÉRGIO CROVELLA;MAURA BIN","3005;2793;1429;744;488;449;424;383;383;319;244;244;215;205;197;183;182;181;165;159","ALESSANDRO VENTURA;STEFANO MARTELOSSI;SÉRGIO CROVELLA;LUCA RONFANI;ALBERTO TOMMASINI;PAOLO GASPARINI;ANDREA TADDIO;EGIDIO BARBI;MARCELLA MONTICO;GIORGIO ZAULI;MASSIMO MEZZAVILLA;TAMARA STAMPALIJA;ANTONIETTA ROBINO;LAURA TRAVAN;FEDERICA PEDERIVA;LORENZO MONASTA;TARCISIO NOT;MONICA MARTINELLI;SARA DE IUDICIBUS;STEFANIA LUPPI","15;13;9;8;8;8;7;7;7;6;6;6;6;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;SOCIOLOGY;PHYSICS;MATHEMATICS;MATERIALS SCIENCE;ECONOMICS;ENGINEERING;GEOGRAPHY;HISTORY;PHILOSOPHY;POLITICAL SCIENCE;ART;GEOLOGY","128;96;18;17;12;10;9;8;4;3;3;3;3;3;3;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;IMMUNOLOGY;SURGERY;PATHOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;OBSTETRICS;CELL BIOLOGY;GASTROENTEROLOGY;DEMOGRAPHY;ENDOCRINOLOGY;BIOINFORMATICS;PHARMACOLOGY;INTENSIVE CARE MEDICINE;COMPUTATIONAL BIOLOGY;NEUROSCIENCE;PALEONTOLOGY;PHYSICAL THERAPY;PSYCHIATRY;SOCIAL PSYCHOLOGY","76;72;32;24;21;20;19;16;13;11;11;10;10;9;9;8;7;7;7;7;7;7","GENE;DISEASE;POPULATION;PREGNANCY;CANCER;COHORT;ENZYME;RETROSPECTIVE COHORT STUDY;BLOOD PRESSURE;INFLAMMATION;TRANSPLANTATION;ANTIBODY;CHEMOTHERAPY;CONFIDENCE INTERVAL;IN VITRO;ADVERSE EFFECT;ANTIBIOTICS;BREASTFEEDING;INTELLECTUAL DISABILITY;JUVENILE;LUNG;ODDS RATIO;PERSONALITY;RANDOMIZED CONTROLLED TRIAL;SPERM","43;29;21;19;12;9;9;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4","GENOTYPE;PHENOTYPE;MUTATION;FETUS;ALLELE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DNA SEQUENCING;GESTATIONAL AGE;EXON;GESTATION;AZATHIOPRINE;GENOME;HEART RATE;INFLAMMATORY BOWEL DISEASE;ULCERATIVE COLITIS;CERVICAL CANCER;ENDOMETRIAL CANCER;GENE EXPRESSION;GENETIC VARIATION;INFERTILITY;PI3K/AKT/MTOR PATHWAY;PLACEBO;REDUCTASE;SENSORINEURAL HEARING LOSS","20;15;13;12;9;7;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","SINGLE-NUCLEOTIDE POLYMORPHISM;EXOME SEQUENCING;HAPLOTYPE;GENE MUTATION;GENETIC HETEROGENEITY;SANGER SEQUENCING;ALLELE FREQUENCY;INTRAUTERINE GROWTH RESTRICTION;MEVALONATE PATHWAY;MISSENSE MUTATION;AMNIOTIC FLUID;DNA METHYLATION;FANCONI ANEMIA;FETAL HEART RATE;GENETIC VARIANTS;HPV INFECTION;MALE INFERTILITY;MEVALONIC ACID;MTORC1;ORAL FOOD CHALLENGE;PENETRANCE;PHARMACOGENETICS;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);UNTRANSLATED REGION;WHOLE GENOME SEQUENCING","13;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;ADULT;ADOLESCENT;CHILD;ITALY;MIDDLE AGED;CHILD, PRESCHOOL;YOUNG ADULT;CELIAC DISEASE;AGED;INFANT;POLYMORPHISM, SINGLE NUCLEOTIDE;INFANT, NEWBORN;PREGNANCY;RETROSPECTIVE STUDIES;GENETIC PREDISPOSITION TO DISEASE;GENOTYPE","115;86;74;41;39;35;33;31;25;22;22;19;17;16;15;14;14;14;13;12","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GENOMIC STUDIES AND ASSOCIATION ANALYSES;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC ANALYSIS OF ANCIENT DNA;MALE REPRODUCTIVE HEALTH;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;SWEETENERS' TASTE AND IMPACT ON HEALTH;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;GENETIC BASIS OF NEUTROPENIA DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GYNECOLOGIC ONCOLOGY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;MORTALITY AND SEQUELAE OF PRETERM BIRTH;MTOR SIGNALING IN GROWTH AND DISEASE","6;6;5;4;4;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2","GENOME-WIDE ASSOCIATION STUDY;GENETIC ASSOCIATION;BREASTFEEDING;BREASTFEEDING PROMOTION;BREASTFEEDING SUPPORT;SANGER SEQUENCING;SEMEN ANALYSIS;SPERM DNA FRAGMENTATION;1000 GENOMES PROJECT;BREASTFEEDING DURATION;EXOME;FETAL GROWTH RESTRICTION;INTRAUTERINE GROWTH RESTRICTION;MEDICATION USE;MEFV;MEVALONATE PATHWAY;NAFLD;SNP;SPERM QUALITY;TREATMENT OUTCOMES","8;6;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","STEM CELL;ACUTE LYMPHOBLASTIC;BOWEL DISEASE;CELIAC DISEASE;CELL TRANSPLANTATION;COHORT STUDY;GENOME-WIDE ASSOCIATION;HEARING LOSS;HEMATOPOIETIC STEM;INFLAMMATORY BOWEL;LYMPHOBLASTIC LEUKEMIA;PROSPECTIVE STUDY;ULCERATIVE COLITIS;AKT REACTIVATION;ASSOCIATION STUDIES;ASSOCIATION STUDY;AUTOINFLAMMATORY DISORDERS;B-PRECURSOR ACUTE;CLINICAL PHENOTYPES;COELIAC DISEASE;ECTODERMAL DYSPLASIA;ENDOMETRIAL CANCER;FANCONI ANEMIA;FETAL GROWTH;FETAL HEART;GENERATION SEQUENCING;GESTATIONAL AGE;HEART RATE;INHIBITOR TORIN-;ISOLATED POPULATIONS","5;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FOOD PREFERENCES;MEVALONATE KINASE;CROSSREF MEDLINE;BLOOD PRESSURE;MEDLINE GOOGLE;CROSSREF PUBMED;GENETIC VARIANTS;PUBMED SCOPUS;RISK FACTORS;BOWEL DISEASE;GENOME-WIDE ASSOCIATION;GESTATIONAL AGE;HEARING LOSS;INFLAMMATORY BOWEL;LIVER DISEASE;ULCERATIVE COLITIS;CANCER ASIR;EFFECTIVE POPULATION;GENE EXPRESSION;GROWTH FACTOR;HEMATOPOIETIC STEM;HOME ENVIRONMENT;INTELLECTUAL DISABILITY;IVIG INFUSIONS;POPULATION SIZE;STEM CELL;AVD RATES;CONFIDENCE INTERVAL;FOOD CHOICES;IL- IL-","16;12;10;9;9;8;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5;5",73,0.46,10.55,10,3,2,2,6.75,1.75,0,1.5,12,2.5,0,8.5,1,7,3,3,7,7,0,0,71,71,1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,3,0.68,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CALLIGARIS LORENZO;GERMANI CLAUDIO;ZANON DAVIDE","1;1;1","IRCCS MATERNO-INFANTILE BURLO GAROFOLO-OSEDALE DI ALTA SPECIALIZZAZION E DI RILIEVO NAZIONALE PER","1","34 CHEMICAL SCIENCES;3406 PHYSICAL CHEMISTRY;46 INFORMATION AND COMPUTING SCIENCES","1;1;1",NA,NA,NA,NA,"A61K31/19;A61K31/198;A61K31/7004;A61K33/14","1;1;1;1","A61K31/19;A61K31/198;A61K31/7004;A61K33/14;A61K47/02;A61K47/26;A61K9/0019;A61P7/08","1;1;1;1;1;1;1;1",7,2.29,454.29,3.91,1,0.14,12.57,0,0,0,0,4,0,0,3,0,5,2,0,0,0,0,0,0,6,1,0,7,0,0,0,0,0,0,0,0,0,"Italy","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE","7;4;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PAIN RESEARCH;DIGESTIVE DISEASES;NEUROSCIENCES;BIOMEDICAL IMAGING;BRAIN DISORDERS;COMPARATIVE EFFECTIVENESS RESEARCH;CONTRACEPTION/REPRODUCTION;DENTAL/ORAL AND CRANIOFACIAL DISEASE;FOOD ALLERGIES;FOODBORNE ILLNESS;IMMUNIZATION;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LIVER DISEASE;NUTRITION;PATIENT SAFETY;PEDIATRIC RESEARCH INITIATIVE","7;5;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM;REPRODUCTIVE HEALTH AND CHILDBIRTH","2;1;1;1","6.1 PHARMACEUTICALS","3","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","1;1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2",1,176580,88290,5,2,1,1,8,17658,9.004417261298,"IRCCS MATERNO INFANTILE BURLO GAROFOLO;ISTITUTO GIANNINA GASLINI","1;1","TELETHON FOUNDATION","1",NA,NA,"TELETHON GRANT PROJECTS - 2015 (PROGRAM)","1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES","1;1;1","AUTOIMMUNE DISEASE;GENETICS;LUPUS;PEDIATRIC;PREVENTION","1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,15,"PUBLIC LIBRARY OF SCIENCE;AMERICAN CHEMICAL SOCIETY","14;1","42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;36 CREATIVE ARTS AND WRITING;4202 EPIDEMIOLOGY;52 PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3603 MUSIC;41 ENVIRONMENTAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;44 HUMAN SOCIETY;3105 GENETICS;3215 REPRODUCTIVE MEDICINE;39 EDUCATION;3901 CURRICULUM AND PEDAGOGY;4102 ECOLOGICAL APPLICATIONS;4206 PUBLIC HEALTH;4403 DEMOGRAPHY;5202 BIOLOGICAL PSYCHOLOGY;5204 COGNITIVE AND COMPUTATIONAL PSYCHOLOGY","11;6;4;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;BEHAVIORAL AND SOCIAL SCIENCE;MENTAL HEALTH;PREVENTION;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETICS;HIV/AIDS;HUMAN GENOME;INFECTIOUS DISEASES;LUNG;MIND AND BODY;NUTRITION;OBESITY;ORPHAN DRUG;RARE DISEASES;REHABILITATION","4;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MENTAL HEALTH;CANCER;METABOLIC AND ENDOCRINE","2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;5.1 PHARMACEUTICALS","1;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","2;1;1","PUBLIC HEALTH;BASIC SCIENCE","5;1","NOT SITE-SPECIFIC CANCER","1","2 ZERO HUNGER;3 GOOD HEALTH AND WELL BEING","1;1"
"IRCCS_BURLOGAROFOLO",2016,173,11.7919075144509,2.68208092485549,0.323699421965318,0.398843930635838,0.323699421965318,2.09954751131222,1.30232558139535,1.86486486486486,1.21739130434783,0.549132947976879,1,80,43,18,6,0.46,0.25,0.1,0.03,34.69,1.06805500736204,4.73282442748091,0.416184971098266,0.92485549132948,0.508,0.331,0.382,0.349,"SÉRGIO CROVELLA;ALESSANDRO VENTURA;EGIDIO BARBI;LUCA RONFANI;PAOLO GASPARINI;TAMARA STAMPALIJA;LUISA ZUPIN;STEFANO MARTELOSSI;LORENZO MONASTA;MANOLA COMAR;C. CERVESI;TARCISIO NOT;ANDREA TADDIO;MASSIMO DI GRAZIA;SERGIO DEMARINI;CLAUDIA LOGANES;LUIGINA DE LEO;ALBERTO TOMMASINI;SAMUELE NAVIGLIO;LUDOVICA SEGAT","12;10;10;9;8;8;8;8;7;6;6;6;6;6;6;6;6;6;6;6","EGIDIO BARBI;ALESSANDRO VENTURA;SÉRGIO CROVELLA;MASSIMO DI GRAZIA;GIORGIO COZZI;LUISA ZUPIN;STEFANO MARTELOSSI;C. CERVESI;LUCA RONFANI;G. P. MANDRUZZATO;SAMUELE NAVIGLIO;MANOLA COMAR;ANDREA TADDIO;ADITYA SAREEN;J. SEVILLA LLEWELLYN-JONES;INMACULADA PEÑUELAS‐CALVO;A. GONZÁLEZ MORENO;TAMARA STAMPALIJA;SERGIO DEMARINI;LORENZO MONASTA","1.99;1.78;1.74;1.34;1.22;1.21;1.2;1.04;1.01;1;0.99;0.97;0.97;0.97;0.97;0.97;0.97;0.96;0.95;0.93","SÉRGIO CROVELLA;ALESSANDRO VENTURA;EGIDIO BARBI;LUCA RONFANI;PAOLO GASPARINI;TAMARA STAMPALIJA;LUISA ZUPIN;STEFANO MARTELOSSI;LORENZO MONASTA;MANOLA COMAR;C. CERVESI;TARCISIO NOT;ANDREA TADDIO;MASSIMO DI GRAZIA;SERGIO DEMARINI;CLAUDIA LOGANES;LUIGINA DE LEO;ALBERTO TOMMASINI;SAMUELE NAVIGLIO;LUDOVICA SEGAT","12;10;10;9;8;8;8;8;7;6;6;6;6;6;6;6;6;6;6;6","EGIDIO BARBI;ALESSANDRO VENTURA;SÉRGIO CROVELLA;MASSIMO DI GRAZIA;GIORGIO COZZI;LUISA ZUPIN;STEFANO MARTELOSSI;C. CERVESI;LUCA RONFANI;G. P. MANDRUZZATO;SAMUELE NAVIGLIO;MANOLA COMAR;ANDREA TADDIO;TAMARA STAMPALIJA;SERGIO DEMARINI;LORENZO MONASTA;CHIARA AGOSTINIS;ROBERTA BULLA;CLAUDIA LOGANES;GABRIELE CONT","1.99;1.78;1.74;1.34;1.22;1.21;1.2;1.04;1.01;1;0.99;0.97;0.97;0.96;0.95;0.93;0.92;0.92;0.88;0.83","ILARIA GANDIN;JAMES F. WILSON;PAOLO GASPARINI;MASSIMO MEZZAVILLA;MASSIMILIANO COCCA;DANIELA TONIOLO;DAVID SCHLESSINGER;HARRY CAMPBELL;LUIGI FERRUCCI;MARCUS DÖRR;THOMAS MEITINGER;ELEFTHERIA ZEGGINI;GEORGE DEDOUSSIS;NICOLA PIRASTU;CORNELIA M. VAN DUIJN;CINZIA SALA;CHARLES KOOPERBERG;JOSINE L. MIN;MICHELA TRAGLIA;MORRIS A. SWERTZ","2999;2993;2941;2874;2843;2834;2806;2806;2806;2806;2806;2793;2793;2788;2780;2764;2751;2751;2751;2751","MASSIMO MEZZAVILLA;ANTONIETTA ROBINO;SHEILA ULIVI;CHIARA AGOSTINIS;LORENZO MONASTA;LUCA RONFANI;GIUSEPPE RICCI;MASSIMILIANO COCCA;ANNA SAVOIA;DANIELA DE ROCCO;MICHELA FALESCHINI;MANOLA COMAR;CATERINA MORASSUTTO;LAURA TRAVAN;ALBERT HOFMAN;IAN FORD;PAOLO GASPARINI;EGIDIO BARBI;CLAUDIA LOGANES;VANNA PECILE","2836;493;437;294;219;217;212;153;142;142;140;138;137;129;125;125;114;106;105;100","ALESSANDRO VENTURA;SÉRGIO CROVELLA;EGIDIO BARBI;LUCA RONFANI;TAMARA STAMPALIJA;STEFANO MARTELOSSI;LORENZO MONASTA;LUIGINA DE LEO;TARCISIO NOT;ANDREA TADDIO;C. CERVESI;LUDOVICA SEGAT;SERGIO DEMARINI;LUISA ZUPIN;ALBERTO TOMMASINI;FEDERICA SCRIMIN;ANTONIETTA ROBINO;CHIARA AGOSTINIS;GIORGIO COZZI;GABRIELE CONT","10;10;9;8;8;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;SOCIOLOGY;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;ENGINEERING;POLITICAL SCIENCE;HISTORY;ECONOMICS;GEOGRAPHY","143;92;28;19;14;12;11;8;8;7;5;4;3;2;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PATHOLOGY;PEDIATRICS;SURGERY;PSYCHIATRY;ENVIRONMENTAL HEALTH;OBSTETRICS;BIOCHEMISTRY;DEVELOPMENTAL PSYCHOLOGY;ENDOCRINOLOGY;SOCIAL PSYCHOLOGY;CLINICAL PSYCHOLOGY;GYNECOLOGY;DEMOGRAPHY;GASTROENTEROLOGY;RADIOLOGY;ANATOMY;CANCER RESEARCH;DERMATOLOGY;OPTICS","92;64;33;33;31;30;26;18;16;15;14;14;13;11;11;10;10;10;9;9;9;9","GENE;PREGNANCY;DISEASE;POPULATION;COHORT;IMMUNE SYSTEM;LOGISTIC REGRESSION;PROSPECTIVE COHORT STUDY;COHORT STUDY;ANTIBODY;CANCER;CONFIDENCE INTERVAL;ODDS RATIO;RANDOMIZED CONTROLLED TRIAL;COGNITION;INFLAMMATION;ADVERSE EFFECT;ASBESTOS;DNA;EMERGENCY DEPARTMENT;EPIDEMIOLOGY;HUMAN SEXUALITY;INCIDENCE (GEOMETRY);LESION;PHYSICAL EXAMINATION;RECEPTOR;RHEUMATOID ARTHRITIS;TRANSPLANTATION;TUMOR NECROSIS FACTOR ALPHA;VIRUS","37;27;24;16;12;12;9;9;8;7;7;7;7;7;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5","GENOTYPE;ALLELE;FETUS;GENOME;GESTATIONAL AGE;GESTATION;BIRTH WEIGHT;ULCERATIVE COLITIS;GENE EXPRESSION;INFLAMMATORY BOWEL DISEASE;INNATE IMMUNE SYSTEM;ADALIMUMAB;AUTOANTIBODY;BREAST CANCER;COMPLEMENT SYSTEM;DNA SEQUENCING;GENETIC PREDISPOSITION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;LOCUS (GENETICS);OBSTETRICS AND GYNAECOLOGY;PHENOTYPE;PSYCHOMOTOR LEARNING","15;11;9;8;8;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","SINGLE-NUCLEOTIDE POLYMORPHISM;HAPLOTYPE;GENOTYPING;COPY-NUMBER VARIATION;DNA METHYLATION;PLACENTA;ALLELE FREQUENCY;BAYLEY SCALES OF INFANT DEVELOPMENT;CALPROTECTIN;EXOME SEQUENCING;FAMILY PLANNING;HPV INFECTION;INTRAUTERINE GROWTH RESTRICTION;ION SEMICONDUCTOR SEQUENCING;MICROSATELLITE;MODIFIED RANKIN SCALE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;SMALL FOR GESTATIONAL AGE;ACUTE SEVERE ASTHMA;AMPLICON;ANTIRHEUMATIC DRUGS;BALANCING SELECTION;BILIARY ATRESIA;BONE MARROW TRANSPLANT;BUSINESS PROCESS MANAGEMENT;CAESAREAN DELIVERY;CAREGIVER BURDEN;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHROMOSOME 15;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS;COMPLEMENTATION;CXCL10;DNA OXIDATION;DOUBLE BLIND;ENHANCER;ENTEROBACTER;EOTAXIN;ETV6;EUKARYOTIC DNA REPLICATION;FANCONI ANEMIA;FARNESYL PYROPHOSPHATE;FETAL GROWTH;GASTROSCHISIS;GENETIC ARCHITECTURE;GENOMICS;GESTATIONAL DIABETES;GESTATIONAL HYPERTENSION;GLUCOSE TOLERANCE TEST;GLYCATED HEMOGLOBIN;GROWTH RESTRICTION;HEMATOPOIETIC STEM CELL;HENOCH-SCHONLEIN PURPURA;HUMAN GENOME;HYDROPS FETALIS;IDIOPATHIC SHORT STATURE;IMPAIRED GLUCOSE TOLERANCE;KARYOTYPE;LDL RECEPTOR;MAMMOGRAPHY;MANIA;MEAN ARTERIAL PRESSURE;MEVALONATE PATHWAY;MINICHROMOSOME;MISSENSE MUTATION;NEONATAL MENINGITIS;NOD2;NOXIOUS STIMULUS;PHARMACOGENETICS;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;PROBAND;RIBAVIRIN;SADISTIC PERSONALITY DISORDER;SH-SY5Y;STEATOHEPATITIS;SYSTEMIC THERAPY;TAQMAN;TEMPERAMENT AND CHARACTER INVENTORY;TETHERIN;TLR2;TRANSFERRIN SATURATION;TROUGH LEVEL;TWIN PREGNANCY;TWO-DIMENSIONAL GEL ELECTROPHORESIS;ZONA PELLUCIDA","9;6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;CHILD;ADOLESCENT;ITALY;CHILD, PRESCHOOL;INFANT;MIDDLE AGED;POLYMORPHISM, SINGLE NUCLEOTIDE;GENOTYPE;INFANT, NEWBORN;RETROSPECTIVE STUDIES;PREGNANCY;YOUNG ADULT;AGED;HIV INFECTIONS;TREATMENT OUTCOME","117;92;69;56;36;36;31;29;28;20;19;18;17;16;15;14;14;13;13;13","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;UROTRAUMA AND GENITOURINARY DEVELOPMENT;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;EFFECTS OF CAFFEINE ON HUMAN HEALTH;EFFECTS OF NOISE POLLUTION ON HEALTH AND WELL-BEING;FEEDING DISORDERS IN CHILDREN WITH AUTISM SPECTRUM DISORDERS;GENETIC DISORDERS CAUSING TISSUE MINERALIZATION ABNORMALITIES;GENOMIC STUDIES AND ASSOCIATION ANALYSES","6;6;6;5;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2","ASBESTOS EXPOSURE;GENOME-WIDE ASSOCIATION STUDY;BLADDER EXSTROPHY;HIV;PRESENTATION (OBSTETRICS);ULCERATIVE COLITIS;DIAGNOSIS;DISEASE-MODIFYING ANTIRHEUMATIC DRUGS;FETAL GROWTH RESTRICTION;FETAL PROGRAMMING;GENETIC ASSOCIATION;GENETIC PREDISPOSITION;HYPERTENSION RISK;MALIGNANT PLEURAL MESOTHELIOMA;MATERNAL WEIGHT GAIN;PAIN ASSESSMENT TOOLS;PEDIATRIC PAIN;TRIAGE;1000 GENOMES PROJECT;ADNEXAL MASS","5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2","BIRTH COHORT;HEMATOPOIETIC STEM;STEM CELL;CELL TRANSPLANT;GENE POLYMORPHISMS;HYPERTENSIVE DISORDERS;LAND-USE VARIABLES;MOLECULAR DIAGNOSIS;ULCERATIVE COLITIS;ABDOMINAL PAIN;ATTRIBUTIONAL STYLE;BLADDER EXSTROPHY;BOWEL DISEASE;CAMP-PCT-CGRP AXIS;CANCER-DIAGNOSED CHILDREN;COELIAC DISEASE;COHORT STUDY;CONTROLLED TRIAL;CORTICAL RESPONSE;DEFB POLYMORPHISMS;DIFFERENTIAL DIAGNOSIS;DNA SAMPLES;E-LEARNING IMPROVES;GENETIC LOCI;GENETIC POLYMORPHISMS;GESTATIONAL AGE;GROWTH RESTRICTION;IMPROVES ATTRIBUTIONAL;INFLAMMATORY BOWEL;INTRAUTERINE GROWTH","5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DS DS;COGNITIVE DISTORTIONS;ADVERSE EVENTS;ANTI-APOA- IGG;CARDIAC INVOLVEMENT;PREGNANT WOMEN;BREAST FEEDING;CD PATIENTS;IL- IL-;LGBT HEALTH;PUBMED SCOPUS;DISEASE CD;HEALTHY SUBJECTS;MEDICAL SCHOOLS;MEDICAL STUDENTS;MORAL DISENGAGEMENT;PERSONALITY ORGANIZATION;SELF-REPORTED NCGS;ULCERATIVE COLITIS;ANTIRETROVIRAL TREATMENT;ASBESTOS FIBERS;ASSOCIATION STUDY;ATOPIC DERMATITIS;BREAST CANCER;CELL LINE;CHILDRENS ANXIETY;CONFIDENCE INTERVAL;CROSSREF PUBMED;ETV-RELATED THROMBOCYTOPENIA;FLUORESCENCE EMISSION","13;10;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5",80,0.46,5.69,6,1.25,2,1,4,2.5,1,1,7.25,2,1,5.5,2.5,2,1,2,4,3,0,0,75.25,77.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,1.67,390,2.43,0,0,1.6,0,0,0,0,1,0,1,3,0,3,0,0,0,0,0,0,0,5,0,0,3,2,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;50 PHILOSOPHY AND RELIGIOUS STUDIES;5002 HISTORY AND PHILOSOPHY OF SPECIFIC FIELDS","4;1;1;1;1;1;1;1;1;1","PEDIATRIC;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;INFANT MORTALITY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREVENTION;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEALTH SERVICES;HEMATOLOGY;INFECTIOUS DISEASES;NEUROSCIENCES;NUTRITION;PAIN RESEARCH;SEPSIS","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH;RESPIRATORY","1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;8.1 ORGANISATION AND DELIVERY OF SERVICES","2;1;1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","18;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;31 BIOLOGICAL SCIENCES;44 HUMAN SOCIETY;3202 CLINICAL SCIENCES;3105 GENETICS;3107 MICROBIOLOGY;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;36 CREATIVE ARTS AND WRITING;3602 CREATIVE AND PROFESSIONAL WRITING;40 ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","20;8;4;4;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;PATIENT SAFETY;PEDIATRIC","1;1;1;1;1","INFECTION;CANCER;ORAL AND GASTROINTESTINAL","2;1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","1;1","CLINICAL","6","CLINICAL MEDICINE AND SCIENCE","2","CERVICAL CANCER;BREAST CANCER","4;1",NA,NA
"IRCCS_BURLOGAROFOLO",2017,160,15.68125,2.825,0.38125,0.40625,0.58125,2.28282828282828,1.56410256410256,1.96969696969697,1.36764705882353,0.625,1,74,50,12,13,0.46,0.31,0.07,0.08,27.69,0.939354522283277,5.08350515463918,0.3125,0.9375,0.499,0.391,0.449,0.456,"ALESSANDRO VENTURA;EGIDIO BARBI;STEFANO MARTELOSSI;SÉRGIO CROVELLA;ALBERTO TOMMASINI;GIORGIO COZZI;GABRIELE STOCCO;LORENZO MONASTA;GIULIANA DECORTI;GIUSEPPE RICCI;SAMUELE NAVIGLIO;PAOLO GASPARINI;MARCELLA MONTICO;SERENA PASTORE;MANOLA COMAR;ANDREA TADDIO;FULVIO CELSI;MARCO GATTORNO;ANTONELLA INSALACO;LUCA CEGOLON﻿﻿","20;15;14;12;11;10;9;9;9;8;8;7;7;7;6;6;6;6;6;5","EGIDIO BARBI;ALESSANDRO VENTURA;SÉRGIO CROVELLA;GIORGIO COZZI;MARIA-GRAZIA SCARPA;STEFANO MARTELOSSI;LUCA CEGOLON﻿﻿;SAMUELE NAVIGLIO;LORENZO MONASTA;PAOLA MAURA TRICARICO;W. C. HEYMANN;JOHN H. LANGE;GIUSEPPE RICCI;FULVIO CELSI;ALBERTO TOMMASINI;MANOLA COMAR;GIANLUCA TORNESE;GIULIANA DECORTI;GABRIELE STOCCO;SERENA PASTORE","2.7;2.69;1.93;1.49;1.44;1.43;1.28;1.27;1.19;1.1;1.08;1.08;1.08;1.03;0.95;0.88;0.79;0.78;0.76;0.75","ALESSANDRO VENTURA;EGIDIO BARBI;STEFANO MARTELOSSI;SÉRGIO CROVELLA;ALBERTO TOMMASINI;GIORGIO COZZI;LORENZO MONASTA;GIULIANA DECORTI;GIUSEPPE RICCI;SAMUELE NAVIGLIO;PAOLO GASPARINI;MARCELLA MONTICO;SERENA PASTORE;MANOLA COMAR;ANDREA TADDIO;FULVIO CELSI;LUCA CEGOLON﻿﻿;MARIA CHIARA PELLEGRIN;GIANLUCA TORNESE;TAMARA STAMPALIJA","20;15;14;12;11;10;9;9;8;8;7;7;7;6;6;6;5;5;5;5","EGIDIO BARBI;ALESSANDRO VENTURA;SÉRGIO CROVELLA;GIORGIO COZZI;MARIA-GRAZIA SCARPA;STEFANO MARTELOSSI;LUCA CEGOLON﻿﻿;SAMUELE NAVIGLIO;LORENZO MONASTA;PAOLA MAURA TRICARICO;GIUSEPPE RICCI;FULVIO CELSI;ALBERTO TOMMASINI;MANOLA COMAR;GIANLUCA TORNESE;GIULIANA DECORTI;SERENA PASTORE;GIULIA PAVIOTTI;SERGIO DEMARINI;MARCELLA MONTICO","2.7;2.69;1.93;1.49;1.44;1.43;1.28;1.27;1.19;1.1;1.08;1.03;0.95;0.88;0.79;0.78;0.75;0.66;0.66;0.66","MARCO BRUMAT;RENÉE DE MUTSERT;EULALIA CATAMO;ALISON M. DUNNING;AYUSH GIRI;DANIEL I. CHASMAN;ELLEN W. DEMERATH;ERIC BOERWINKLE;JOE DENNIS;LINDA BROER;SVEN BERGMANN;ILARIA GANDIN;ALBERT V. SMITH;ALEXANDER TEUMER;ARCHIE CAMPBELL;CATERINA BARBIERI;ECO J. C. DE GEUS;HARRY CAMPBELL;ILJA M. NOLTE;JOUKE‐JAN HOTTENGA","989;989;848;834;834;834;834;834;834;834;834;684;660;660;660;660;660;660;660;660","EULALIA CATAMO;ALBERTO TOMMASINI;ANGELA D’EUSTACCHIO;SERENA PASTORE;STEFANIA CAPPELLANI;ANDREA TADDIO;PAOLO GASPARINI;LORENZO MONASTA;FLAVIO FALETRA;ERICA VALENCIC;ALESSANDRO VENTURA;SÉRGIO CROVELLA;DIEGO VOZZI;ANNA MONICA BIANCO;TAMARA STAMPALIJA;STEFANO MARTELOSSI;MANOLA COMAR;DRAGANA VUCKOVIC;PAOLA MAURA TRICARICO;ANNA SAVOIA","834;561;409;365;338;281;275;252;248;244;242;239;236;217;196;190;172;155;143;142","ALESSANDRO VENTURA;EGIDIO BARBI;STEFANO MARTELOSSI;SÉRGIO CROVELLA;GIORGIO COZZI;ALBERTO TOMMASINI;LORENZO MONASTA;GIUSEPPE RICCI;ANDREA TADDIO;SERENA PASTORE;MANOLA COMAR;GIULIANA DECORTI;MARCELLA MONTICO;PAOLO GASPARINI;FULVIO CELSI;F. BUONOMO;GIANLUCA TORNESE;LUCA CEGOLON﻿﻿;NATALIA MAXIMOVA;PAOLA MAURA TRICARICO","19;14;14;12;10;10;9;8;7;7;7;6;6;6;6;5;5;5;5;5","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;POLITICAL SCIENCE;MATERIALS SCIENCE;SOCIOLOGY;MATHEMATICS;ENGINEERING;BUSINESS;ECONOMICS;GEOGRAPHY;PHILOSOPHY;GEOLOGY;HISTORY","143;76;19;17;10;10;8;6;6;5;4;3;2;2;2;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;PATHOLOGY;IMMUNOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;OPTICS;CANCER RESEARCH;OBSTETRICS;PSYCHIATRY;RADIOLOGY;PHARMACOLOGY;ENDOCRINOLOGY;FAMILY MEDICINE;GYNECOLOGY;ANESTHESIA;BIOINFORMATICS;CELL BIOLOGY;ONCOLOGY","96;54;38;29;28;27;22;21;16;15;12;12;12;12;11;10;9;9;8;8;8;8","GENE;DISEASE;POPULATION;INCIDENCE (GEOMETRY);PREGNANCY;CANCER;COHORT;RETROSPECTIVE COHORT STUDY;ADVERSE EFFECT;ANTIBODY;APOPTOSIS;ENZYME;INFLAMMATION;EMERGENCY DEPARTMENT;MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;CONFIDENCE INTERVAL;IMMUNE SYSTEM;IN VITRO;ODDS RATIO;PROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL","37;24;20;14;13;11;8;8;7;7;7;7;7;6;6;6;5;5;5;5;5;5","GENOTYPE;INFLAMMATORY BOWEL DISEASE;PHENOTYPE;MUTATION;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;AUTOPHAGY;FETUS;INNATE IMMUNE SYSTEM;ULCERATIVE COLITIS;ALLELE;AZATHIOPRINE;ENDOMETRIAL CANCER;GENETIC PREDISPOSITION;GENOME;GESTATION;HAEMATOPOIESIS;LOCUS (GENETICS);PRENYLATION;ADNEXAL DISEASES;AUTOANTIBODY;BAP1;BLOT;BREAST CANCER;CALCIUM OXALATE;CHEMOKINE;CHROMOSOME;CHRONIC PERIODONTITIS;COMPLEMENT SYSTEM;CORPUS ALBICANS;CROHN'S DISEASE;DNA REPAIR;DNA SEQUENCING;ENCEPHALITIS;EXON;FATTY LIVER;GENETIC VARIATION;GLYCOLYSIS;HEART RATE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HUMAN FACTORS AND ERGONOMICS;HUMAN LEUKOCYTE ANTIGEN;INFLAMMASOME;INFLIXIMAB;MULTICENTER STUDY;MYELODYSPLASTIC SYNDROMES;PERIPHERAL BLOOD MONONUCLEAR CELL;PLACEBO;PROGRAMMED CELL DEATH;PROINFLAMMATORY CYTOKINE;PROSTATE CANCER;PROTEOMICS;REDUCTASE;SEROLOGY;THALIDOMIDE;TISSUE TRANSGLUTAMINASE;TOLERABILITY","13;9;8;7;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SINGLE-NUCLEOTIDE POLYMORPHISM;MEVALONATE PATHWAY;SMALL FOR GESTATIONAL AGE;THIOPURINE METHYLTRANSFERASE;ALLELE FREQUENCY;CRYSTALLURIA;EXOME SEQUENCING;GENETIC HETEROGENEITY;INTRAUTERINE GROWTH RESTRICTION;ION SEMICONDUCTOR SEQUENCING;LONG NON-CODING RNA;ADIPOKINE;AMNIOTIC FLUID;ATG16L1;BAYLEY SCALES OF INFANT DEVELOPMENT;CANAKINUMAB;CARDIAC INDEX;CARDIOTOCOGRAPHY;CASPASE;CASPOFUNGIN;CENTRAL PRECOCIOUS PUBERTY;CENTROMERE;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHROMOSOME 21;CHROMOSOME 7 (HUMAN);CLASSICAL COMPLEMENT PATHWAY;COMPLEMENT C1Q;COMPLEMENT RECEPTOR 1;COMPOUND HETEROZYGOSITY;CONDOM;CYP3A5;DEHYDROEPIANDROSTERONE;DEHYDROEPIANDROSTERONE SULFATE;DNA METHYLATION;DUCTUS VENOSUS;ECHINOCANDIN;FACTOR V LEIDEN;FAMILY PLANNING;FANCONI ANEMIA;FAT FREE MASS;FLUORESCENCE IN SITU HYBRIDIZATION;GASTROSCHISIS;GENE MUTATION;GENE POLYMORPHISM;GENETIC ARCHITECTURE;GENETIC VARIANTS;GENOMICS;GERANYLGERANYL PYROPHOSPHATE;GERANYLGERANYLATION;GERMLINE MUTATION;GLUTAMINOLYSIS;GSTP1;GUANINE;HPV INFECTION;HUMAN GENOME;IBRUTINIB;IMPAIRED GLUCOSE TOLERANCE;IRF3;JC VIRUS;JOB ATTITUDE;KARYOTYPE;LEAD ZIRCONATE TITANATE;LOSS FUNCTION;MATERNAL HEALTH;MEASLES VIRUS;MESODERM;MEVALONIC ACID;MICAFUNGIN;MISSENSE MUTATION;MITOCHONDRIAL DISEASE;MUSCULOSKELETAL DISORDER;NOD2;NUCLEOTIDE EXCISION REPAIR;OMALIZUMAB;OSTEOPROTEGERIN;OVARIAN TUMOR;PEMETREXED;PENETRANCE;PHARMACOGENETICS;PHOSPHOGLYCERATE MUTASE;PNEUMOCOCCAL CONJUGATE VACCINE;POLYARTERITIS NODOSA;PRENATAL DIAGNOSIS;PROMOTER;RECTAL EXAMINATION;RENAL ISCHEMIA;RESPIRATORY RATE;RIBAVIRIN;RIGHT BREAST;RUBELLA;SANGER SEQUENCING;SH-SY5Y;STEATOHEPATITIS;STIMULATOR OF INTERFERON GENES;STROKE VOLUME;SURFACE-ENHANCED RAMAN SPECTROSCOPY;THROMBOPOIETIN;UBIQUITIN LIGASE;UMBILICAL ARTERY;UNTRANSLATED REGION;URETEROPELVIC JUNCTION;UTERINE ARTERY;VIRAL ENCEPHALITIS;WHOLE GENOME SEQUENCING;ZIDOVUDINE","8;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;ITALY;;CHILD, PRESCHOOL;ADULT;INFANT;INFLAMMATORY BOWEL DISEASES;RETROSPECTIVE STUDIES;BIOMARKERS;MIDDLE AGED;AGED;THROMBOCYTOPENIA;CASE-CONTROL STUDIES;COHORT STUDIES;ANTI-BACTERIAL AGENTS;APOPTOSIS","120;84;81;48;43;42;37;36;25;25;22;22;20;19;16;13;12;12;11;11","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;GENOMIC STUDIES AND ASSOCIATION ANALYSES;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLOBAL IMPACT OF ARBOVIRAL DISEASES;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;MOLECULAR BIOLOGY OF STEROIDOGENESIS AND DISORDERS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE","6;5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","GENOME-WIDE ASSOCIATION STUDY;GENETIC ASSOCIATION;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;ASBESTOS EXPOSURE;GENETIC PREDISPOSITION;HEMATOLOGY;INFLAMMATION;PEDIATRICS;ADNEXAL MASS;DIAGNOSIS;GOLD STANDARD (TEST);JUVENILE IDIOPATHIC ARTHRITIS;MEDICAL RECORD;MEVALONATE PATHWAY;NEPHROLOGY;PATHOGENESIS;THIOPURINE METHYLTRANSFERASE;TREATMENT;ADNEXAL DISEASES;AFFECT (LINGUISTICS)","6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2","INFLAMMATORY BOWEL;BOWEL DISEASE;ITALIAN SOCIETY;IDIOPATHIC ARTHRITIS;INVASIVE TREATMENT;JUVENILE IDIOPATHIC;KINASE DEFICIENCY;MALIGNANT PLEURAL;MEVALONATE KINASE;MINIMALLY INVASIVE;PLEURAL MESOTHELIOMA;STEM CELL;ABDOMINAL PAIN;ADNEXAL MASSES;CANDIDA ALBICANS;CASE-CONTROL STUDY;CELIAC DISEASE;CELL LINE;CELL TRANSPLANT;CHRONIC PERIODONTITIS;COMPLEMENT PROTEIN;EMERGENCY DEPARTMENT;EMERGENCY DEPARTMENTS;ENDOMETRIAL CANCER;EUROPEAN SOCIETY;EUTECTIC MIXTURE;HEMATOPOIETIC STEM;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HYALURONIC ACID;HYPERTENSIVE DISORDERS","9;8;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HYPERTENSIVE DISORDERS;ITALY SEARCH;TRIESTE ITALY;PUBMED SCOPUS;CARDIAC OUTPUT;INTERNAL MEDICINE;CLINICAL RESPONSE;INFLAMMATORY BOWEL;PAVIA ITALY;PAVIA PAVIA;ODDS RATIO;BONE MARROW;PRIMARY CARE;CHILD HEALTH;CONFIDENCE INTERVAL;CROSSREF PUBMED;IRCCS POLICLINICO;MATTEO FOUNDATION;MEDICINE IRCCS;PERIPHERAL BLOOD;POLICLINICO SAN;SAN MATTEO;TROUGH MCGML;BURLO GAROFOLO;CLINICAL REMISSION;HEALTH IRCCS;IRCCS BURLO;ITALY DEPARTMENT;LT WEEKS;CHRONIC SPONTANEOUS","36;20;20;18;16;15;14;14;14;14;13;12;12;11;11;11;11;11;11;11;11;11;11;10;10;10;10;10;10;9",89,0.56,3.35,5,1,1,1,6.5,2,0,1,6,1,1,5,1,1,1,2,3,4,0,0,58,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4.75,509,2.19,2,0.5,33.75,0,0,0,0,0,0,1,3,0,3,1,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Japan","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS","4;2;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;NEUROSCIENCES;PEDIATRIC RESEARCH INITIATIVE;BRAIN DISORDERS;COMPARATIVE EFFECTIVENESS RESEARCH;INFANT MORTALITY;INFECTIOUS DISEASES;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN","3;3;2;2;2;2;1;1;1;1;1;1","REPRODUCTIVE HEALTH AND CHILDBIRTH;RESPIRATORY","1;1","6.1 PHARMACEUTICALS;6.7 PHYSICAL","2;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","25;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;34 CHEMICAL SCIENCES;4905 STATISTICS;42 HEALTH SCIENCES;37 EARTH SCIENCES;52 PSYCHOLOGY;3401 ANALYTICAL CHEMISTRY;3705 GEOLOGY;44 HUMAN SOCIETY;46 INFORMATION AND COMPUTING SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;3406 PHYSICAL CHEMISTRY;41 ENVIRONMENTAL SCIENCES;4202 EPIDEMIOLOGY;4206 PUBLIC HEALTH;4406 HUMAN GEOGRAPHY;4409 SOCIAL WORK","22;9;9;5;5;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1","DIGESTIVE DISEASES;AUTOIMMUNE DISEASE;INFLAMMATORY BOWEL DISEASE;CLINICAL RESEARCH;CROHN'S DISEASE;PEDIATRIC;IMMUNIZATION;INFECTIOUS DISEASES;LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA;PREVENTION;VACCINE RELATED","9;7;6;2;2;2;1;1;1;1;1;1;1","ORAL AND GASTROINTESTINAL;INFECTION","8;3","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","2;1;1;1","CLINICAL","3","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","13;4","COLON AND RECTAL CANCER","1","3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_BURLOGAROFOLO",2018,168,12.0952380952381,2.7202380952381,0.273809523809524,0.44047619047619,0.321428571428571,2.40526315789474,1.21052631578947,2.38709677419355,1.31707317073171,0.636904761904762,2,66,62,19,6,0.39,0.37,0.11,0.04,15.8,0.51800969289566,5.02018348623854,0.363095238095238,0.964285714285714,0.464,0.389,0.393,0.447,"EGIDIO BARBI;MANOLA COMAR;PAOLO GASPARINI;GIORGIO COZZI;ALESSANDRO VENTURA;GIUSEPPE RICCI;NUNZIA ZANOTTA;LUCA RONFANI;SÉRGIO CROVELLA;LORELLA PASCOLO;ALESSANDRA GIANONCELLI;LORENZO MONASTA;GIUSEPPINA CAMPISCIANO;ALBERTO TOMMASINI;ORIANO RADILLO;GIORGIA GIROTTO;LUISA ZUPIN;NATALIA MAXIMOVA;ROBERTO DI LENARDA;MATTEO BRAMUZZO","24;11;11;10;10;10;9;9;9;8;7;7;7;7;6;6;6;6;5;5","EGIDIO BARBI;GIORGIO COZZI;SÉRGIO CROVELLA;MASSIMO DI GRAZIA;ALESSANDRO VENTURA;NATALIA MAXIMOVA;MANOLA COMAR;GIUSEPPE RICCI;FRANCESCO DE SETA;NUNZIA ZANOTTA;PAOLO GASPARINI;LORELLA PASCOLO;M. DI GRAZIA;LUCA RONFANI;ALESSANDRA GIANONCELLI;LORENZO MONASTA;GIUSEPPINA CAMPISCIANO;LUISA ZUPIN;ALBERTO TOMMASINI;EVA ORZAN","4.03;1.57;1.51;1.46;1.33;1.32;1.28;1.21;1.13;1.06;1.02;1.01;1;1;0.93;0.91;0.82;0.81;0.78;0.7","EGIDIO BARBI;MANOLA COMAR;PAOLO GASPARINI;GIORGIO COZZI;ALESSANDRO VENTURA;GIUSEPPE RICCI;NUNZIA ZANOTTA;LUCA RONFANI;SÉRGIO CROVELLA;LORELLA PASCOLO;LORENZO MONASTA;GIUSEPPINA CAMPISCIANO;ALBERTO TOMMASINI;ORIANO RADILLO;GIORGIA GIROTTO;NATALIA MAXIMOVA;MATTEO BRAMUZZO;EVA ORZAN;DAVIDE ZANON;VANNA PECILE","24;11;11;10;10;10;9;9;9;8;7;7;7;6;6;6;5;5;5;4","EGIDIO BARBI;GIORGIO COZZI;SÉRGIO CROVELLA;MASSIMO DI GRAZIA;ALESSANDRO VENTURA;NATALIA MAXIMOVA;MANOLA COMAR;GIUSEPPE RICCI;FRANCESCO DE SETA;NUNZIA ZANOTTA;PAOLO GASPARINI;LORELLA PASCOLO;M. DI GRAZIA;LUCA RONFANI;LORENZO MONASTA;GIUSEPPINA CAMPISCIANO;ALBERTO TOMMASINI;EVA ORZAN;FEDERICA PEDERIVA;DAVIDE ZANON","4.03;1.57;1.51;1.46;1.33;1.32;1.28;1.21;1.13;1.06;1.02;1.01;1;1;0.91;0.82;0.78;0.7;0.62;0.61","MANOLA COMAR;PAOLO GASPARINI;NUNZIA ZANOTTA;GIUSEPPINA CAMPISCIANO;GIORGIA GIROTTO;SIMONE CESARO;FRANCESCO DE SETA;MATTEO BIASOTTO;GIULIA OTTAVIANI;CLAUDIO FAVRE;MARCO ZECCA;MARCO RABUSIN;ARCANGELO PRETE;FRANCA FAGIOLI;FRANCO LOCATELLI;MIMMO RIPALDI;MARCO SERI;MARGHERITA GOBBO;LUCA RONFANI;FRANCESCO SAGLIO","305;276;250;201;189;186;183;174;171;169;169;167;163;163;163;163;160;158;151;150","NUNZIA ZANOTTA;MANOLA COMAR;GIUSEPPINA CAMPISCIANO;PAOLO GASPARINI;GIORGIA GIROTTO;MARCO RABUSIN;LUCA RONFANI;GIULIO ANDREA ZANAZZO;FRANCESCO DE SETA;FEDERICO VERZEGNASSI;EGIDIO BARBI;DAVIDE ZANON;LORENZO MONASTA;STEFANIA CAPPELLANI;VANNA PECILE;MATTEO BRAMUZZO;ALESSANDRO VENTURA;ALBERTO TOMMASINI;STEFANO MARTELOSSI;LORELLA PASCOLO","250;204;201;198;171;167;151;143;128;125;124;112;108;102;102;97;94;88;84;83","EGIDIO BARBI;MANOLA COMAR;GIUSEPPE RICCI;GIORGIO COZZI;LUCA RONFANI;NUNZIA ZANOTTA;PAOLO GASPARINI;ALESSANDRO VENTURA;LORELLA PASCOLO;SÉRGIO CROVELLA;LORENZO MONASTA;GIUSEPPINA CAMPISCIANO;ALBERTO TOMMASINI;NATALIA MAXIMOVA;EVA ORZAN;DAVIDE ZANON;ORIANO RADILLO;GIORGIA GIROTTO;ANTONIETTA ROBINO;CHIARA AGOSTINIS","21;10;10;10;9;9;8;8;8;8;7;7;6;6;5;5;5;5;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;MATERIALS SCIENCE;COMPUTER SCIENCE;MATHEMATICS;SOCIOLOGY;ECONOMICS;PHILOSOPHY;ENGINEERING;GEOGRAPHY;ART;POLITICAL SCIENCE;BUSINESS;GEOLOGY","151;81;20;15;15;10;7;6;6;5;5;4;3;2;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;SURGERY;PATHOLOGY;PEDIATRICS;BIOCHEMISTRY;GASTROENTEROLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;CANCER RESEARCH;AUDIOLOGY;ONCOLOGY;ENDOCRINOLOGY;OPTICS;CELL BIOLOGY;NEUROSCIENCE;NURSING;RADIOLOGY;CLINICAL PSYCHOLOGY;PHYSICAL THERAPY","85;54;38;35;33;29;22;19;17;15;12;11;11;10;10;9;9;9;9;8;8","GENE;DISEASE;CANCER;POPULATION;IMMUNE SYSTEM;ANTIBODY;TRANSPLANTATION;EMERGENCY DEPARTMENT;INFLAMMATION;PREGNANCY;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;CHEMOTHERAPY;RETROSPECTIVE COHORT STUDY;VIRUS;ADVERSE EFFECT;COHORT;ENZYME;HEARING LOSS;INTERQUARTILE RANGE;ODDS RATIO;QUALITY OF LIFE (HEALTHCARE);STEM CELL","44;22;14;13;11;9;9;7;7;7;7;7;6;6;6;5;5;5;5;5;5;5;5","PHENOTYPE;MUTATION;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ALLELE;GENE EXPRESSION;INFLAMMATORY BOWEL DISEASE;BREAST CANCER;FLUORESCENCE MICROSCOPE;IMMUNOGLOBULIN E;LOCUS (GENETICS);CANDIDATE GENE;DOWNREGULATION AND UPREGULATION;GENOME;INNATE IMMUNE SYSTEM;MICRORNA;MUCOSITIS;ULCERATIVE COLITIS;ANDROGEN;BASAL (MEDICINE);BIOSYNTHESIS;CHELATION THERAPY;CHEMOKINE;CHROMOSOME;CHRONIC PERIODONTITIS;CLINICAL ENDPOINT;COLORECTAL CANCER;CRYOPRESERVATION;CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;DEFENSIN;DEMENTIA;EPIGENETICS;FETUS;FOOD ALLERGY;GARDNERELLA VAGINALIS;HAEMATOPOIESIS;HORMONE REPLACEMENT THERAPY (FEMALE-TO-MALE);IN SILICO;INFLIXIMAB;LEFT VENTRICULAR HYPERTROPHY;MUTANT;OVERWEIGHT;PLACEBO;PROGENITOR CELL;PROGRAMMED CELL DEATH;PROSTATE CANCER;REAL-TIME POLYMERASE CHAIN REACTION;SEROLOGY;TRAMADOL;TUMOR PROGRESSION;VAGINAL DELIVERY;VIRAL LOAD;VULVODYNIA","17;12;9;7;6;5;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MISSENSE MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;EXOME SEQUENCING;HAPLOTYPE;LOSS FUNCTION;OMALIZUMAB;BETA DEFENSIN;BUSULFAN;CALPROTECTIN;COMPOUND HETEROZYGOSITY;FRAMESHIFT MUTATION;GERMLINE MUTATION;HEREDITARY SPASTIC PARAPLEGIA;KARYOTYPE;MEVALONATE PATHWAY;ORAL FOOD CHALLENGE;SEROPREVALENCE;TRANSCRIPTOME;ABDOMINAL OBESITY;ACUTE LYMPHOCYTIC LEUKEMIA;AMNIOTIC FLUID;AMPLICON;ANDROGEN DEFICIENCY;ANDROGEN RECEPTOR;ASPARTATE TRANSAMINASE;BACTEROIDETES;BIFIDOBACTERIUM;BK VIRUS;BOND STRENGTH;BREAKPOINT;CAESAREAN DELIVERY;CCL2;CD18;CENTRAL PRECOCIOUS PUBERTY;CLASSICAL HODGKIN LYMPHOMA;COGNITIVE DECLINE;COLD SENSITIVITY;COLLECTIN;COMPLEMENTATION;CONCENTRIC HYPERTROPHY;CONNEXIN;COPY-NUMBER VARIATION;CRYOPROTECTANT;CXCR4;CYCLIC NEUTROPENIA;CYSTECTOMY;DELTA WAVE;DEMOGRAPHIC HISTORY;DISCRIMINANT VALIDITY;DNA METHYLATION;EGG ALLERGY;EOTAXIN;FAMILIAL ADENOMATOUS POLYPOSIS;FIRMICUTES;FLUDARABINE;FRONTOTEMPORAL DEMENTIA;FRUCTOSE-BISPHOSPHATE ALDOLASE;GASTRIC BYPASS;GENE MUTATION;GENETIC HETEROGENEITY;GPVI;HAPLOINSUFFICIENCY;HBSAG;HEALTH FACILITY;HETEROZYGOTE ADVANTAGE;HORMONE THERAPY;HSP70;ICATIBANT;IL-2 RECEPTOR;IMMUNOGLOBULIN A;INFLAMMATORY BOWEL DISEASES;JC VIRUS;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS;LEUKOARAIOSIS;LOW LEVEL LASER THERAPY;MALE BREAST CANCER;MECONIUM;MELTING CURVE ANALYSIS;MERKEL CELL POLYOMAVIRUS;MEVALONIC ACID;MICROARRAY ANALYSIS TECHNIQUES;MOLECULAR MEDICINE;NOD2;OMIM : ONLINE MENDELIAN INHERITANCE IN MAN;PAIN LADDER;PANCREATIC DUCTAL ADENOCARCINOMA;PLACENTA;PLEIOTROPY;POINT MUTATION;POLYCYSTIC OVARY;POSACONAZOLE;PRESENILIN;REPORTER GENE;RIBAVIRIN;RNA SPLICING;SEROTONIN TRANSPORTER;SLEEP SPINDLE;SOD2;SURFACTANT PROTEIN D;TANDEM REPEAT;TAQMAN;THROMBOPOIETIN;TOTAL BODY IRRADIATION;TRANSACTIVATION;TROUGH LEVEL;UPPER MOTOR NEURON;VARIABLE NUMBER TANDEM REPEAT;VASCULAR DEMENTIA;VILLOUS ATROPHY;WHOLE GENOME SEQUENCING","7;7;5;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADOLESCENT;CHILD;;ITALY;CHILD, PRESCHOOL;INFANT;MIDDLE AGED;ADULT;AGED;RETROSPECTIVE STUDIES;YOUNG ADULT;CYTOKINES;HEMATOPOIETIC STEM CELL TRANSPLANTATION;VAGINA;HIV INFECTIONS;THROMBOCYTOPENIA;TREATMENT OUTCOME","122;92;83;47;47;41;37;36;30;29;27;19;16;16;12;12;12;11;11;11","PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF URTICARIA;FERTILITY PRESERVATION IN CANCER PATIENTS;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;DENTAL RESTORATIVE MATERIALS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF FETAL AND NEONATAL TUMORS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EFFECTS OF HORMONES ON MENOPAUSAL WOMEN'S HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;HEMATOPOIETIC STEM CELL BIOLOGY;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;INTEROCEPTION AND SOMATIC SYMPTOMS","6;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","HEARING LOSS;INTERQUARTILE RANGE;CANDIDATE GENE;GENETIC ASSOCIATION;HEMATOPOIETIC CELL TRANSPLANTATION;HORMONE THERAPY;LOSS FUNCTION;LOW-LEVEL LASER THERAPY;MENOPAUSE;MUCOSITIS;OMALIZUMAB;PAIN ASSESSMENT TOOLS;PAIN MEASUREMENT;PEDIATRIC PAIN;PHOTOBIOMODULATION;SNP;THERAPEUTIC PHOTOBIOMODULATION;VAGINAL MICROBIOME;VENIPUNCTURE;ANDROGEN DEFICIENCY","9;5;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","STEM CELL;CELL TRANSPLANTATION;BREAST CANCER;EMERGENCY DEPARTMENT;HEARING LOSS;HEMATOPOIETIC STEM;INFLAMMATORY BOWEL;AGE-RELATED HEARING;ASSOCIATION STUDY;BOWEL DISEASE;CCL CCL;CHRONIC SPONTANEOUS;DE LA;MULTICENTER STUDY;PERIODIC FEVER;SPONTANEOUS URTICARIA;ABDOMINAL PAIN;ARTIFICIAL NUTRITION;BARIATRIC SURGERY;CARBON NANOTUBES;CELIAC DISEASE;CELL LINE;CROSS-SECTIONAL STUDY;DE ENDOCRINOLOGÍA;ENDOCRINOLOGÍA GINECOLÓGICA;FLUORESCENCE MICROSCOPY;GENE INVOLVED;GENITOURINARY SYNDROME;GUT MICROBIOTA;LA MENOPAUSIA","6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;KLINEFELTER SYNDROME;CROSSREF PUBMED;ABDOMINAL PAIN;PUBMED GOOGLE;BURLO GAROFOLO;HEARING LOSS;IRCCS BURLO;STEM CELL;CELL TRANSPLANTATION;PULMONARY SEQUESTRATION;RISK FACTORS;CHILDJ PEDIATR;HEMATOPOIETIC STEM;PEDIATR -CROSSREF;TRANSPLANTATION HSCT;ACUTE HAE;BLADDER CANCER;EXTRALOBAR PULMONARY;GAROFOLO TRIESTE;MULTIVARIATE ANALYSIS;PE SERA;PEDIATRICS IRCCS;SV TAG;BOSANKO KA;BREAST MILK;CLIN PEDIATR;CUMULATIVE INCIDENCE;DE NOVO;DETECTION AGE","21;14;12;11;11;9;9;9;9;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5",99,0.59,7.79,6.5,2,1,1,3.5,2,0,1,7,1,1,6,0,5.75,1,2,4,3,0,0,62.5,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,4.46,471.54,7.39,3,0.23,23.15,0,0,0,0,4,0,0,9,0,7,6,0,0,0,0,0,0,11,2,0,13,0,0,0,0,0,0,0,0,0,"United States;Germany","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;31 BIOLOGICAL SCIENCES;3105 GENETICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","12;6;3;2;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;AUTOIMMUNE DISEASE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;GENETICS;ORPHAN DRUG;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;HEMATOLOGY;INFANT MORTALITY;INFLAMMATORY BOWEL DISEASE;NEUROSCIENCES;PATIENT SAFETY;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREVENTION","10;10;6;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CANCER;ORAL AND GASTROINTESTINAL;INFLAMMATORY AND IMMUNE SYSTEM;REPRODUCTIVE HEALTH AND CHILDBIRTH;MENTAL HEALTH;NEUROLOGICAL","3;3;2;2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;8.1 ORGANISATION AND DELIVERY OF SERVICES","6;3;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BREAST CANCER;COLON AND RECTAL CANCER;OVARIAN CANCER;SARCOMA","2;1;1;1;1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;SPRINGER NATURE;MENDELEY DATA;TAYLOR & FRANCIS GROUP","9;4;3;2;1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;43 HISTORY, HERITAGE AND ARCHAEOLOGY;44 HUMAN SOCIETY;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;37 EARTH SCIENCES;4303 HISTORICAL STUDIES;4401 ANTHROPOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3701 ATMOSPHERIC SCIENCES;40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","25;12;8;4;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1","GENETICS;RARE DISEASES;CLINICAL RESEARCH;GENETIC TESTING;HUMAN GENOME;CARDIOVASCULAR;HEART DISEASE;NEURODEGENERATIVE;ALCOHOLISM, ALCOHOL USE AND HEALTH;ATHEROSCLEROSIS;BIOTECHNOLOGY;CANCER;DIGESTIVE DISEASES;HEART DISEASE - CORONARY HEART DISEASE;HYPERTENSION;KIDNEY DISEASE;PANCREATIC CANCER;PATIENT SAFETY;PREVENTION;SUBSTANCE MISUSE","6;4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;NEUROLOGICAL;CONGENITAL","8;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;8.1 ORGANISATION AND DELIVERY OF SERVICES","3;2;2;1","CLINICAL;BIOMEDICAL","3;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","5;4","NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER","1;1","2 ZERO HUNGER","1"
"IRCCS_BURLOGAROFOLO",2019,217,14.2626728110599,3.00921658986175,0.350230414746544,0.423963133640553,0.433179723502304,2.77872340425532,1.35714285714286,2.19047619047619,1.38235294117647,0.640552995391705,0,98,44,28,15,0.45,0.2,0.13,0.07,20.46,0.84142469705015,5.15661641541039,0.373271889400922,0.944700460829493,0.501,0.407,0.462,0.479,"EGIDIO BARBI;GIUSEPPE RICCI;MATTEO BRAMUZZO;LUCA RONFANI;ANDREA TADDIO;GIORGIO COZZI;ALBERTO TOMMASINI;LORENZO MONASTA;FEDERICO ROMANO;FLAVIO FALETRA;FABIO BARBONE;SÉRGIO CROVELLA;TAMARA STAMPALIJA;SERENA PASTORE;PAOLO GASPARINI;TARCISIO NOT;GIUSEPPINA CAMPISCIANO;NATALIA MAXIMOVA;STEFANO MARTELOSSI;GABRIELE STOCCO","37;17;14;14;13;13;13;11;10;10;9;9;9;9;8;8;8;8;8;7","EGIDIO BARBI;GIORGIO COZZI;ANDREA TADDIO;GIUSEPPE RICCI;LUCA RONFANI;NATALIA MAXIMOVA;ALBERTO TOMMASINI;MATTEO BRAMUZZO;FEDERICO ROMANO;SERENA PASTORE;FLAVIO FALETRA;LORENZO MONASTA;MASSIMO GREGORI;SÉRGIO CROVELLA;GIULIA GORTANI;FABIO BARBONE;MARIA CHIARA PELLEGRIN;GIUSEPPINA CAMPISCIANO;DAVIDE ZANON;GIANLUCA TORNESE","7.15;2.72;1.92;1.9;1.62;1.6;1.56;1.32;1.23;1.2;1.19;1.17;1.12;1.09;1.08;0.98;0.92;0.9;0.83;0.82","EGIDIO BARBI;GIUSEPPE RICCI;MATTEO BRAMUZZO;LUCA RONFANI;ANDREA TADDIO;GIORGIO COZZI;ALBERTO TOMMASINI;LORENZO MONASTA;FEDERICO ROMANO;FLAVIO FALETRA;FABIO BARBONE;SÉRGIO CROVELLA;TAMARA STAMPALIJA;SERENA PASTORE;PAOLO GASPARINI;TARCISIO NOT;GIUSEPPINA CAMPISCIANO;NATALIA MAXIMOVA;STEFANO MARTELOSSI;GABRIELE STOCCO","37;17;14;14;13;13;13;11;10;10;9;9;9;9;8;8;8;8;8;7","EGIDIO BARBI;GIORGIO COZZI;ANDREA TADDIO;GIUSEPPE RICCI;LUCA RONFANI;NATALIA MAXIMOVA;ALBERTO TOMMASINI;MATTEO BRAMUZZO;FEDERICO ROMANO;SERENA PASTORE;FLAVIO FALETRA;LORENZO MONASTA;MASSIMO GREGORI;SÉRGIO CROVELLA;GIULIA GORTANI;FABIO BARBONE;MARIA CHIARA PELLEGRIN;GIUSEPPINA CAMPISCIANO;DAVIDE ZANON;GIANLUCA TORNESE","7.15;2.72;1.92;1.9;1.62;1.6;1.56;1.32;1.23;1.2;1.19;1.17;1.12;1.09;1.08;0.98;0.92;0.9;0.83;0.82","LUCA CEGOLON﻿﻿;CHIKA HAYASHI;DIANA ESTEVEZ;ELAINE BORGHI;GRETCHEN A STEVENS;HANNAH BLENCOWE;JOY E. LAWN;JULIA KRASEVEC;MERCEDES DE ONÍS;ROBERT E. BLACK;SIMON COUSENS;SUHAIL SHIEKH;VICTORIA PONCE HARDY;XIAOYI AN;PETER J. VAN DER MOST;ERIC BOERWINKLE;JONATHAN MARTEN;M. ARFAN IKRAM;RENÉE DE MUTSERT;TAMARA B. HARRIS","923;871;871;871;871;871;871;871;871;871;871;871;871;871;591;562;562;562;562;562","LUCA CEGOLON﻿﻿;MASSIMILIANO COCCA;MARIA PINA CONCAS;PAOLO GASPARINI;LUCA RONFANI;GIORGIA GIROTTO;EULALIA CATAMO;LORENZO MONASTA;GIUSEPPE RICCI;GIUSEPPINA CAMPISCIANO;EGIDIO BARBI;ANTONELLA FABRETTO;ALDO SKABAR;MATTEO BRAMUZZO;MANOLA COMAR;ANTONIETTA ROBINO;F. BUONOMO;CHIARA AGOSTINIS;ALBERTO TOMMASINI;FRANCESCO DE SETA","910;560;504;373;360;351;349;297;287;229;203;182;180;179;177;171;157;138;134;131","EGIDIO BARBI;GIUSEPPE RICCI;LUCA RONFANI;MATTEO BRAMUZZO;GIORGIO COZZI;ALBERTO TOMMASINI;ANDREA TADDIO;LORENZO MONASTA;FEDERICO ROMANO;FLAVIO FALETRA;TAMARA STAMPALIJA;SERENA PASTORE;FABIO BARBONE;GIUSEPPINA CAMPISCIANO;NATALIA MAXIMOVA;F. BUONOMO;MANOLA COMAR;MARIA PINA CONCAS;TARCISIO NOT;ALESSANDRO VENTURA","31;15;14;14;13;13;12;11;10;10;9;9;9;8;8;7;7;7;7;6","MEDICINE;BIOLOGY;CHEMISTRY;SOCIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;PHYSICS;ECONOMICS;PHILOSOPHY;MATERIALS SCIENCE;ENGINEERING;GEOGRAPHY;HISTORY;ENVIRONMENTAL SCIENCE;ART;BUSINESS;POLITICAL SCIENCE","196;113;24;15;14;12;11;10;9;7;6;3;3;3;2;1;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;IMMUNOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;OBSTETRICS;RADIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;PSYCHIATRY;GYNECOLOGY;BIOINFORMATICS;DEMOGRAPHY;FAMILY MEDICINE;ANATOMY;CANCER RESEARCH;ANESTHESIA;PHARMACOLOGY","112;86;46;46;38;38;33;23;19;18;16;16;16;15;13;13;13;11;11;10;10","GENE;PREGNANCY;DISEASE;POPULATION;COHORT;CANCER;RETROSPECTIVE COHORT STUDY;ANTIBODY;IMMUNE SYSTEM;IN VITRO;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;PHYSICAL EXAMINATION;STEM CELL;ADVERSE EFFECT;HYSTERECTOMY;ULTRASOUND;ALTERNATIVE MEDICINE;ASYMPTOMATIC;CHEMOTHERAPY;COHORT STUDY;HEARING LOSS;INFLAMMATION;URINARY SYSTEM;UTERUS","49;38;34;28;19;13;9;8;8;8;8;7;7;7;6;6;6;5;5;5;5;5;5;5;5","FETUS;GENOTYPE;INFLAMMATORY BOWEL DISEASE;PHENOTYPE;MUTATION;GESTATIONAL AGE;CAESAREAN SECTION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;GENE EXPRESSION;GESTATION;ULCERATIVE COLITIS;ABORTION;CHILDBIRTH;CROHN'S DISEASE;HAEMATOPOIESIS;ALLELE;COELIAC DISEASE;DOWNREGULATION AND UPREGULATION;ENDOMETRIAL CANCER;GENETIC PREDISPOSITION;GENOME;INFERTILITY;INFLIXIMAB;MYOMETRIUM;NEUTROPENIA;OOCYTE","14;13;12;10;9;7;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","SINGLE-NUCLEOTIDE POLYMORPHISM;PRENATAL DIAGNOSIS;PLACENTA;DNA METHYLATION;MISSENSE MUTATION;ALLELE FREQUENCY;CERVICAL PREGNANCY;DEFIBROTIDE;DILATION AND CURETTAGE;FETAL DISTRESS;GENE EXPRESSION PROFILING;GERMLINE MUTATION;GLYCATED HEMOGLOBIN;HEMATOPOIETIC STEM CELL;POLYHYDRAMNIOS;SMALL FOR GESTATIONAL AGE;THIOPURINE METHYLTRANSFERASE;UTERINE ARTERY;ABSOLUTE NEUTROPHIL COUNT;ACHÉ;AKKERMANSIA;ALPORT SYNDROME;AMPA RECEPTOR;AMPEROMETRY;ANTIMYCOBACTERIAL;CARDIOTOCOGRAPHY;CD90;CEFTAZIDIME;CERVICAL CANAL;CHIMERIC ANTIGEN RECEPTOR;CLASSICAL COMPLEMENT PATHWAY;CLINICAL PHENOTYPE;COLECTOMY;COLONOSCOPY;COMPLEMENTATION;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;CYCLIC NEUTROPENIA;DNA EXTRACTION;DUCTUS VENOSUS;EARLY PREGNANCY LOSS;EMBRYO CRYOPRESERVATION;EPIRETINAL MEMBRANE;EVANS SYNDROME;EXHALED NITRIC OXIDE;EXOME SEQUENCING;FACTOR H;FERTILITY PRESERVATION;FETAL GROWTH;FETAL HEART RATE;FIRST TRIMESTER;FOLLICULAR FLUID;FOXM1;FUSOBACTERIUM;GASTRIC BYPASS;GENETIC ARCHITECTURE;GENETIC HETEROGENEITY;GENETIC VARIANTS;GENOMIC INFORMATION;GENOMICS;GENOTYPING;GESTATIONAL SAC;GLUTAMATERGIC;GROWTH HORMONE DEFICIENCY;GROWTH HORMONE SECRETAGOGUE RECEPTOR;HEAD CIRCUMFERENCE;HEMATOPOIETIC CELL;HENOCH-SCHONLEIN PURPURA;HEPATIC VENO-OCCLUSIVE DISEASE;HUMAN GROWTH HORMONE;HUMAN VIROME;HYDROPS FETALIS;IDIOPATHIC NEPHROTIC SYNDROME;IDIOTYPE;IMMUNOTOXIN;INDUCED PLURIPOTENT STEM CELL;INFLAMMATORY BOWEL DISEASES;INHA;INSULIN SENSITIVITY;INTEGRON;JUVENILE MYELOMONOCYTIC LEUKEMIA;KARYOTYPE;LONG NON-CODING RNA;LUXOL FAST BLUE STAIN;MALE BREAST CANCER;MALE INFERTILITY;MEN WHO HAVE SEX WITH MEN;MERKEL CELL POLYOMAVIRUS;MMP2;MMP9;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NOD2;NON-CODING RNA;OVARIAN CORTEX;PARS PLANA;PEDIATRIC EMERGENCY MEDICINE;PERFORIN;PHARMACOGENETICS;PIM1;PLEIOTROPY;POINT MUTATION;PONSETI METHOD;POUCHITIS;PRENATAL EXPOSURE;PROBAND;PROCTITIS;PROCTOCOLECTOMY;PROTEIN PHOSPHORYLATION;REFERENCE GENES;REFERENCE GENOME;RETINOID;RIBOSOME;SANGER SEQUENCING;SCHISTOSOMA HAEMATOBIUM;SCHISTOSOMA MANSONI;SEED DORMANCY;SEX REASSIGNMENT SURGERY (MALE-TO-FEMALE);SH-SY5Y;SIDA;SLEEP SPINDLE;STRUCTURAL VARIATION;TRANSCRIPTOME;TRIPLE-NEGATIVE BREAST CANCER;TRPV1;UMBILICAL ARTERY;UNTRANSLATED REGION;URETEROPELVIC JUNCTION;USHER SYNDROME;VENTRICULOMEGALY;VESICOURETERAL REFLUX;VILLOUS ATROPHY;WANDERING SPLEEN","7;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;;MALE;ITALY;CHILD;ADOLESCENT;ADULT;CHILD, PRESCHOOL;INFANT;INFANT, NEWBORN;INFLAMMATORY BOWEL DISEASES;YOUNG ADULT;MIDDLE AGED;NEOPLASMS;PREGNANCY;RETROSPECTIVE STUDIES;CELIAC DISEASE;COHORT STUDIES;AGED","133;91;80;78;48;44;38;34;28;27;23;23;22;19;19;16;15;14;14;12","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;MATERNAL MORBIDITY ASSOCIATED WITH PREGNANCY AND CHILDBIRTH;ANESTHESIA AND SEDATION MANAGEMENT;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS;IMPACT OF PESTICIDES USE IN AGRICULTURE;MOLECULAR BIOLOGY OF STEROIDOGENESIS AND DISORDERS;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;PEDIATRIC URINARY TRACT INFECTIONS;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;DIAGNOSIS AND MANAGEMENT OF ECTOPIC PREGNANCY;DIAGNOSIS AND TREATMENT OF SPINAL INFECTIONS;DISEASES RELATED TO BLOOD GROUP VARIANTS;EFFECTS OF HORMONES ON MENOPAUSAL WOMEN'S HEALTH;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA","6;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","DIAGNOSIS;PRENATAL DIAGNOSIS;CHILDBIRTH EXPERIENCE;ECTOPIC PREGNANCY;GENOME-WIDE ASSOCIATION STUDY;HEARING LOSS;PATHOGENESIS;DOSE;FETAL DNA ANALYSIS;FETAL GROWTH RESTRICTION;GENETIC PREDISPOSITION;GIRL;HUMAN INBORN ERRORS;INTERQUARTILE RANGE;MALNUTRITION IMPACTS;MICROCEPHALY;MYOMETRIUM;PEDIATRICS;PLACENTA ACCRETA;PLACENTAL DEVELOPMENT","8;7;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","BOWEL DISEASE;INFLAMMATORY BOWEL;GIULIA REGION;ITALIAN COHORT;ITALIAN SOCIETY;STEM CELL;ADOPAD STUDY;CLINICAL PRACTICE;COHORT STUDY;DE LA;FRIULI VENEZIA;GENERATION SEQUENCING;HEARING LOSS;HEMATOPOIETIC STEM;HYSTEROSCOPIC TREATMENT;INVASIVE TREATMENT;MAGNETIC RESONANCE;MINIMALLY INVASIVE;NORTH-EASTERN ITALY;OC DIAGNOSTIC;PEDIATRIC PATIENTS;PRENATAL DIAGNOSIS;REGION NORTH-EASTERN;RETROSPECTIVE STUDY;VENEZIA GIULIA;ANALYSES REVEAL;AUTOIMMUNE HEMOLYTIC;BASED STUDY;BREAST CANCER;CELIAC DISEASE","9;9;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;RADIAL NERVE;NERVE PALSY;UNIT DEPARTMENT;BURLO GAROFOLO;IRCCS BURLO;BREAST CANCER;CHILD HEALTH;GAROFOLO TRIESTE;INFLAMMATORY BOWEL;INTERQUARTILE RANGE;PREGNANCY LOSS;BOWEL DISEASE;CHILDRENS HOSPITAL;GENETIC DIAGNOSIS;HEALTH IRCCS;PAIN CATASTROPHIZING;RISK FACTORS;TRIESTE ITALYSEARCH;ESOPHAGEAL DUPLICATION;CLINICAL RESPONSE;FONDAZIONE IRCCS;IRCCS ISTITUTO;ISOLATED RADIAL;CLINICAL REMISSION;CORD BLOOD;DISEASE ACTIVITY;LOGISTIC REGRESSION;MEDIAN AGE","30;22;20;19;14;13;13;11;11;11;11;11;11;10;10;10;10;10;10;10;9;8;8;8;8;7;7;7;7;7",94,0.43,7.41,5,1,1,0,4,2,0,3.5,6,2,1,5,1,1,2,2,4,4.75,0,0,48,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,4.12,1613.57,3.65,1,0.12,30.88,0,0,0,0,3,0,0,5,0,4,3,0,0,0,0,0,0,8,0,0,7,1,0,0,0,0,0,0,0,0,"Germany","1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3203 DENTISTRY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4204 MIDWIFERY","7;4;3;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;CANCER;CHRONIC PAIN;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEALTH SERVICES;HEMATOLOGY;NEUROSCIENCES;PAIN RESEARCH;PEDIATRIC RESEARCH INITIATIVE;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;GENETICS;INFANT MORTALITY;INFECTIOUS DISEASES;NUTRITION","6;6;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1;1;1;1","6.1 PHARMACEUTICALS;8.1 ORGANISATION AND DELIVERY OF SERVICES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2;2;1;1","LEUKEMIA / LEUKAEMIA","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",1,1353725,75206.94,4,18,8,1,230,36459.7361111111,5.95177099852539,"CHARITÉ - UNIVERSITY MEDICINE BERLIN;CHIBA UNIVERSITY;IMPERIAL COLLEGE LONDON;IRCCS MATERNO INFANTILE BURLO GAROFOLO;LOUGHBOROUGH UNIVERSITY;NATIONAL HEALTH LABORATORY SERVICE;QUEEN'S MEDICAL CENTRE;RADBOUD UNIVERSITY NIJMEGEN;THE OHIO STATE UNIVERSITY;TULANE UNIVERSITY;UNIVERSITY OF ABERDEEN;UNIVERSITY OF CAPE TOWN;UNIVERSITY OF DEBRECEN;UNIVERSITY OF EDINBURGH;UNIVERSITY OF EXETER;UNIVERSITY OF MANCHESTER;UNIVERSITY OF MINNESOTA SYSTEM;UNIVERSITY OF MONTANA","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICAL RESEARCH COUNCIL","1","COALITION S;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","1;1;1","RESEARCH GRANT (PROJECT CATEGORY)","1","31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","1;1;1;1;1","INFECTIOUS DISEASES","1","INFECTION","1","1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING);2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1","NOT SITE-SPECIFIC CANCER","1","1.5 RESOURCES AND INFRASTRUCTURE;2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1;1;1","A01 CLINICAL MEDICINE","1",NA,NA,28,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;TAYLOR & FRANCIS GROUP","22;5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3215 REPRODUCTIVE MEDICINE;4204 MIDWIFERY;31 BIOLOGICAL SCIENCES;39 EDUCATION;3105 GENETICS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3210 NUTRITION AND DIETETICS;49 MATHEMATICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3902 EDUCATION POLICY, SOCIOLOGY AND PHILOSOPHY;4206 PUBLIC HEALTH;4901 APPLIED MATHEMATICS","44;16;15;6;5;4;3;3;3;3;3;2;2;1;1","CLINICAL RESEARCH;PREVENTION;PEDIATRIC;GENETICS;BRAIN DISORDERS;CANCER;HUMAN GENOME;AGING;BIOTECHNOLOGY;BREAST CANCER;HEALTH SERVICES;NEUROSCIENCES;NUTRITION;OBESITY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;GENETIC TESTING;INFANT MORTALITY;LUNG;LUNG CANCER;RARE DISEASES","9;8;7;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1","CANCER;CARDIOVASCULAR;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;EAR;REPRODUCTIVE HEALTH AND CHILDBIRTH;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH","6;3;3;3;2;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;8.1 ORGANISATION AND DELIVERY OF SERVICES;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","7;2;2;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","6;5;1","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH;BASIC SCIENCE;HEALTH SERVICES RESEARCH","8;3;2;1","BREAST CANCER;LUNG CANCER","2;1",NA,NA
"IRCCS_BURLOGAROFOLO",2020,291,10.1443298969072,3.03436426116838,0.402061855670103,0.443298969072165,0.491408934707904,3.10915492957746,1.64788732394366,2.63265306122449,1.60674157303371,0.673539518900344,15,121,72,36,8,0.42,0.25,0.12,0.03,19.25,0.764102811194439,5.90888888888888,0.268041237113402,0.920962199312715,0.596,0.526,0.429,0.489,"EGIDIO BARBI;GIUSEPPE RICCI;ANDREA TADDIO;GIANLUCA TORNESE;FEDERICO ROMANO;SÉRGIO CROVELLA;LORENZO MONASTA;TAMARA STAMPALIJA;FLAVIO FALETRA;IRENE BERTI;SERENA PASTORE;ALBERTO TOMMASINI;FLORA MARIA MURRU;LUCA CEGOLON﻿﻿;GIORGIO COZZI;ANDREA TROMBETTA;MARZIA LAZZERINI;LUISA ZUPIN;MANOLA COMAR;PAOLO GASPARINI","67;24;19;16;15;14;14;14;14;13;13;12;12;11;11;11;10;10;9;9","EGIDIO BARBI;GIANLUCA TORNESE;ANDREA TROMBETTA;GIUSEPPE RICCI;LUCA CEGOLON﻿﻿;ANDREA TADDIO;RICCARDO DAVANZO;IRENE BERTI;LORENZO MONASTA;FEDERICO ROMANO;FLORA MARIA MURRU;SÉRGIO CROVELLA;SERENA PASTORE;GIORGIO COZZI;LUISA CORTELLAZZO WIEL;MARZIA LAZZERINI;FLAVIO FALETRA;LUISA ZUPIN;DAVIDE ZANON;PAOLO GASPARINI","12.92;4.3;3.38;3.01;2.68;2.6;2.56;2.5;2.23;2.03;2;1.97;1.94;1.91;1.89;1.65;1.64;1.53;1.37;1.34","EGIDIO BARBI;GIUSEPPE RICCI;ANDREA TADDIO;GIANLUCA TORNESE;FEDERICO ROMANO;SÉRGIO CROVELLA;LORENZO MONASTA;TAMARA STAMPALIJA;FLAVIO FALETRA;IRENE BERTI;SERENA PASTORE;ALBERTO TOMMASINI;FLORA MARIA MURRU;LUCA CEGOLON﻿﻿;GIORGIO COZZI;ANDREA TROMBETTA;MARZIA LAZZERINI;LUISA ZUPIN;MANOLA COMAR;PAOLO GASPARINI","67;24;19;16;15;14;14;14;14;13;13;12;12;11;11;11;10;10;9;9","EGIDIO BARBI;GIANLUCA TORNESE;ANDREA TROMBETTA;GIUSEPPE RICCI;LUCA CEGOLON﻿﻿;ANDREA TADDIO;RICCARDO DAVANZO;IRENE BERTI;LORENZO MONASTA;FEDERICO ROMANO;FLORA MARIA MURRU;SÉRGIO CROVELLA;SERENA PASTORE;GIORGIO COZZI;MARZIA LAZZERINI;FLAVIO FALETRA;LUISA ZUPIN;DAVIDE ZANON;PAOLO GASPARINI;VALENTINA MORESSA","12.92;4.3;3.38;3.01;2.68;2.6;2.56;2.5;2.23;2.03;2;1.97;1.94;1.91;1.65;1.64;1.53;1.37;1.34;1.32","EGIDIO BARBI;MARZIA LAZZERINI;FEDERICO MARCHETTI;FABIO CARDINALE;ANDREA APICELLA;GIANLUCA TROBIA;E. FERRAZZI;C. LEES;KURT HECHER;AHMET BASCHAT;F. FIGUERAS;FABRÍCIO DA SILVA COSTA;JOHN KINGDOM;JULIA UNTERSCHEIDER;LAURENT SALOMON;LIONA C. POON;T. STAMPALIJA;GIOVANNI PUTOTO;GIANLUCA TORNESE;LORENZO MONASTA","1821;1821;1360;1226;1208;1208;570;543;541;484;484;484;484;484;484;484;484;380;311;308","MARZIA LAZZERINI;EGIDIO BARBI;T. STAMPALIJA;GIANLUCA TORNESE;LORENZO MONASTA;GIUSEPPE RICCI;ELENA FALESCHINI;ILARIA MARIANI;BENEDETTA COVI;STEFANIA BIFFI;LUCA CEGOLON﻿﻿;BENEDETTA ARMOCIDA;CLAUDIA CARLETTI;GIORGIO COZZI;LUCA RONFANI;FEDERICO ROMANO;LUISA ZUPIN;MANOLA COMAR;PAOLO GASPARINI;GABRIELLA ZITO","1819;1656;484;311;308;262;186;180;177;173;164;160;158;155;153;151;118;116;113;111","EGIDIO BARBI;GIUSEPPE RICCI;GIANLUCA TORNESE;ANDREA TADDIO;FEDERICO ROMANO;LORENZO MONASTA;TAMARA STAMPALIJA;FLAVIO FALETRA;FLORA MARIA MURRU;IRENE BERTI;SERENA PASTORE;GIORGIO COZZI;ALBERTO TOMMASINI;LUISA ZUPIN;LUCA CEGOLON﻿﻿;DAVIDE ZANON;PAOLO GASPARINI;MARZIA LAZZERINI;MATTEO BRAMUZZO;LUCA RONFANI","61;21;16;16;15;14;13;13;13;13;13;11;11;10;10;9;9;9;9;9","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;COMPUTER SCIENCE;PHILOSOPHY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;GEOGRAPHY;HISTORY;BUSINESS;MATHEMATICS;ART","267;111;30;29;23;23;22;21;16;14;9;9;8;7;6;6;3","INTERNAL MEDICINE;PEDIATRICS;GENETICS;PATHOLOGY;SURGERY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;FAMILY MEDICINE;VIROLOGY;OBSTETRICS;NURSING;RADIOLOGY;LAW;BIOINFORMATICS;OPTICS;DEMOGRAPHY;ANESTHESIA;ENDOCRINOLOGY;MEDICAL EMERGENCY","159;89;77;70;63;40;37;31;29;28;27;26;25;23;22;20;17;17;16;15;15;15","DISEASE;PREGNANCY;GENE;POPULATION;OUTBREAK;RETROSPECTIVE COHORT STUDY;CANCER;COHORT;EMERGENCY DEPARTMENT;HEALTH CARE;LOGISTIC REGRESSION;ADVERSE EFFECT;MAGNETIC RESONANCE IMAGING;PHYSICAL EXAMINATION;DIABETES MELLITUS;INCIDENCE (GEOMETRY);PROSPECTIVE COHORT STUDY;BACTERIA;CHILD HEALTH;CONFIDENCE INTERVAL;CONTEXT (ARCHAEOLOGY);IMMUNE SYSTEM;PUBLIC HEALTH","70;37;32;30;19;19;17;17;13;12;11;10;10;10;9;9;9;8;8;8;8;8;8","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;FETUS;GESTATION;GESTATIONAL AGE;MUTATION;ALLELE;BIRTH WEIGHT;COLORECTAL CANCER;GENOTYPE;INFLAMMATORY BOWEL DISEASE;CANDIDATE GENE;CHILDBIRTH;CYTOTOXICITY;DEXMEDETOMIDINE;DYSBIOSIS;GLOMERULONEPHRITIS;GROWTH HORMONE;INFERTILITY;INJURY PREVENTION;PHENOTYPE;REPRODUCTIVE MEDICINE;VIRAL LOAD","34;18;15;9;9;7;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);PRENATAL DIAGNOSIS;ANTIRETROVIRAL THERAPY;INTRAUTERINE GROWTH RESTRICTION;EXOME SEQUENCING;FETAL DISTRESS;GROWTH HORMONE DEFICIENCY;MISSENSE MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL FOR GESTATIONAL AGE;YEARS OF POTENTIAL LIFE LOST;AMPHIPHILE;COMPOUND HETEROZYGOSITY;DNA METHYLATION;FETAL GROWTH;GENETIC HETEROGENEITY;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;PLACENTA;PRODUCTS OF CONCEPTION;RESPIRATORY RATE;UNEXPLAINED INFERTILITY","34;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;ITALY;CHILD;ADULT;ADOLESCENT;CHILD, PRESCHOOL;INFANT, NEWBORN;PREGNANCY;RETROSPECTIVE STUDIES;CORONAVIRUS INFECTIONS;INFANT;MIDDLE AGED;PNEUMONIA, VIRAL;COVID-19;CELIAC DISEASE;PROSPECTIVE STUDIES;RISK FACTORS","167;118;73;58;51;46;31;30;27;21;20;19;17;17;17;17;16;13;12;12","PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;IMPACT OF COVID-19 INFECTION ON PREGNANCY OUTCOMES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;ANESTHESIA AND SEDATION MANAGEMENT;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND MANAGEMENT OF ECTOPIC PREGNANCY;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLOBAL MATERNAL AND CHILD HEALTH OUTCOMES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IMPACT OF COVID-19 ON MENTAL HEALTH;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES","8;7;6;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3","2019-20 CORONAVIRUS OUTBREAK;PANDEMIC;DIAGNOSIS;CHILD HEALTH;CROSS-SECTIONAL STUDY;FETAL GROWTH RESTRICTION;HEARING LOSS;PRENATAL DIAGNOSIS;BETACORONAVIRUS;CORONAVIRUS INFECTIONS;FETAL DNA ANALYSIS;FETAL PROGRAMMING;NEPHROLOGY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;CANDIDATE GENE;CORONAVIRUS;DEXMEDETOMIDINE;DYSBIOSIS;ENDOMETRIAL RECEPTIVITY;ERYTHEMA","19;17;11;8;7;7;7;7;6;6;6;6;6;5;4;4;4;4;4;4","COHORT STUDY;CROSS-SECTIONAL STUDY;FETAL GROWTH;HEARING LOSS;EMERGENCY DEPARTMENT;GLOBAL BURDEN;GROWTH RESTRICTION;MAGNETIC RESONANCE;NEPHROTIC SYNDROME;PEDIATRIC EMERGENCY;RETROSPECTIVE STUDY;BOWEL DISEASE;COVID- PANDEMIC;DIABETES MELLITUS;DISEASE ACTIVITY;DISEASE STUDY;FRIULI VENEZIA;GIULIA REGION;GROWTH CHARTS;GROWTH HORMONE;HIDRADENITIS SUPPURATIVA;HOSPITAL CARE;INFLAMMATORY BOWEL;ITALIAN POPULATION;MULTICENTRE STUDY;NON-SYNDROMIC HEARING;NORTH-EASTERN ITALY;PHOTOBIOMODULATION THERAPY;REGION NORTH-EASTERN;RESONANCE IMAGING","6;6;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;TRIESTE ITALYSEARCH;CHILD HEALTH;BURLO GAROFOLO;IRCCS BURLO;GAROFOLO TRIESTE;HEALTH IRCCS;TRIESTE TRIESTE;FETAL GROWTH;GROWTH CHARTS;EMERGENCY DEPARTMENT;DATE ACCESSED;GESTATIONAL AGE;TRIESTE ITALY;DUCTUS VENOSUS;SUPPORTING INFORMATION;DEPARTMENT INSTITUTE;PAEDIATRIC DEPARTMENT;ACCESSED MARCH;MARCH DATE;MARCH GOOGLE;BIRTH WEIGHT;CLIN IMMUNOL;MAGNETIC RESONANCE;RISK FACTORS;RESONANCE IMAGING;GROWTH RESTRICTION;INTENSIVE CARE;ADVERSE OUTCOME","54;42;42;39;38;36;34;34;30;29;27;20;18;18;18;17;17;16;16;15;15;15;14;14;14;14;13;12;12;11",135,0.46,5.08,5,2,1,0,2.5,1.5,1,1,5,4,0,5,1,1,2,4,4,4,0,0,62,62,1,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,3,0.34,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CALLIGARIS LORENZO;GERMANI CLAUDIO;ZANON DAVIDE","1;1;1","IRCCS MATERNO-INFANTILE BURLO GAROFOLO - OSPEDALE DI ALTA SPECIALIZZAZIONE E DI RILIEVO NAZIONALE PER LA SALUTE DELLA DONNA E DEL BAMBINO","1","34 CHEMICAL SCIENCES;3406 PHYSICAL CHEMISTRY;46 INFORMATION AND COMPUTING SCIENCES","1;1;1","PEDIATRIC","1",NA,NA,"A61K47/02;A61K47/26;A61K9/00;A61P7/08","1;1;1;1","A61K31/19;A61K31/198;A61K31/7004;A61K33/14;A61K47/02;A61K47/26;A61K9/0019;A61P7/08","1;1;1;1;1;1;1;1",11,2.64,1476.2,4.21,0,0,6.82,0,0,0,0,0,0,2,9,0,2,8,0,0,0,0,0,0,10,1,0,9,1,0,1,0,0,0,0,0,0,"Italy;Sweden;Germany;Norway;Portugal;Spain;United Kingdom","2;2;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;44 HUMAN SOCIETY;4402 CRIMINOLOGY;4409 SOCIAL WORK;46 INFORMATION AND COMPUTING SCIENCES;5203 CLINICAL AND HEALTH PSYCHOLOGY","10;4;2;2;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;PREVENTION;DIGESTIVE DISEASES;MENTAL HEALTH;NEUROSCIENCES;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;ORPHAN DRUG;PAIN RESEARCH;ANTIMICROBIAL RESISTANCE;AUTOIMMUNE DISEASE;BIOENGINEERING;BIOMEDICAL IMAGING;CANCER;CHILD ABUSE AND NEGLECT RESEARCH;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DEPRESSION","7;6;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","MENTAL HEALTH;INFECTION;NEUROLOGICAL;CANCER;GENERIC HEALTH RELEVANCE;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","3;2;2;1;1;1;1;1","6.1 PHARMACEUTICALS;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;8.1 ORGANISATION AND DELIVERY OF SERVICES","3;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER;PANCREATIC CANCER","1;1;1;1","4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",1,0,0,5,1,1,0,1,18801.7361111111,15.4772941328556,"IRCCS MATERNO INFANTILE BURLO GAROFOLO","1","ITALIAN ASSOCIATION FOR CANCER RESEARCH","1","ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","1",NA,NA,"31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1","CANCER;CLINICAL RESEARCH;GENETICS;HEMATOLOGY;PEDIATRIC;RARE DISEASES","1;1;1;1;1;1","CANCER","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1","LEUKEMIA / LEUKAEMIA","1","2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","1","A01 CLINICAL MEDICINE","1",NA,NA,22,"PUBLIC LIBRARY OF SCIENCE;FUTURE SCIENCE GROUP;FRONTIERS;AMERICAN CHEMICAL SOCIETY;SPRINGER NATURE","10;6;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3101 BIOCHEMISTRY AND CELL BIOLOGY;49 MATHEMATICAL SCIENCES;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;4612 SOFTWARE ENGINEERING;3105 GENETICS;3203 DENTISTRY;3212 OPHTHALMOLOGY AND OPTOMETRY;3501 ACCOUNTING, AUDITING AND ACCOUNTABILITY;38 ECONOMICS;3801 APPLIED ECONOMICS;42 HEALTH SCIENCES","27;10;7;4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;ANTIMICROBIAL RESISTANCE;BIODEFENSE;BIOTECHNOLOGY;CONTRACEPTION/REPRODUCTION;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;INFERTILITY;LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA;PREVENTION;VACCINE RELATED;ENDOMETRIOSIS;GENETICS;KIDNEY DISEASE;POLYCYSTIC KIDNEY DISEASE","3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH;RENAL AND UROGENITAL","2;2;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","3;2;2;1;1","BIOMEDICAL;CLINICAL","3;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","3;2","ENDOMETRIAL CANCER","1",NA,NA
"IRCCS_BURLOGAROFOLO",2021,374,11.8930481283422,2.94385026737968,0.377005347593583,0.451871657754011,0.475935828877005,3.59803921568627,1.71951219512195,2.48529411764706,1.81632653061224,0.74331550802139,6,161,83,41,7,0.43,0.22,0.11,0.02,9.97,0.646397830785869,5.77313054499366,0.29144385026738,0.93048128342246,0.585,0.44,0.464,0.473,"EGIDIO BARBI;LUCA RONFANI;GIORGIO COZZI;TAMARA STAMPALIJA;ALBERTO TOMMASINI;GIANLUCA TORNESE;GIUSEPPE RICCI;PAOLO GASPARINI;MATTEO BRAMUZZO;LORENZO MONASTA;FEDERICO ROMANO;FRANCESCO DE SETA;FLAVIO FALETRA;ALESSANDRO MANGOGNA;GIORGIA GIROTTO;EVA ORZAN;IRENE BERTI;ILARIA MARIANI;ANDREA TADDIO;FRANCESCO MARIA RISSO","78;24;24;21;21;20;19;16;16;16;15;13;13;13;12;12;11;11;11;11","EGIDIO BARBI;GIORGIO COZZI;GIANLUCA TORNESE;TAMARA STAMPALIJA;LUCA RONFANI;ALBERTO TOMMASINI;ANDREA TROMBETTA;FRANCESCO DE SETA;IRENE BERTI;MATTEO BRAMUZZO;EVA ORZAN;GIUSEPPE RICCI;IRENE DEL RIZZO;LORENZO MONASTA;FRANCESCO MARIA RISSO;ALESSANDRO BOSCARELLI;PRISCA DA LOZZO;SARAH CONTORNO;PAOLO GASPARINI;DAVIDE ZANON","13.94;4.19;3.73;2.94;2.92;2.92;2.83;2.63;2.24;2.19;1.93;1.9;1.9;1.84;1.8;1.78;1.69;1.69;1.59;1.56","EGIDIO BARBI;LUCA RONFANI;GIORGIO COZZI;TAMARA STAMPALIJA;ALBERTO TOMMASINI;GIANLUCA TORNESE;GIUSEPPE RICCI;PAOLO GASPARINI;MATTEO BRAMUZZO;LORENZO MONASTA;FEDERICO ROMANO;FRANCESCO DE SETA;FLAVIO FALETRA;ALESSANDRO MANGOGNA;GIORGIA GIROTTO;EVA ORZAN;IRENE BERTI;ILARIA MARIANI;ANDREA TADDIO;FRANCESCO MARIA RISSO","78;24;24;21;21;20;19;16;16;16;15;13;13;13;12;12;11;11;11;11","EGIDIO BARBI;GIORGIO COZZI;GIANLUCA TORNESE;TAMARA STAMPALIJA;LUCA RONFANI;ALBERTO TOMMASINI;ANDREA TROMBETTA;FRANCESCO DE SETA;IRENE BERTI;MATTEO BRAMUZZO;EVA ORZAN;GIUSEPPE RICCI;IRENE DEL RIZZO;LORENZO MONASTA;FRANCESCO MARIA RISSO;ALESSANDRO BOSCARELLI;PRISCA DA LOZZO;SARAH CONTORNO;PAOLO GASPARINI;DAVIDE ZANON","13.94;4.19;3.73;2.94;2.92;2.92;2.83;2.63;2.24;2.19;1.93;1.9;1.9;1.84;1.8;1.78;1.69;1.69;1.59;1.56","ALBERTO TOMMASINI;EULALIA CATAMO;MASSIMO MEZZAVILLA;GEORGE DAVEY SMITH;ANDREA TADDIO;EGIDIO BARBI;PAOLO GASPARINI;MARTINA FABRIS;HARRY CAMPBELL;ALVISA PALESE;CATERINA BARBIERI;CARLO TASCINI;ELENA GRAZIANO;FRANCESCO CURCIO;FRANCESCO MARRELLA;GIULIA BONTEMPO;MADDALENA PEGHIN;MARGHERITA VENTURINI;MARIA DE MARTINO;MIRIAM ISOLA","433;375;314;297;294;294;275;268;264;263;257;254;254;254;254;254;254;254;254;254","ALBERTO TOMMASINI;EULALIA CATAMO;ANDREA TADDIO;PAOLO GASPARINI;EGIDIO BARBI;GIUSEPPE RICCI;FEDERICO ROMANO;LUCA RONFANI;LORENZO MONASTA;ILARIA MARIANI;GIANLUCA TORNESE;MARZIA LAZZERINI;MANUELA GIANGRECO;MANOLA COMAR;ALESSANDRO MANGOGNA;FRANCESCO DE SETA;TAMARA STAMPALIJA;GIOVANNI DI LORENZO;GIUSEPPINA CAMPISCIANO;FLAVIO FALETRA","415;329;279;264;236;226;206;204;179;172;171;167;163;159;145;142;132;126;124;113","EGIDIO BARBI;GIORGIO COZZI;LUCA RONFANI;TAMARA STAMPALIJA;GIANLUCA TORNESE;GIUSEPPE RICCI;ALBERTO TOMMASINI;LORENZO MONASTA;MATTEO BRAMUZZO;FEDERICO ROMANO;ALESSANDRO MANGOGNA;FLAVIO FALETRA;FRANCESCO DE SETA;PAOLO GASPARINI;ILARIA MARIANI;IRENE BERTI;FRANCESCO MARIA RISSO;MANUELA GIANGRECO;EVA ORZAN;ANNA MORGAN","68;24;24;21;20;18;18;16;16;15;13;13;12;12;11;11;11;11;11;10","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;SOCIOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS;POLITICAL SCIENCE;PHILOSOPHY;MATERIALS SCIENCE;ART;BUSINESS;GEOGRAPHY;GEOLOGY","339;157;43;31;29;25;24;17;16;14;12;11;6;5;5;4;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;PEDIATRICS;SURGERY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;NURSING;BIOCHEMISTRY;OBSTETRICS;FAMILY MEDICINE;ENDOCRINOLOGY;GASTROENTEROLOGY;DERMATOLOGY;INTENSIVE CARE MEDICINE;RADIOLOGY;MICROBIOLOGY;PHYSICAL THERAPY;VIROLOGY","197;111;99;92;77;46;39;39;33;32;31;26;24;24;23;20;20;18;18;18","DISEASE;GENE;PREGNANCY;POPULATION;CANCER;COHORT;RETROSPECTIVE COHORT STUDY;BACTERIA;ALTERNATIVE MEDICINE;IMMUNE SYSTEM;OUTBREAK;PROSPECTIVE COHORT STUDY;COHORT STUDY;OBSERVATIONAL STUDY;TRANSPLANTATION;HEARING LOSS;INFLAMMATION;ANTIBIOTICS;HEALTH CARE;INCIDENCE (GEOMETRY);PSYCHOLOGICAL INTERVENTION","78;56;46;32;27;24;17;15;14;14;13;13;12;12;12;11;11;10;10;10;10","INFECTIOUS DISEASE (MEDICAL SPECIALTY);FETUS;GENOTYPE;PHENOTYPE;GESTATIONAL AGE;MUTATION;2019-20 CORONAVIRUS OUTBREAK;BIRTH WEIGHT;INFLAMMATORY BOWEL DISEASE;COLORECTAL CANCER;GESTATION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ALLELE;STAPHYLOCOCCUS AUREUS;BREAST CANCER;GENE EXPRESSION;INSULIN RESISTANCE;OSTEOARTHRITIS;SENSORINEURAL HEARING LOSS;CROHN'S DISEASE;DYSBIOSIS;ENDOMETRIAL CANCER;EXON;INNATE IMMUNE SYSTEM;OVARIAN CANCER;PI3K/AKT/MTOR PATHWAY;SUICIDE PREVENTION;ULCERATIVE COLITIS;VIRAL LOAD","38;17;16;16;15;15;11;10;9;8;8;8;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);MISSENSE MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;EXOME SEQUENCING;FETAL GROWTH;SMALL FOR GESTATIONAL AGE;UNICOMPARTMENTAL KNEE ARTHROPLASTY;FRAMESHIFT MUTATION;INTRAUTERINE GROWTH RESTRICTION;PRENATAL DIAGNOSIS;BAYLEY SCALES OF INFANT DEVELOPMENT;COLONOSCOPY;DNA METHYLATION;FETAL DISTRESS;KRAS;ACANTHOSIS NIGRICANS;ENTEROCOCCUS FAECALIS;FANCONI ANEMIA;GENE EXPRESSION PROFILING;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;IDIOPATHIC SHORT STATURE;LOSS FUNCTION;LYMPHOVASCULAR INVASION;MEVALONATE PATHWAY;ORAL FOOD CHALLENGE;ORAL IMMUNOTHERAPY;PHARMACOGENETICS;PLACENTA;PLASMACYTOID DENDRITIC CELL;PROPIDIUM IODIDE;STIMULATOR OF INTERFERON GENES;TELEHEALTH;TOXIC SHOCK SYNDROME;VESICOURETERAL REFLUX","38;10;10;5;5;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;CHILD;MALE;ITALY;COVID-19;ADOLESCENT;CHILD, PRESCHOOL;ADULT;INFANT;SARS-COV-2;RETROSPECTIVE STUDIES;INFANT, NEWBORN;MIDDLE AGED;PREGNANCY;INFLAMMATORY BOWEL DISEASES;COHORT STUDIES;PROSPECTIVE STUDIES;ANIMALS","188;183;88;67;63;56;44;40;30;28;28;26;25;20;17;17;15;14;14;13","PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;VAGINAL MICROBIOME AND SEXUALLY TRANSMITTED INFECTIONS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;IMPACT OF COVID-19 INFECTION ON PREGNANCY OUTCOMES;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;AIRBORNE TRANSMISSION OF RESPIRATORY VIRUSES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;IMPACT OF HEARING LOSS ON COGNITIVE FUNCTION;MOBILE HEALTH INTERVENTIONS AND APPLICATIONS","10;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","PANDEMIC;FETAL GROWTH RESTRICTION;2019-20 CORONAVIRUS OUTBREAK;FETAL PROGRAMMING;HEARING LOSS;CHILD HEALTH;CROSS-SECTIONAL STUDY;VAGINAL MICROBIOME;ETIOLOGY;FETAL DEVELOPMENT;MATERNAL WEIGHT GAIN;SPEECH PERCEPTION;GIRL;NEPHROLOGY;PEDIATRIC PAIN;PRESENTATION (OBSTETRICS);CHILDBIRTH EXPERIENCE;CYSTIC FIBROSIS;DIABETES;FETAL DNA ANALYSIS","23;11;10;9;9;8;8;8;7;7;7;7;6;6;6;6;5;5;5;5","COVID- PANDEMIC;FETAL GROWTH;GROWTH RESTRICTION;BOWEL DISEASE;INFLAMMATORY BOWEL;VAGINAL MICROBIOME;CYSTIC FIBROSIS;CROSS-SECTIONAL STUDY;HEARING LOSS;KNEE ARTHROPLASTY;STEM CELL;UNICOMPARTMENTAL KNEE;CELL TRANSPLANTATION;ENDOMETRIAL CANCER;FRIULI VENEZIA;PEDIATRIC INFLAMMATORY;RISK FACTORS;SARS-COV- INFECTION;TYPE DIABETES;VENEZIA GIULIA;ALLOGENEIC HEMATOPOIETIC;CANCER PATIENTS;CARE UNIT;CHILD HEALTH;COHORT STUDY;DISEASE PATIENTS;EWING SARCOMA;GIULIA ITALY;HEALTH SYSTEM;HEMATOPOIETIC STEM","11;11;9;8;8;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","TRIESTE ITALYSEARCH;BURLO GAROFOLO;GAROFOLO TRIESTE;OBSTET GYNECOL;CHILD HEALTH;FETAL GROWTH;GROWTH RESTRICTION;TRIESTE TRIESTE;PUBMED SCOPUS;TRIESTE ITALY;HEALTH SCIENCES;MEDICINE SURGERY;SCIENCES UNIVERSITY;GESTATIONAL AGE;ULTRASOUND OBSTET;HEALTH IRCCS;IRCCS BURLO;CROSSREF PUBMED;RISK FACTORS;BIRTH WEIGHT;COVID- PANDEMIC;EGIDIO BARBI;PEDIATRIC DEPARTMENT;PHYSICAL ACTIVITY;INCREASED RISK;FULL-TEXT VERSION;SHORT STATURE;HEALTH BURLO;PEDIATRIC PATIENTS;COHORT STUDY","56;46;43;43;41;38;33;30;29;27;24;24;24;22;22;21;21;19;19;18;18;16;16;16;15;14;14;13;13;12",178,0.48,5,6,1,1.25,0,3,2,1,1,8,3,0,6,1.5,1,1,3,4,3,0,0,37.75,37.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,2.5,359.75,6.27,2,0.11,7.17,0,0,1,0,1,0,1,15,0,4,12,0,0,0,0,0,0,16,2,0,16,2,0,0,0,0,0,0,0,0,"France;Italy","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;3203 DENTISTRY;3215 REPRODUCTIVE MEDICINE;4205 NURSING;3105 GENETICS;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4208 TRADITIONAL, COMPLEMENTARY AND INTEGRATIVE MEDICINE","14;8;4;3;3;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;PATIENT SAFETY;PREVENTION;CANCER;RARE DISEASES;INFECTIOUS DISEASES;MENTAL HEALTH;NEUROSCIENCES;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DENTAL/ORAL AND CRANIOFACIAL DISEASE;ORPHAN DRUG;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;CHRONIC PAIN;HEMATOLOGY;NUTRITION;PAIN RESEARCH;PEDIATRIC CANCER","16;12;7;6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2","CANCER;ORAL AND GASTROINTESTINAL;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;GENERIC HEALTH RELEVANCE;NEUROLOGICAL","3;3;2;2;2;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY;8.1 ORGANISATION AND DELIVERY OF SERVICES","6;3;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER;SARCOMA;MYELOMA;NON-HODGKIN'S LYMPHOMA","2;2;2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.9 RESOURCES AND INFRASTRUCTURE RELATED TO CANCER CONTROL, SURVIVORSHIP, AND OUTCOMES RESEARCH","4;2;2;1;1",1,1933172,241646.5,6,8,4,1,162,59076.1527777778,6.33081171360036,"IMPERIAL COLLEGE LONDON;IRCCS MATERNO INFANTILE BURLO GAROFOLO;QUEEN'S MEDICAL CENTRE;UNIVERSITY OF CAPE TOWN;UNIVERSITY OF EDINBURGH;UNIVERSITY OF EXETER;UNIVERSITY OF MANCHESTER;UNIVERSITY OF MONTANA","1;1;1;1;1;1;1;1","MEDICAL RESEARCH COUNCIL","1","COALITION S;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","1;1;1","RESEARCH GRANT (PROJECT CATEGORY)","1","31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","1;1;1;1;1","HIV/AIDS;INFECTIOUS DISEASES","1;1","GENERIC HEALTH RELEVANCE;INFECTION","1;1","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT","1","NOT SITE-SPECIFIC CANCER","1","2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1;1","A05 BIOLOGICAL SCIENCES","1","3 GOOD HEALTH AND WELL BEING","1",30,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE","22;8","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3107 MICROBIOLOGY;3204 IMMUNOLOGY;3215 REPRODUCTIVE MEDICINE;3213 PAEDIATRICS;42 HEALTH SCIENCES;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","40;14;13;8;6;4;2;1;1;1;1","CLINICAL RESEARCH;GENETICS;LUNG;RARE DISEASES;PATIENT SAFETY;CANCER;DIGESTIVE DISEASES;LUNG CANCER;ORPHAN DRUG;PEDIATRIC;PREVENTION;DENTAL/ORAL AND CRANIOFACIAL DISEASE;INFECTIOUS DISEASES;AUTOIMMUNE DISEASE;CROHN'S DISEASE;INFLAMMATORY BOWEL DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;CONTRACEPTION/REPRODUCTION;DEPRESSION","18;14;13;10;9;8;8;8;8;6;6;5;5;3;2;2;1;1;1;1","CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;CONGENITAL;ORAL AND GASTROINTESTINAL","8;6;5;2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY","10;7;3;2;1;1","CLINICAL;BIOMEDICAL","18;4","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","17;7;1","LUNG CANCER;NOT SITE-SPECIFIC CANCER","8;1",NA,NA
"IRCCS_BURLOGAROFOLO",2022,364,12.8956043956044,2.9532967032967,0.357142857142857,0.447802197802198,0.513736263736264,3.52459016393443,1.54761904761905,2.71666666666667,1.7,0.769230769230769,16,131,82,40,6,0.36,0.23,0.11,0.02,7.09,0.79461843737365,5.19442832269297,0.335164835164835,0.895604395604396,0.574,0.476,0.5,0.531,"EGIDIO BARBI;ILARIA MARIANI;GIORGIO COZZI;GIUSEPPE RICCI;LORENZO MONASTA;MARZIA LAZZERINI;MATTEO BRAMUZZO;TAMARA STAMPALIJA;EMANUELLE PESSA VALENTE;BENEDETTA COVI;SÉRGIO CROVELLA;ANDREA TADDIO;ALESSANDRO AMADDEO;PAOLO GASPARINI;LUCA RONFANI;FEDERICO ROMANO;FLAVIO FALETRA;GIANLUCA TORNESE;LUISA ZUPIN;MANUELA GIANGRECO","68;31;29;24;23;20;19;19;18;17;17;15;14;14;13;12;12;11;11;11","EGIDIO BARBI;GIORGIO COZZI;ILARIA MARIANI;ANDREA TROMBETTA;GIUSEPPE RICCI;GIANLUCA TORNESE;MATTEO BRAMUZZO;SÉRGIO CROVELLA;IRENE BERTI;LORENZO MONASTA;GIULIA GORTANI;MARZIA LAZZERINI;ANDREA TADDIO;LAURA DE NARDI;EMANUELLE PESSA VALENTE;ANTIMO TESSITORE;BENEDETTA COVI;ALESSANDRO AMADDEO;LUISA ZUPIN;SERENA PASTORE","11.36;5.03;3.37;3.34;3.22;2.66;2.47;2.47;2.36;2.3;2.23;2;1.97;1.9;1.85;1.78;1.77;1.77;1.75;1.74","EGIDIO BARBI;ILARIA MARIANI;GIORGIO COZZI;GIUSEPPE RICCI;LORENZO MONASTA;MARZIA LAZZERINI;MATTEO BRAMUZZO;TAMARA STAMPALIJA;EMANUELLE PESSA VALENTE;BENEDETTA COVI;ANDREA TADDIO;ALESSANDRO AMADDEO;PAOLO GASPARINI;LUCA RONFANI;FEDERICO ROMANO;FLAVIO FALETRA;GIANLUCA TORNESE;LUISA ZUPIN;MANUELA GIANGRECO;GUGLIELMO STABILE","68;31;29;24;23;20;19;19;18;17;15;14;14;13;12;12;11;11;11;10","EGIDIO BARBI;GIORGIO COZZI;ILARIA MARIANI;ANDREA TROMBETTA;GIUSEPPE RICCI;GIANLUCA TORNESE;MATTEO BRAMUZZO;IRENE BERTI;LORENZO MONASTA;GIULIA GORTANI;MARZIA LAZZERINI;ANDREA TADDIO;LAURA DE NARDI;EMANUELLE PESSA VALENTE;ANTIMO TESSITORE;BENEDETTA COVI;ALESSANDRO AMADDEO;LUISA ZUPIN;SERENA PASTORE;ALBERTO TOMMASINI","11.36;5.03;3.37;3.34;3.22;2.66;2.47;2.36;2.3;2.23;2;1.97;1.9;1.85;1.78;1.77;1.77;1.75;1.74;1.58","MARIA PINA CONCAS;EULALIA CATAMO;ARCHIE CAMPBELL;CHRISTIAN FUCHSBERGER;JENNIFER A. BRODY;MASSIMILIANO COCCA;XIUQING GUO;ALESSANDRA CHESI;ALESSANDRO DELITALA;ALEXANDER DIETL;ALIKI‐ELENI FARMAKI;ALIREZA ANI;AMY MOORE;ANDERS U. ELIASEN;ANETTE P. GJESING;ANUJ GOEL;ARIF B. EKICI;AYŞE DEMIRKAN;BRIAN E. CADE;CAROLINA MEDINA‐GÓMEZ","507;420;416;416;416;416;416;393;393;393;393;393;393;393;393;393;393;393;393;393","MARIA PINA CONCAS;EULALIA CATAMO;MASSIMILIANO COCCA;LORENZO MONASTA;ILARIA MARIANI;LUCA RONFANI;MARZIA LAZZERINI;EGIDIO BARBI;EMANUELLE PESSA VALENTE;BENEDETTA COVI;BENEDETTA ARMOCIDA;GIUSEPPE RICCI;MANOLA COMAR;PAOLO GASPARINI;LUCIA DE ZEN;PAOLA MAURA TRICARICO;F. BUONOMO;GIUSEPPINA CAMPISCIANO;MANUELA GIANGRECO;GIANLUCA TORNESE","507;420;416;305;275;223;200;189;184;183;174;139;132;112;108;103;99;98;96;94","EGIDIO BARBI;ILARIA MARIANI;GIORGIO COZZI;LORENZO MONASTA;GIUSEPPE RICCI;MARZIA LAZZERINI;MATTEO BRAMUZZO;TAMARA STAMPALIJA;EMANUELLE PESSA VALENTE;BENEDETTA COVI;ALESSANDRO AMADDEO;ANDREA TADDIO;LUCA RONFANI;PAOLO GASPARINI;FEDERICO ROMANO;FLAVIO FALETRA;GIANLUCA TORNESE;LUISA ZUPIN;MANUELA GIANGRECO;GUGLIELMO STABILE","64;31;29;23;21;20;19;18;18;17;14;14;13;12;12;12;11;11;11;10","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;SOCIOLOGY;MATHEMATICS;COMPUTER SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;ECONOMICS;MATERIALS SCIENCE;BUSINESS;ENGINEERING;GEOGRAPHY;ART;GEOLOGY;ENVIRONMENTAL SCIENCE;HISTORY","338;154;39;35;31;30;19;18;18;18;10;9;8;7;7;6;3;2;2","INTERNAL MEDICINE;GENETICS;PEDIATRICS;PATHOLOGY;SURGERY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PSYCHIATRY;OBSTETRICS;BIOCHEMISTRY;DEMOGRAPHY;FAMILY MEDICINE;RADIOLOGY;NURSING;VIROLOGY;GASTROENTEROLOGY;DERMATOLOGY;LAW;BIOINFORMATICS;OPTICS;PHYSICAL THERAPY","208;106;93;85;79;51;45;37;35;29;29;29;29;28;27;25;19;18;17;17;17","DISEASE;GENE;PREGNANCY;POPULATION;CANCER;COHORT;RETROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;OUTBREAK;INCIDENCE (GEOMETRY);EMERGENCY DEPARTMENT;HEALTH CARE;PROSPECTIVE COHORT STUDY;LOGISTIC REGRESSION;ANTIBODY;IN VITRO;VIRUS;GIRL;MAGNETIC RESONANCE IMAGING;MULTIVARIATE ANALYSIS","87;51;50;41;28;27;25;17;16;15;14;13;13;12;11;11;11;10;10;10","INFECTIOUS DISEASE (MEDICAL SPECIALTY);FETUS;PHENOTYPE;2019-20 CORONAVIRUS OUTBREAK;CHILDBIRTH;GENOTYPE;INFLAMMATORY BOWEL DISEASE;MUTATION;CROHN'S DISEASE;GESTATION;COLORECTAL CANCER;OSTEOARTHRITIS;HIDRADENITIS SUPPURATIVA;ENDOMETRIAL CANCER;GENOME;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;OVARIAN CANCER;BURDEN OF DISEASE;COPOLYMER;CRONBACH'S ALPHA;GENE EXPRESSION;HEART RATE;PROTOCOL (SCIENCE);PSORIATIC ARTHRITIS;TYPE 1 DIABETES;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;VERO CELL","47;19;15;14;13;12;12;12;9;8;7;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;SINGLE-NUCLEOTIDE POLYMORPHISM;PLACENTA;ACRYLAMIDE;KRAS;PROBAND;UNICOMPARTMENTAL KNEE ARTHROPLASTY;GENETIC HETEROGENEITY;INTRAUTERINE GROWTH RESTRICTION;MICROVESICLES;OXFORD KNEE SCORE;TRANSCRIPTOME;UTERINE ARTERY;ABSOLUTE NEUTROPHIL COUNT;ANTI-NUCLEAR ANTIBODY;BRADYCARDIA;CALPROTECTIN;COLONOSCOPY;CONGENITAL NEUTROPENIA;COPY-NUMBER VARIATION;FETAL GROWTH;FRAMESHIFT MUTATION;GENOTYPING;GLOMERULOPATHY;GROWTH HORMONE DEFICIENCY;HYPOALLERGENIC;INFLAMMATORY BOWEL DISEASES;ORAL IMMUNOTHERAPY;PRENATAL DIAGNOSIS;YEARS OF POTENTIAL LIFE LOST","47;11;9;7;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;COVID-19;CHILD;PREGNANCY;INFANT, NEWBORN;RETROSPECTIVE STUDIES;MALE;PANDEMICS;ADOLESCENT;INFANT;ITALY;SARS-COV-2;ADULT;PROSPECTIVE STUDIES;PLACENTA;CHILD, PRESCHOOL;PHENOTYPE;ULTRASONOGRAPHY, PRENATAL","192;170;83;69;65;43;31;31;30;25;24;21;19;18;17;15;13;11;11;11","MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;TREATMENT AND PATHOGENESIS OF HIDRADENITIS SUPPURATIVA;IMPACT OF COVID-19 INFECTION ON PREGNANCY OUTCOMES;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;FORMATION AND HEALTH EFFECTS OF ACRYLAMIDE IN FOOD;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;CORONAVIRUS DISEASE 2019 RESEARCH;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPILEPSY AND SEIZURES","13;11;8;7;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3","PANDEMIC;CHILDBIRTH EXPERIENCE;2019-20 CORONAVIRUS OUTBREAK;GIRL;FETAL GROWTH RESTRICTION;HIDRADENITIS SUPPURATIVA;DIAGNOSIS;TREATMENT;CROSS-SECTIONAL STUDY;EXOME;FETAL DNA ANALYSIS;FETAL MRI;FETAL PROGRAMMING;GENOME-WIDE ASSOCIATION STUDY;KNEE BIOMECHANICS;PATHOGENESIS;SINGLE CENTER;TASTE RECEPTORS;TROPHOBLAST;ACRYLAMIDE","32;15;14;10;7;7;6;6;5;5;5;5;5;5;5;5;5;5;5;4","COVID- PANDEMIC;HIDRADENITIS SUPPURATIVA;SCPCOVIDSCP PANDEMIC;SCPIMAGINE EUROSCP;CROHNS DISEASE;EUROSCP STUDY;GROWTH RESTRICTION;NEWBORN CARE;COHORT STUDY;EUROPEAN REGION;KNEE ARTHROPLASTY;MULTICENTER STUDY;PANDEMIC RESULTS;COVID- VACCINATION;EMERGENCY DEPARTMENT;ENDOMETRIAL CANCER;FETAL GROWTH;MAGNETIC RESONANCE;MENTAL HEALTH;PEDIATRIC PATIENTS;PEDIATRIC POPULATION;SARS-COV- INFECTION;TYPE DIABETES;UNICOMPARTMENTAL KNEE;CROSS-SECTIONAL STUDY;CYSTIC FIBROSIS;DRUG MONITORING;EXOME SEQUENCING;GLOBAL BURDEN;GROWTH HORMONE","9;7;7;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","COVID- PANDEMIC;ΜGG CREATININE;MEDIAN AGE;SIGNIFICANT DIFFERENCES;CHILD HEALTH;GROWTH RESTRICTION;PEDIATRIC PATIENTS;BURLO GAROFOLO;FETAL GROWTH;LOGISTIC REGRESSION;MENTAL HEALTH;NEWBORN CARE;RETROSPECTIVE STUDY;SARS-COV- INFECTION;CLINICAL FEATURES;QUALITY MEASURES;B- ΜGG;COHORT STUDY;CREATININE CI;RISK FACTORS;TRIESTE ITALYSEARCH;EMERGENCY DEPARTMENT;EUROPEAN COUNTRIES;IRCCS BURLO;LATEONSET FGR;CARE QMNC;DALY RATES;EXCLUSIVE BREASTFEEDING;HEALTH IRCCS;IL- IL-","30;28;20;18;17;17;17;16;16;16;16;16;16;16;15;15;14;14;14;14;14;13;13;13;13;12;12;12;12;12",175,0.48,8,7,1,2,0,2,0,1,1.25,8,1.5,0,6,0,1,1,3,4,3,0,0,21,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,2.91,143,4.2,1,0.08,11.75,0,0,1,0,1,0,1,9,0,5,6,0,0,0,0,0,0,11,1,0,11,1,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;4203 HEALTH SERVICES AND SYSTEMS;3203 DENTISTRY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;36 CREATIVE ARTS AND WRITING;3603 MUSIC;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;46 INFORMATION AND COMPUTING SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","9;4;3;2;2;1;1;1;1;1;1;1;1;1;1","PEDIATRIC;CLINICAL RESEARCH;AUTOIMMUNE DISEASE;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;PATIENT SAFETY;PEDIATRIC CANCER;DIGESTIVE DISEASES;NEUROSCIENCES;PAIN RESEARCH;PREVENTION;STEM CELL RESEARCH;TRANSPLANTATION;ARTHRITIS;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BRAIN DISORDERS","10;8;5;4;3;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;GENERIC HEALTH RELEVANCE;INFECTION;MENTAL HEALTH;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","3;1;1;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;5.1 PHARMACEUTICALS;8.3 POLICY, ETHICS, AND RESEARCH GOVERNANCE","5;2;2;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;KIDNEY CANCER","3;2;1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","3;3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,60,"SPRINGER NATURE;FRONTIERS;PUBLIC LIBRARY OF SCIENCE;KARGER PUBLISHERS;TAYLOR & FRANCIS GROUP;APOLLO;SCIELO JOURNALS","28;14;12;2;2;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;4206 PUBLIC HEALTH;4905 STATISTICS;3208 MEDICAL PHYSIOLOGY;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3207 MEDICAL MICROBIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS;46 INFORMATION AND COMPUTING SCIENCES;48 LAW AND LEGAL STUDIES;4805 LEGAL SYSTEMS;51 PHYSICAL SCIENCES","67;41;33;12;7;5;3;3;3;2;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;GENETICS;PEDIATRIC;HUMAN GENOME;BRAIN DISORDERS;CONTRACEPTION/REPRODUCTION;PATIENT SAFETY;RARE DISEASES;CARDIOVASCULAR;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EMERGING INFECTIOUS DISEASES;HEART DISEASE;HEMATOLOGY;INFANT MORTALITY;INFECTIOUS DISEASES;NEUROSCIENCES;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREVENTION;AGING;ARTHRITIS","14;9;9;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1","CARDIOVASCULAR;INFECTION;METABOLIC AND ENDOCRINE;NEUROLOGICAL;REPRODUCTIVE HEALTH AND CHILDBIRTH;MENTAL HEALTH;STROKE","2;2;2;2;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;6.4 SURGERY;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","13;2;2;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","9;7;4","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","13;6;4","LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER","2;1","3 GOOD HEALTH AND WELL BEING","2"
"IRCCS_BURLOGAROFOLO",2023,278,14.0251798561151,2.86690647482014,0.334532374100719,0.384892086330935,0.410071942446043,2.77162629757785,1.27397260273973,1.74193548387097,1.5,0.694244604316547,15,99,60,33,7,0.36,0.22,0.12,0.03,3.6,0.821502613905328,5.0303867403315,0.356115107913669,0.902877697841727,0.559,0.477,0.472,0.493,"EGIDIO BARBI;GIUSEPPE RICCI;MATTEO BRAMUZZO;CHIARA AGOSTINIS;ROBERTA BULLA;GIORGIO COZZI;ALESSANDRO AMADDEO;GIORGIA GIROTTO;GIANLUCA TORNESE;MANUELA GIANGRECO;ALESSANDRO MANGOGNA;TAMARA STAMPALIJA;NATALIA MAXIMOVA;LUCA RONFANI;ANDREA TADDIO;SÉRGIO CROVELLA;DAVIDE ZANON;ANDREA BALDUIT;GIULIA ZAMAGNI;GABRIELLA ZITO","41;21;18;15;14;13;12;12;12;12;12;11;11;10;10;10;10;10;9;9","EGIDIO BARBI;GIANLUCA TORNESE;LAURA DE NARDI;ALBERTO TOMMASINI;GIUSEPPE RICCI;CHIARA AGOSTINIS;ROBERTA BULLA;GIORGIO COZZI;SIMONE BENVENUTO;ALESSANDRO ZAGO;GRAZIA DI LEO;NATALIA MAXIMOVA;ANDREA BALLABEN;MATTEO BRAMUZZO;DAVIDE ZANON;ALESSANDRO AMADDEO;ALESSANDRO MANGOGNA;ANDREA TADDIO;GUGLIELMO STABILE;MANUELA GIANGRECO","5.81;2.85;2.07;1.99;1.96;1.89;1.79;1.71;1.64;1.5;1.49;1.46;1.45;1.42;1.35;1.25;1.24;1.23;1.2;1.15","EGIDIO BARBI;GIUSEPPE RICCI;MATTEO BRAMUZZO;CHIARA AGOSTINIS;GIORGIO COZZI;ALESSANDRO AMADDEO;GIORGIA GIROTTO;GIANLUCA TORNESE;MANUELA GIANGRECO;ALESSANDRO MANGOGNA;TAMARA STAMPALIJA;NATALIA MAXIMOVA;LUCA RONFANI;ANDREA TADDIO;SÉRGIO CROVELLA;DAVIDE ZANON;ANDREA BALDUIT;GIULIA ZAMAGNI;GABRIELLA ZITO;ALBERTO TOMMASINI","41;21;18;15;13;12;12;12;12;12;11;11;10;10;10;10;10;9;9;9","EGIDIO BARBI;GIANLUCA TORNESE;LAURA DE NARDI;ALBERTO TOMMASINI;GIUSEPPE RICCI;CHIARA AGOSTINIS;GIORGIO COZZI;SIMONE BENVENUTO;ALESSANDRO ZAGO;GRAZIA DI LEO;NATALIA MAXIMOVA;ANDREA BALLABEN;MATTEO BRAMUZZO;DAVIDE ZANON;ALESSANDRO AMADDEO;ALESSANDRO MANGOGNA;ANDREA TADDIO;GUGLIELMO STABILE;MANUELA GIANGRECO;IRENE MALNI","5.81;2.85;2.07;1.99;1.96;1.89;1.71;1.64;1.5;1.49;1.46;1.45;1.42;1.35;1.25;1.24;1.23;1.2;1.15;1.14","MARCO RABUSIN;MARIA ANTONIETTA DE IORIS;FRANCO LOCATELLI;ANGELA MASTRONUZZI;ANNALISA SERRA;BIAGIO DE ANGELIS;CONCETTA QUINTARELLI;DARIA PAGLIARA;F BONETTI;FEDERICA GALAVERNA;FRANCESCA DEL BUFALO;GIADA DEL BALDO;GIOVANNA LEONE;GIOVANNA STEFANIA COLAFATI;GIUSEPPINA LI PIRA;IGNAZIO CARUANA;KATIA PERRUCCIO;LAURA IAFFALDANO;MARIA CARMEN GARGANESE;MARIA FELICIA VILLANI","243;236;234;232;232;232;232;232;232;232;232;232;232;232;232;232;232;232;232;232","MARCO RABUSIN;EGIDIO BARBI;ILARIA FANTASIA;MARCO PENNESI;MANOLA COMAR;GIUSEPPE RICCI;MANUELA GIANGRECO;MATTEO BRAMUZZO;ANNA MORGAN;CHIARA AGOSTINIS;ANDREA TADDIO;JENNY BUA;ALESSANDRO AMADDEO;FRANCESCO DE SETA;GIORGIA GIROTTO;MARIA PINA CONCAS;GIANLUCA TORNESE;PAOLO GASPARINI;GIORGIO COZZI;FLAVIO FALETRA","242;138;67;53;46;45;42;40;36;35;32;32;31;31;31;31;29;29;28;26","EGIDIO BARBI;GIUSEPPE RICCI;MATTEO BRAMUZZO;CHIARA AGOSTINIS;GIORGIO COZZI;MANUELA GIANGRECO;ALESSANDRO MANGOGNA;ALESSANDRO AMADDEO;GIANLUCA TORNESE;TAMARA STAMPALIJA;NATALIA MAXIMOVA;LUCA RONFANI;DAVIDE ZANON;GIORGIA GIROTTO;ALBERTO TOMMASINI;MARIA PINA CONCAS;ANDREA TADDIO;GABRIELLA ZITO;ANDREA BALDUIT;GIULIA ZAMAGNI","39;20;18;15;13;12;12;12;12;11;11;10;10;9;9;9;9;9;8;8","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;MATERIALS SCIENCE;PHILOSOPHY;ENGINEERING;BUSINESS;GEOGRAPHY;GEOLOGY;ART;ENVIRONMENTAL SCIENCE;HISTORY","241;115;41;31;25;21;16;14;14;12;8;8;6;4;3;3;2;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;PATHOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;ENDOCRINOLOGY;GASTROENTEROLOGY;NURSING;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;FAMILY MEDICINE;OPTICS;CANCER RESEARCH;NEUROSCIENCE;OBSTETRICS;MICROBIOLOGY;PHYSICAL THERAPY","147;88;69;54;53;44;30;28;24;24;22;21;20;19;16;15;15;15;14;14","DISEASE;GENE;PREGNANCY;POPULATION;CANCER;COHORT;RETROSPECTIVE COHORT STUDY;INCIDENCE (GEOMETRY);ADVERSE EFFECT;CONFIDENCE INTERVAL;RECEPTOR;DIABETES MELLITUS;IMMUNE SYSTEM;ANTIBODY;HEALTH CARE;LOGISTIC REGRESSION;TRANSPLANTATION;ANTIBIOTICS;BACTERIA;COGNITION;EMERGENCY DEPARTMENT;INTERQUARTILE RANGE;QUALITY OF LIFE (HEALTHCARE)","70;51;33;27;20;20;18;11;10;10;10;9;9;8;8;8;8;7;7;7;7;7;7","INFECTIOUS DISEASE (MEDICAL SPECIALTY);FETUS;PHENOTYPE;INFLAMMATORY BOWEL DISEASE;MUTATION;GENOTYPE;GESTATION;ULCERATIVE COLITIS;GESTATIONAL AGE;2019-20 CORONAVIRUS OUTBREAK;HEMATOPOIETIC STEM CELL TRANSPLANTATION;AUTISM SPECTRUM DISORDER;COMPLEMENT SYSTEM;TYPE 1 DIABETES;COLORECTAL CANCER;CROHN'S DISEASE;DYSBIOSIS;GENE EXPRESSION;GRAFT-VERSUS-HOST DISEASE;INFLIXIMAB;NEUROBLASTOMA","21;15;14;11;11;9;8;8;7;6;6;5;5;5;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;SINGLE-NUCLEOTIDE POLYMORPHISM;PLACENTA;COMPLEMENTATION;MISSENSE MUTATION;PRENATAL DIAGNOSIS;CALPROTECTIN;CENTRAL PRECOCIOUS PUBERTY;HAPLOINSUFFICIENCY;PENETRANCE;PROCTITIS;UNICOMPARTMENTAL KNEE ARTHROPLASTY;BONE MARROW FAILURE;COLONOSCOPY;DEFIBROTIDE;DNA METHYLATION;FANCONI ANEMIA;GENETIC HETEROGENEITY;HAPLOTYPE;HYPERTRIGLYCERIDEMIA;KRAS;LOSS FUNCTION;PROBAND;RNA SPLICING;STROKE VOLUME;TELEHEALTH;THIOPURINE METHYLTRANSFERASE;USTEKINUMAB;VEDOLIZUMAB","21;6;6;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;CHILD;FEMALE;COVID-19;RETROSPECTIVE STUDIES;PREGNANCY;MALE;INFANT, NEWBORN;ITALY;ADOLESCENT;INFANT;ADULT;CROSS-SECTIONAL STUDIES;INFLAMMATORY BOWEL DISEASES;PANDEMICS;CHILD, PRESCHOOL;MUTATION;QUALITY OF LIFE;SURVEYS AND QUESTIONNAIRES","141;137;59;57;27;25;24;23;16;16;14;14;13;11;11;11;10;10;10;9","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEMATOPOIETIC STEM CELL BIOLOGY;NEUROBLASTOMA RESEARCH AND TREATMENT;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IMPACT OF COVID-19 INFECTION ON PREGNANCY OUTCOMES;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;DIVERSITY AND FUNCTION OF GUT MICROBIOME;EPIDEMIOLOGY AND MANAGEMENT OF NEONATAL SEPSIS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLOBAL MATERNAL AND CHILD HEALTH OUTCOMES;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;MORTALITY AND SEQUELAE OF PRETERM BIRTH;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;PROJECTIONS AND OUTCOMES OF ARTHROPLASTY SURGERY IN THE US;TREATMENT AND PATHOGENESIS OF HIDRADENITIS SUPPURATIVA;ANESTHESIA AND SEDATION MANAGEMENT;ANKYLOGLOSSIA AND ITS IMPACT ON BREASTFEEDING AND SPEECH","9;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2","PANDEMIC;INTERQUARTILE RANGE;2019-20 CORONAVIRUS OUTBREAK;NEUROBLASTOMA;BREASTFEEDING SUPPORT;DIABETES;GRAFT-VERSUS-HOST DISEASE;SINGLE CENTER;COMPLEMENT (MUSIC);CONCORDANCE;CONTINUOUS GLUCOSE MONITORING;CROSS-SECTIONAL STUDY;DISCONTINUATION;DYSBIOSIS;FETAL DNA ANALYSIS;GENOME-WIDE ASSOCIATION STUDY;GIRL;HIDRADENITIS SUPPURATIVA;JUVENILE IDIOPATHIC ARTHRITIS;OBESITY-ASSOCIATED MICROBIOME","14;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","BOWEL DISEASE;INFLAMMATORY BOWEL;IBD PORTO;COVID- PANDEMIC;ACUTE LYMPHOBLASTIC;AUTISM SPECTRUM;CLINICAL TRIAL;COHORT STUDY;HIDRADENITIS SUPPURATIVA;KNEE ARTHROPLASTY;LYMPHOBLASTIC LEUKEMIA;MULTICENTER STUDY;SPECTRUM DISORDER;COMPLEMENT COMPONENT;COMPONENT CQ;DISEASE INCIDENCE;EMERGENCY DEPARTMENT;EMERGENCY LAPAROTOMY;GROWTH RESTRICTION;HEMATOPOIETIC STEM;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;MULTICENTRE STUDY;OBSERVATIONAL STUDY;ONSET INFLAMMATORY;PAEDIATRIC IBD;PARKINSONS DISEASE;PEDIATRIC IBD;PILOT STUDY;PRIMARY SCLEROSING","7;7;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CREATINE KINASE;PEDIATRIC PATIENTS;VACCINE MRNA;GESTATIONAL AGE;COVID- PANDEMIC;RETROSPECTIVE STUDY;CHILD HEALTH;MEDIAN AGE;BIRTH WEIGHT;SOCIAL MEDIA;RHGH THERAPY;RISK FACTORS;ACTIVE DISEASE;EMERGENCY LAPAROTOMY;LOGISTIC REGRESSION;PREGNANT WOMEN;PUBMED SCOPUS;REFERENCE RANGES;RS RS;ADVERSE EVENTS;BURLO GAROFOLO;CLINICAL REMISSION;COHORT STUDY;EXCLUSIVE BREASTFEEDING;GRAFT-VERSUS-HOST DISEASE;INTERQUARTILE RANGE;IRCCS BURLO;KINASE LEVELS;MENTAL HEALTH;MUSCULAR DISEASE","20;16;16;14;13;13;12;12;11;11;10;10;9;9;9;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8",115,0.41,4.6,6,1.25,2.25,0,47.5,0,1,0,7.5,1.75,1,6,1,0,1,2,4,4,0,0,11,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,3,155.62,2.93,0,0,16.25,0,0,1,0,1,0,0,6,0,3,5,0,0,0,0,0,0,6,2,0,8,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3215 REPRODUCTIVE MEDICINE;3202 CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;2;2;1;1;1;1;1;1;1;1","PEDIATRIC;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;CARDIOVASCULAR;CHRONIC PAIN;HEART DISEASE;HEMATOLOGY;NEUROSCIENCES;PAIN RESEARCH;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BIOMEDICAL IMAGING;BRAIN DISORDERS;CONTRACEPTION/REPRODUCTION;DEPRESSION;DRUG ABUSE (NIDA ONLY);GENETICS;HYPERTENSION;INFANT MORTALITY","6;5;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","REPRODUCTIVE HEALTH AND CHILDBIRTH;CARDIOVASCULAR;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;NEUROLOGICAL","3;2;1;1;1;1","6.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES","3;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE","12;6","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3212 OPHTHALMOLOGY AND OPTOMETRY;3202 CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;42 HEALTH SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;49 MATHEMATICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;36 CREATIVE ARTS AND WRITING;3602 CREATIVE AND PROFESSIONAL WRITING;44 HUMAN SOCIETY;4403 DEMOGRAPHY;4608 HUMAN-CENTRED COMPUTING;47 LANGUAGE, COMMUNICATION AND CULTURE;4703 LANGUAGE STUDIES","25;14;6;5;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","GENETICS;BIOTECHNOLOGY;HUMAN GENOME;EYE DISEASE AND DISORDERS OF VISION;NEUROSCIENCES;CLINICAL RESEARCH;CANCER;HEMATOLOGY;PATIENT SAFETY;PREVENTION;RARE DISEASES;BIOENGINEERING;LYMPHOMA;NANOTECHNOLOGY;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;VACCINE RELATED","8;7;6;5;5;4;2;2;2;2;2;1;1;1;1;1;1;1","EYE;CANCER;GENERIC HEALTH RELEVANCE","5;2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;2.4 SURVEILLANCE AND DISTRIBUTION","2;2;1;1;1","BIOMEDICAL;HEALTH SERVICES & SYSTEMS;CLINICAL","8;2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","3;2","LUNG CANCER;NON-HODGKIN'S LYMPHOMA","1;1",NA,NA
"IRCCS_BURLOGAROFOLO",2024,268,14.0485074626866,2.7910447761194,0.33955223880597,0.391791044776119,0.369402985074627,2.55670103092783,1.18181818181818,1.92592592592593,1.19277108433735,0.619402985074627,15,108,39,29,13,0.4,0.15,0.11,0.05,0.56,0.589547101910146,4.22424242424242,0.369402985074627,0.895522388059702,0.509,0.465,0.473,0.519,"EGIDIO BARBI;MARZIA LAZZERINI;GIUSEPPE RICCI;LORENZO MONASTA;MATTEO BRAMUZZO;TAMARA STAMPALIJA;GIANLUCA TORNESE;GIULIA ZAMAGNI;ALESSANDRO AMADDEO;ENRICO FELICI;EMANUELLE PESSA VALENTE;GIORGIO COZZI;LUCA RONFANI;ILARIA MARIANI;LUCA SCARALLO;MARTINA FRANZIN;ALBERTO TOMMASINI;NATALIA MAXIMOVA;MARIA PINA CONCAS;PAOLO DALENA","31;20;17;16;15;14;13;12;11;10;10;10;9;9;9;8;8;8;8;7","EGIDIO BARBI;GIANLUCA TORNESE;TAMARA STAMPALIJA;LORENZO MONASTA;GIUSEPPE RICCI;GIORGIO COZZI;MARZIA LAZZERINI;ALESSANDRO AMADDEO;GIULIA ZAMAGNI;FRANCESCA BURLO;MARCO SUTERA;MARTINA D’AGOSTIN;MARTINA FRANZIN;MATTEO BRAMUZZO;MARIA PINA CONCAS;NATALIA MAXIMOVA;MARIA ANDREA LANZETTA;ELETTRA ZULIANI;BEATRICE BELLUZZI;DANIELE FRACAS","3.8;2.51;1.97;1.94;1.76;1.63;1.55;1.48;1.39;1.29;1.17;1.14;1.09;1.03;1.03;1.01;1;1;1;1","EGIDIO BARBI;MARZIA LAZZERINI;GIUSEPPE RICCI;LORENZO MONASTA;MATTEO BRAMUZZO;TAMARA STAMPALIJA;GIANLUCA TORNESE;GIULIA ZAMAGNI;ALESSANDRO AMADDEO;EMANUELLE PESSA VALENTE;GIORGIO COZZI;LUCA RONFANI;ILARIA MARIANI;MARTINA FRANZIN;ALBERTO TOMMASINI;NATALIA MAXIMOVA;MARIA PINA CONCAS;PAOLO DALENA;ERICA VALENCIC;GIORGIA GIROTTO","31;20;17;16;15;14;13;12;11;10;10;9;9;8;8;8;8;7;7;7","EGIDIO BARBI;GIANLUCA TORNESE;TAMARA STAMPALIJA;LORENZO MONASTA;GIUSEPPE RICCI;GIORGIO COZZI;MARZIA LAZZERINI;ALESSANDRO AMADDEO;GIULIA ZAMAGNI;FRANCESCA BURLO;MARCO SUTERA;MARTINA D’AGOSTIN;MARTINA FRANZIN;MATTEO BRAMUZZO;MARIA PINA CONCAS;NATALIA MAXIMOVA;MARIA ANDREA LANZETTA;ELETTRA ZULIANI;BEATRICE BELLUZZI;DANIELE FRACAS","3.8;2.51;1.97;1.94;1.76;1.63;1.55;1.48;1.39;1.29;1.17;1.14;1.09;1.03;1.03;1.01;1;1;1;1","EGIDIO BARBI;MARZIA LAZZERINI;PAOLO DALENA;ENRICO FELICI;HERMANN BRENNER;SILVIA BRESSAN;SILVIA FASOLI;VALENTINA BALTAG;ILARIA MARIANI;RICCARDO LUBRANO;ALBERTO TOMMASINI;ALESSANDRO AIUTI;DAVIDE MONTIN;FEDERICO MARCHETTI;LUCIA LEONARDI;MARCO RABUSIN;MARTA MINUTE;RAFFAELE BADOLATO;ALESSANDRO AMADDEO;ANGELA TROISI","31;25;21;13;13;13;13;13;12;12;11;11;10;10;10;10;10;10;9;9","EGIDIO BARBI;MARZIA LAZZERINI;PAOLO DALENA;ILARIA MARIANI;ALBERTO TOMMASINI;MARCO RABUSIN;ALESSANDRO AMADDEO;GIORGIA GIROTTO;LAURA TRAVAN;LORENZO MONASTA;MARIA PINA CONCAS;JENNY BUA;MADDALENA ERMACORA;MARTINA GIRARDELLI;MATTEO BRAMUZZO;SABRINA PLET;URSULA MANZON;MARTINA FRANZIN;TAMARA STAMPALIJA;GIANLUCA TORNESE","28;25;21;12;10;10;9;9;9;9;9;8;8;8;8;8;8;6;6;5","EGIDIO BARBI;MARZIA LAZZERINI;LORENZO MONASTA;MATTEO BRAMUZZO;TAMARA STAMPALIJA;GIUSEPPE RICCI;GIULIA ZAMAGNI;ALESSANDRO AMADDEO;GIANLUCA TORNESE;EMANUELLE PESSA VALENTE;LUCA RONFANI;GIORGIO COZZI;ILARIA MARIANI;MARCO RABUSIN;MARIA PINA CONCAS;NATALIA MAXIMOVA;EVA ORZAN;MARTINA FRANZIN;ALBERTO TOMMASINI;ERICA VALENCIC","29;20;16;15;14;14;12;11;11;10;9;9;9;8;8;8;8;8;7;7","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHILOSOPHY;CHEMISTRY;SOCIOLOGY;PHYSICS;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;ART;BUSINESS;GEOGRAPHY;ENGINEERING;HISTORY;MATERIALS SCIENCE","222;100;39;35;24;23;23;19;17;13;11;6;6;5;3;2;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;PATHOLOGY;ENVIRONMENTAL HEALTH;SURGERY;IMMUNOLOGY;PSYCHIATRY;FAMILY MEDICINE;INTENSIVE CARE MEDICINE;NURSING;OBSTETRICS;BIOCHEMISTRY;ENDOCRINOLOGY;DEMOGRAPHY;RADIOLOGY;VIROLOGY;CARDIOLOGY;CANCER RESEARCH;CELL BIOLOGY;ECONOMIC GROWTH;GASTROENTEROLOGY;GYNECOLOGY;NEUROSCIENCE;PHARMACOLOGY","124;68;57;39;33;30;29;25;24;24;22;22;20;18;16;16;15;13;12;12;12;12;12;12;12","DISEASE;GENE;PREGNANCY;CANCER;COHORT;HEALTH CARE;RETROSPECTIVE COHORT STUDY;POPULATION;EPIDEMIOLOGY;TRANSPLANTATION;QUALITY (PHILOSOPHY);COHORT STUDY;DIABETES MELLITUS;INCIDENCE (GEOMETRY);BACTERIA;OUTBREAK;BREASTFEEDING;CONTEXT (ARCHAEOLOGY);IN VITRO;PSYCHOLOGICAL INTERVENTION","48;35;29;21;19;14;14;13;12;11;10;9;9;9;8;8;7;7;7;7","INFECTIOUS DISEASE (MEDICAL SPECIALTY);FETUS;INFLAMMATORY BOWEL DISEASE;2019-20 CORONAVIRUS OUTBREAK;GENOTYPE;ALLELE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;OVARIAN CANCER;TYPE 2 DIABETES;BRONCHIOLITIS;CHROMOSOME;DISEASE BURDEN;GESTATION;PHENOTYPE;TYPE 1 DIABETES;AUTISM SPECTRUM DISORDER;BIOFILM;BURDEN OF DISEASE;COMPLEMENT SYSTEM;DOWNREGULATION AND UPREGULATION;EX VIVO;GENE EXPRESSION;LUNG TRANSPLANTATION;MULTICENTER STUDY;OVERWEIGHT;PROTOCOL (SCIENCE);SINGLETON;UBIQUITIN","18;12;12;7;7;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);INFLAMMATORY BOWEL DISEASES;SINGLE-NUCLEOTIDE POLYMORPHISM;FETAL GROWTH;GENOME INSTABILITY;GROWTH RESTRICTION;HEMATOPOIETIC CELL;LACTOBACILLUS PLANTARUM;LONG NON-CODING RNA;MISSENSE MUTATION;PLACENTA;SMALL FOR GESTATIONAL AGE;TRANSCRIPTOME;UBIQUITIN LIGASE;ADENOSINE DEAMINASE DEFICIENCY;ALLELE FREQUENCY;ALTERNATIVE COMPLEMENT PATHWAY;AMNIOTIC FLUID;AMP DEAMINASE;BACTERIAL CAPSULE;BREAKPOINT;BROMELAIN;BRONCHIOLITIS OBLITERANS;CANAKINUMAB;CARDIAC RESYNCHRONIZATION THERAPY;CENTRAL PRECOCIOUS PUBERTY;CERVICAL DILATATION;CERVICAL DILATION;CERVICAL LYMPH NODES;CHILD ABUSE;CHORIOAMNIONITIS;CLASSICAL COMPLEMENT PATHWAY;COMPLEMENT FACTOR I;COMPOUND HETEROZYGOSITY;CONDITIONING REGIMEN;CONTINUOUS GLUCOSE MONITORING;CONTROLLED OVARIAN HYPERSTIMULATION;COPY-NUMBER VARIATION;CXCL10;DEUBIQUITINATING ENZYME;DIGITAL POLYMERASE CHAIN REACTION;DISABILITY-ADJUSTED LIFE YEAR;DNA METHYLATION;DRIVING UNDER THE INFLUENCE;DYSKINESIA;EDINBURGH POSTNATAL DEPRESSION SCALE;ENDOMYSIUM;FEBUXOSTAT;FLUORESCENCE IN SITU HYBRIDIZATION;GANCICLOVIR;GESTATIONAL DIABETES;GLUCOSE HOMEOSTASIS;GONADOTROPIN-RELEASING HORMONE;HAPLOTYPE;HEMORRHAGIC CYSTITIS;IMPAIRED GLUCOSE TOLERANCE;INDUCED PLURIPOTENT STEM CELL;IVACAFTOR;IΚBΑ;KARYOTYPE;KLEBSIELLA PNEUMONIAE;KNEE PAIN;KRAS;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS REUTERI;LACTOBACILLUS RHAMNOSUS;LOSS FUNCTION;LYMPHEDEMA;MALE INFERTILITY;MATERNAL HEALTH;MERKEL CELL POLYOMAVIRUS;MMP2;MONOCLONAL;NINTEDANIB;OOCYTE DONATION;PEMBROLIZUMAB;PENICILLIN ALLERGY;PERVASIVE DEVELOPMENTAL DISORDER;PRENATAL DIAGNOSIS;PRETERM DELIVERY;PRIMARY CILIARY DYSKINESIA;PUSTULOSIS;QUANTITATIVE PROTEOMICS;QUORUM SENSING;RADICAL HYSTERECTOMY;REPLICON;RIBOSOME;SEMEN ANALYSIS;SHORT QT SYNDROME;STACHYOSE;TELEHEALTH;TERM PREGNANCY;THIRD TRIMESTER;TRANSLATION (BIOLOGY);TWIN PREGNANCY;UNDERWEIGHT;UNICOMPARTMENTAL KNEE ARTHROPLASTY;USTEKINUMAB;VEDOLIZUMAB;VISCERAL PAIN;YEARS OF POTENTIAL LIFE LOST;ZINC FINGER","18;6;4;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;ITALY;CHILD, PRESCHOOL;ADULT;INFANT;RETROSPECTIVE STUDIES;SURVEYS AND QUESTIONNAIRES;MIDDLE AGED;PREGNANCY;SARS-COV-2;COVID-19;CROSS-SECTIONAL STUDIES;YOUNG ADULT;AGED;INFANT, NEWBORN","160;107;74;55;53;34;32;28;25;22;16;15;13;10;10;9;9;9;8;8","PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;PEDIATRIC CANCER AND QUALITY OF LIFE;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;SWEETENERS' TASTE AND IMPACT ON HEALTH;ANESTHESIA AND SEDATION MANAGEMENT;EDUCATION AND PEDAGOGY RESEARCH;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;FORENSIC TOXICOLOGY METHODS AND ANALYSIS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;MOLECULAR MECHANISMS OF CARDIAC ARRHYTHMIAS;ACQUISITION AND DEVELOPMENT OF SIGN LANGUAGE;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;BIOLOGICAL PROPERTIES OF GARLIC AND ITS COMPOUNDS;CORONAVIRUS DISEASE 2019 RESEARCH;DETERMINANTS OF HEALTH CARE EXPENDITURE AND LONGEVITY","11;7;6;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2","PANDEMIC;DIABETES;;2019-20 CORONAVIRUS OUTBREAK;BREASTFEEDING PROMOTION;BREASTFEEDING SUPPORT;FETAL GROWTH RESTRICTION;INFLAMMATORY BOWEL DISEASES;TYPE 1 DIABETES;BREASTFEEDING;DIAGNOSIS;FETAL PROGRAMMING;PEDIATRIC PAIN;CHILDBIRTH EXPERIENCE;CONTINUOUS GLUCOSE MONITORING;CROSS-SECTIONAL STUDY;GENOME-WIDE ASSOCIATION STUDY;HEMATOPOIETIC CELL TRANSPLANTATION;PRENATAL DIAGNOSIS;BRONCHIOLITIS","11;8;7;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;3","INFLAMMATORY BOWEL;ITALIAN SOCIETY;IMAGINE EURO;MULTICENTRE STUDY;BOWEL DISEASE;COVID- PANDEMIC;TYPE DIABETES;NEWBORN CARE;STEM CELL;CELL TRANSPLANTATION;MULTICENTER STUDY;PEDIATRIC INFLAMMATORY;ASSESS QUALITY;BOWEL DISEASES;CELL TRANSPLANT;COHORT STUDY;DISEASE STUDY;EURO STUDY;EUROPEAN COUNTRIES;FETAL GROWTH;FOETAL GROWTH;GLOBAL BURDEN;GROWTH RESTRICTION;GROWTH VELOCITY;HEARING LOSS;HEMATOPOIETIC STEM;INTENSIVE CARE;OVARIAN CANCER;RETROSPECTIVE STUDY;RISK FACTORS","9;9;7;7;6;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PEDIATRIC PATIENTS;COVID- PANDEMIC;MEDIAN AGE;WRITING REVIEW;CONCURRENT HYPONATREMIA;FOOD LIKING;ITALIAN SOCIETY;SARS-COV- INFECTION;CLINICAL PRACTICE;RISK FACTORS;CELIAC DISEASE;INFLAMMATORY BOWEL;PRECOCIOUS PUBERTY;RETROSPECTIVE STUDY;BOWEL DISEASE;CONCEPTUALIZATION SUPERVISION;EPITHELIAL CELLS;GENE EXPRESSION;HEMATOPOIETIC STEM;ITALIAN PEDIATRIC;LEARNING CURVE;MITRAL VALVE;QUALITY MEASURES;RSV INFECTION;STEM CELL;STUDY INCLUDED;ACID BACTERIA;ADVERSE EVENTS;CARE QOC;CELL TRANSPLANTATION","19;12;12;12;11;10;10;10;9;9;8;8;8;8;7;7;7;7;7;7;7;7;7;7;7;7;6;6;6;6",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,607,0.36,0,0,22,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Austria;Canada;Ireland","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3213 PAEDIATRICS","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC","1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"FRONTIERS;TAYLOR & FRANCIS GROUP","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;47 LANGUAGE, COMMUNICATION AND CULTURE;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4704 LINGUISTICS;4203 HEALTH SERVICES AND SYSTEMS","7;6;4;3;3;3;1","CLINICAL RESEARCH;PEDIATRIC;PREVENTION;ASSISTIVE TECHNOLOGY;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;REHABILITATION;AUTOIMMUNE DISEASE;CANCER;DIABETES;HEMATOLOGY","4;4;4;3;3;3;3;1;1;1;1","EAR;METABOLIC AND ENDOCRINE","3;1",NA,NA,"CLINICAL","4","CLINICAL MEDICINE AND SCIENCE","4","LEUKEMIA / LEUKAEMIA","1",NA,NA
